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ABSTRACT OF THE DISSERTATION
Mutations in the Chaperone Hsp104 Differentially Propagate Yeast Prions
by
Jennifer Elizabeth Dulle
Doctor of Philosophy in Biology and Biomedical Sciences
(Molecular Cell Biology)
Washington University in St. Louis, 2013
Professor Heather L. True, Chairperson

Molecular chaperones are critical elements of the protein quality control network and are
responsible for protecting cells from protein misfolding and aggregation. In yeast, molecular
chaperones also participate in the propagation of self-replicating, protein-only elements called
prions. The AAA+ ATPase Hsp104 is a disaggregase essential for yeast prion maintenance
and is responsible for fragmentation of prions to generate the transmissible prion propagons.
This work focuses on further understanding the role of Hsp104 in prion propagation and protein
aggregate resolubilization. To do this, I first identified novel mutations in Hsp104 which altered
[PSI+] propagation and characterized their effects on Hsp104 function, protein disaggregation,
and prion variant propagation. One mutant propagated a phenotypically undetectable [PSI+]
phenotype that resulted from soluble oligomers of Sup35. I discovered that soluble, more SDSsensitive oligomers of Sup35 were sufficient to transmit the prion state but were not capable of
producing the nonsense suppression phenotype associated with Sup35 aggregation in the
[PSI+] state. I found that these oligomers are also present in wild type [PSI+] cells and can be
distinguished from the large Sup35 aggregates and still transmit the prion conformation.
Next, I characterized another set of mutations that are located in a less well-understood
domain of Hsp104. I used these mutations to elucidate the function of the middle domain in
prion maintenance and its affect on the biochemical activities of Hsp104. I found that this
viii

domain mediates the disaggregation and ATPase activities of Hsp104 and has differential
effects on the propagation of specific prion variants. I hypothesize that the regulation of Hsp104
function by the middle domain plays a significant role in the selective amplification of specific
conformational variants.
Finally, I investigated the affect that changes in Hsp104 activity have on prion variant
propagation and protein disaggregation. I utilized two novel mutations which significantly
decreased the activity of Hsp104 to examine the requirements of two individual yeast prions,
[PSI+] and [RNQ+], for Hsp104. I found that propagation of both prions was altered when the
activity of Hsp104 was significantly decreased, although specific conformational variants of each
could be maintained. I hypothesize that structural variants of yeast prions require varying
amounts of Hsp104 activity for optimal propagation.
These experiments elucidate how alterations in the activity of the molecular chaperone
Hsp104 affect remodeling of prions and specific prion conformational variants as well as
amorphous aggregates. As an essential chaperone in yeast prion propagation, characterizing
the disaggregation mechanism of Hsp104 is important for understanding the mechanism of
amyloid aggregation and thus, has broad implications for both functional and disease-related
amyloid models.

ix

Chapter 1: Background and Significance

1

1.1 Overview: Protein Aggregation
Efficient and accurate protein folding is essential for cell function and viability. All proteins possess
the inherent ability to aggregate often resulting in loss-of-function, which in many cases can lead to
1-3

disease by disrupting normal cellular homeostasis.

One broad class of protein conformational disorders

involves the deposition of protein into insoluble and highly-structured fibrillar protein aggregates, called
4, 5

amyloid.

Amyloid deposition is associated with multiple, severe physically and mentally debilitating

neurodegenerative diseases. The mechanisms underlying the amyloid deposition associated with these
diseases are still mostly unclear despite intense investigation.
There are three characterized pathways by which protein conformational disorders develop.
Inherited, familial genetic mutations often enhance the likelihood of protein aggregation and thus disease
progression.

6-9

Alternatively, the majority of protein conformational disorders arise sporadically with age

as the greatest risk factor. One possibility for the strong correlation of protein conformational disorders
with age is decreased function of the protein quality control networks, specifically molecular chaperones,
which regulate and protect the cells from protein misfolding and aggregation. However, the mechanisms
behind sporadic amyloid aggregation as well as the effect of age on the proteostatic cellular pathways are
not well understood. The third known pathway is by infection. Prion diseases are a specific class of
amyloid-associated protein conformational disorders, which are capable of being transmitted between
species, as evidenced by the transmission of bovine spongiform encephalopathy (or Mad Cow disease)
to humans in the late 1990’s. This mode of amyloidosis development is extremely rare, but study of prion
infection across species has led to significant advances in understanding the underlying mechanism of
transmission.
Interestingly, recent data have demonstrated that several non-disease related proteins are capable of
2, 10-18

converting into amyloid-like fibrils.
generic property of polypeptides.

19

These data led to the hypothesis that amyloid fiber formation is a

Furthermore, several examples of functional amyloid that play a role

in normal protein and cellular function have been identified in a variety of organisms, including bacteria,
fungi, insects, and even humans.

20

The identification of functional amyloid suggests that this protein fold

is evolutionarily conserved, and as such, investigation of the regulation of amyloid species by molecular

2

chaperones in lower organisms may provide insight into the role of the protein quality control network in
the mechanism of aggregation of both functional and disease-related amyloid in higher eukaryotes.
In this chapter, I will focus on protein aggregation and its regulation by the protein quality control
network, specifically molecular chaperones. First, I will examine the characteristic features of amyloid
aggregates and discuss the role of amyloid as both a disease-associated and a functional protein
conformation. I will describe what is known about the mechanisms behind amyloid formation, including
the formation of oligomeric intermediates and their proposed role in disease pathology. I will also discuss
conformational variation in amyloid structures and how this impacts both the function and toxicity
associated with these amyloid structures. Next, I will examine the structure and propagation of yeast
prions, specifically the [PSI+] and [RNQ+] prions, and their proposed functional roles in the cell. I will
characterize how conformational variation of these prions affects both their function and their interaction
with molecular chaperones, of which Hsp104 will be the focus. Subsequently, I will discuss the function
of the molecular chaperone Hsp104 by first analyzing each distinct domain of Hsp104 and remarking on
how they cooperate as a functional unit. I will then discuss the role of Hsp104 in yeast prion propagation
and how its interaction with yeast prions differs from its other substrates. Additionally, I will discuss how
other molecular chaperones cooperate with Hsp104 to both promote prion propagation as well as efficient
resolution of stress-related protein aggregation. Finally, I will examine how Hsp104 has been utilized in
studying mammalian protein conformational disorders.

1.2 Amyloid Structure, Mechanism, and Significance
Amyloid is generally defined as a fibrous quaternary protein structure composed of
intermolecularly hydrogen-bonded β-sheets.

21

These β-sheets laterally associate to form fibers that

range from 5 to 15 nm in diameter. Investigation of these amyloid fibers by X-ray diffraction revealed a
22, 23

characteristic pattern of the backbone and side chains called a “cross-β” structure.

This pattern is

reflective of β-sheets oriented parallel to the fibril axis while their extended peptide strands are aligned
perpendicularly to the fibril axis. This “cross-β” structure soon came to be recognized as a hallmark of
amyloid structure. Additionally, amyloid fibers are typically long, unbranched structures formed from the
entwinement of several smaller fibers, which results in a twisted or helical ultrastructural appearance.

3

Amyloid fibers also bind the dye congo red and display fluorescence when bound to the dye thioflavin T.

24

These properties are common to all amyloid structures despite significant variation in the primary
sequence of the amyloidogenic proteins themselves.

25

These properties, unfortunately, also make

investigation of amyloid structures challenging. Amyloid fibers are generally too large to be studied
efficiently using X-ray crystallography or nuclear magnetic resonance (NMR). However, short peptides
from amyloidogenic proteins can fold into the “cross-β” structure allowing characterization by
26

crystallography and NMR.

Both electron microscopy (EM) and atomic force microscopy have been

useful in revealing the higher-order assembly properties of amyloid fibers. In addition, several methods
have been used to elucidate the amyloid-forming regions of the protein including hydrogen-deuterium
exchange (H-D exchange), solid-state NMR (ssNMR), and mutagenesis and conjugation of probes to
specific residues.

27, 28

Within the amyloid fold itself, variation exists in the orientation of β-strands, which comprise what
is called the amyloid core. The core β-strands orient in two common forms within the β-sheet, parallel
and antiparallel, with the former being the most prevalent. Parallel β-sheets can be further described by
the alignment of the amino acids between the strands. For example, parallel, in-register β-sheets are
composed of identical residues on different strands aligned in-register - each residue is adjacent to the
29

identical residue on the neighboring strand – to promote hydrogen bonding between these residues.

Moreover, the columns of hydrogen bonds in a β-sheet are characterized as a polar zipper, hydrogen
bonds between the side chain and main chain amides, and increase stability of the sheets, adding to the
overall strength and stability of the fiber. Parallel β-sheets can also be out-of-register or pseudo-register,
though these structures are much less common than the parallel in-register.

30

Another type of amyloid fold that is different from the parallel or anti-parallel orientations is the βsolenoid structure.

31

In these fibers, a single polypeptide strand forms the first layer then loops back

around to form the second layer as well. Since the same polypeptide strand forms two or more layers,
these strands cannot be in-register as the residues on the first strand will not contact the same residues
on the neighboring strand.

31

These β-solenoid structures can be pseudo-in-register though, provided the

neighboring β-strands share a high degree of sequence similarity.

4

Additionally, the tight packing between β-sheets plays an integral role in the strength and stability
of the amyloid fold. The orientation of these sheets promotes interdigitation of the side chains, such that
even water is excluded from these interfaces.

26

The close packing and interdigitation of the neighboring

β-sheets is called a “steric zipper” for its ultrastructural appearance as well as its exclusion of water
molecules.

26

These “pair-of-sheets” units, as they are termed, are then able to wind around each other to

form the fibrous structure. One hypothesis suggests that these “pair-of-sheets” units are the minimal
structures needed for further propagation and conversion of monomer to the amyloid conformation.
Thus, amyloid fibers are highly structured and stable aggregates; they are significantly different
than unstructured and amorphous aggregates that result from general protein misfolding. Fibers from
amyloidogenic proteins are resistant to proteolysis and denaturation by detergents. Additionally, amyloid
fibers act as a template for the conversion of monomer from a folded or disordered form to a β-sheet rich
structure capable of extending the amyloid fiber.

Disease-Associated Amyloid
Several age-related neurodegenerative disorders are associated with the progressive
accumulation of amyloid fibers. Alzheimer’s disease, the best known and the most prevalent, is
characterized by the extracellular deposition of a proteolytic fragment of the Amyloid Precursor Protein
32

(APP).

This fragment, called Aβ, is secreted by the cell to the extracellular space via the endocytic

pathway where it then forms amyloid plaques. The amyloid formation of Aβ results in widespread
neuronal dysfunction and cell death. Another protein shown to play a role in the pathology of Alzheimer’s
disease is the microtubule-associated protein tau. Aggregated tau is the main constituent of the
neurofibrillary tangles present in the cytoplasm of neurons and in diseased tissues. Aggregated tau is
commonly present in several other neurodegenerative disorders.

33

Nine different neurodegenerative disorders are associated with proteins containing expanded
polyglutamine (polyQ) tracts (homopolymeric amino acid sequences) including Huntington’s disease and
34

several spinocerebellar ataxias.

PolyQ proteins aggregate when the length of the polyQ tract crosses a

critical threshold, resulting in destabilization of the folded protein and amyloid formation.

35

Aggregates of

polyQ proteins occur both in the nucleus and the cytoplasm. Interestingly, glutamine-rich polypeptide

5

domains (25% or more glutamine residues) and polyQ tracts are often identified in transcription factors
and proteins that play roles in DNA and RNA processing.
Another well-studied amyloidogenic protein is the membrane-bound prion protein (PrP). The
mammalian prion diseases such as Creutzfeldt-Jacob disease in humans, scrapie in sheep, and chronic
wasting disease (CWD) in deer and elk, are characterized by the accumulation and aggregation of PrP on
the cell surface. More detail will be provided for mammalian prions in a later chapter.
Several lines of evidence suggest that amyloid aggregates, or amyloid precursors, have a
5

clinically significant role in disease pathogenesis. Multiple hypotheses exist as to how amyloid deposits
may contribute to disease pathology. Initially, the amyloid aggregates themselves were proposed to be
the cause of disease through a toxic gain-of-function.

36

However, this hypothesis is challenged by the

observation of amyloid fibers in the brains of healthy individuals as well as the lack of correlative evidence
between the presence of amyloid aggregates and disease severity.

36

Another more recent hypothesis

suggests that the toxic species are actually intermediates formed during the aggregation process. As a
result, this hypothesis proposes that the amyloid aggregates may be benign or even, perhaps, protective
as a strategy to sequester the toxic species. Toxic oligomers of several amyloidogenic proteins can be
formed in vitro and shown to cause cellular toxicity and disease pathology when introduced into cell and
animal models. Whether these two hypotheses are mutually exclusive or both contribute to disease
progression remains to be seen.

Functional Amyloids
In addition to amyloids associated with degenerative diseases, several functional amyloids have
20

been characterized in bacteria, fungi, insects, and now in humans.

Several of these functional amyloids

have been studied by EM, Congo red and thioflavin T binding, and X-ray diffraction and show similar
structural patterns to the disease-related amyloids described above.

37-39

Bacteria employ several

structural amyloids, such as curli and the chaplins, to establish a bio-matrix that enables surface adhesion
40, 41

and colony formation, respectively.

Fungi also express structural amyloid called hydrophobins that

assemble at the air-water interface and provide stabilization for aerial growth of hyphae for spore
formation.

42

In addition, hydrophobins also provide adherence to the surface of host organisms, thereby

6

facilitating pathogenesis. One final example of a structural amyloid is the chorion proteins, which are
present in fish and insect eggshells and protect the developing larvae from harm by stabilizing the
eggshell structure.

20

Thus, proteins from several different organisms that function in structural roles often

adopt amyloid folds to provide rigid and stable structures for efficient functioning.
Not all functional amyloids are involved in structural roles; the amyloid prions in fungi are known
to facilitate phenotypic variation through the method of protein-only inheritance in a non-Mendelian
manner. The yeast prions formed from the aggregation of the proteins Sup35 and Rnq1 in
Saccharomyces cerevisiae are especially directed towards this role and are discussed in depth in the
next section.

43

The HET-s prion in the fungus Podospora anserina regulates heterokaryon (multi-

nucleated cell) formation important for mating and vegetative growth.
HET-s prion has been identified as the β-solenoid structure.

31

44

Additionally, the structure of the

Non-disease related amyloids have also

been proposed to exist in higher eukaryotes. In sea slugs, the cytoplasmic polyadenylation element
binding protein (CPEB) may also utilize an amyloid fold to regulate synaptic changes important for
learning and memory.

45

Additionally, in humans, the structural protein Pmel17 forms amyloid fibers that

act as a scaffold for melanin deposition in the melanosome.

46

Thus, amyloids have been shown to play

roles in several biological processes, which only underscore the importance of understanding the
mechanisms of amyloid formation and function.

Mechanism of Amyloid Formation
In order for amyloid to form, proteins must first go through the thermodyhamically unfavorable
process of unfolding to increase exposure of amyloid-forming segments.

47

Also, because of the highly

structured and bonded nature of the amyloid cores, several molecules need to come together to form a
27, 48-51

stable nucleating structure capable of further propagation, in a process called nucleation.

For these

reasons, nucleation is a rare event. However, conditions that promote exposure of these regions such as
denaturing conditions, high temperatures, or high protein concentrations often enhance amyloid
formation.

52

In addition, interaction with polyanions, lipids, or proteoglycans can also promote amyloid

fiber formation.

53-58

These amyloid conformers then nucleate the amyloid aggregate by converting

unfolded molecules to the amyloid form, thereby polymerizing into amyloid aggregates. The strongest

7

evidence in favor of the nucleated conformational conversion model is that addition of pre-formed amyloid
fibers to amyloid protein monomer accelerates fiber formation, essentially by eliminating the nucleation
step. This has been demonstrated both in vitro with recombinant protein and in vivo when recombinant
fibers can be introduced into cell and mouse models to induce disease pathology and progression.
Following nucleation, addition of new protein molecules occurs rapidly.

60

57, 59

Several hypotheses

exist for how the growing fiber polymerizes and what the identity of the added unit is. The pre-eminent
hypothesis suggests that fiber polymerization occurs by monomer addition to the ends of fibers.

61

In this

model, the fiber, which has adopted the stable β-sheet rich fold, binds to monomer that has exposed
amyloid-forming segments and templates these destabilized regions to β-sheets. Another hypothesis
suggests that monomer do not template from amyloid aggregates directly, but form oligomeric
intermediates which then polymerize to amyloid fibers. Oligomeric intermediates in the process of
amyloid formation have been described for several amyloidogenic proteins. On the other hand, these
oligomers may not be true intermediates of amyloid formation but may instead assemble as a result of offpathway protein-protein interactions.

62

Although these hypotheses may seem mutually exclusive, recent

data have shown that the same amyloidogenic protein may assemble fibers via multiple pathways.

63

For

example, the human amyloid protein, β2-microglobulin can form two distinct amyloid structures, worm-like
and rod-like, under different conditions at low pH, and that the pathways used to generate these two
fibers are distinct and in direct competition.

64-66

Further examples are observed when the mammalian

prion protein PrP forms amyloid under different conditions. At acidic pH, recombinant PrP assembles into
amyloid oligomers while at neutral pH, recombinant PrP converts into amyloid fibers.

67-70

Interestingly, in the absence of amyloid fibers, the amyloid oligomers of such proteins as Aβ
α-synuclein

73, 74

, polyQ

75, 76

, and PrP

77

71, 72

,

can cause toxicity when introduced into cell and animal models of
78

disease. Amyloid oligomers can encompass a range of sizes and structures , bind the amyloid-binding
79

dyes , and exhibit robust β-sheet structures, similar to the larger amyloid fibers.

80-82

Similar to the

ubiquitous nature of the amyloid fold, amyloid oligomers of several distinct proteins share a common
structure and as such may share a common method of pathogenesis.

83-85

These oligomers, formed in
86

vitro, can nucleate amyloid aggregation and cause disease pathology in disease models.

8

These

findings led to the hypothesis that oligomeric intermediates are the primary toxic species. Consequently,
amyloid fibers may be benign or even protective by sequestering the toxic oligomers.

36, 87-89

1.3 Prions in Mammals and Yeast
Among the amyloid-forming proteins, prions are unique. Prions, or proteinaceous infectious
particles, are infectious amyloid as these aggregated proteins can be transmitted between organisms,
and in some cases, between species. Prions are found in both mammals and yeast, though the protein
determinants of mammalian and yeast prions are not the same. However, mammalian and yeast prions
do share several features, including their amyloid fold structure, the mechanism of formation, and their
ability to exist in several distinct conformations. Unlike mammalian prions, yeast prions are not toxic to
the cell and instead may play a functional role. Given their mechanistic similarities, investigating yeast
prions has proven beneficial to the understanding of mammalian prion propagation, infectivity, and strain
formation.

Mammalian Prions
C

The mammalian prion protein, PrP , is a glycosylphosphatidyl-inositol-linked cell surface protein
expressed mainly in the central nervous system.

90

C

PrP can exist in two states, the soluble PrP state and

the insoluble, protease-resistant aggregate PrP-res.

91

C

The primary structure of the constitutive PrP is

mostly α-helical with the N-terminal domain highly unstructured and containing an octapeptide-repeat
region that contributes to aggregate formation.

92

The aggregated PrP-res is similar to other amyloids,

being highly β-sheet rich and able to bind congo red and thioflavin T.

93

Recombinant PrP can form

amyloid fibers under acidic conditions, perhaps alluding to conditions in the lysosome which might
catalyze PrP aggregation as it travels through the secretory pathway. Interestingly, aggregated
recombinant PrP or PrP-res isolated from the brains of infected animals can be used to nucleate PrP

C

aggregation in an uninfected animal.
Prion populations that differ in their phenotypic or physiochemical properties are known as prion
strains. Prion strains were first characterized by differences their incubation time and neuropathology.

94

Prion strains have been identified in scrapie-infected sheep and goats, cattle, and humans. Differences

9

in prion strains can be characterized by differences in proteinase K sensitivity and cleavage pattern,
stability toward denaturing agents, and glycosylation pattern.

94

Indeed, prion strains resistant to one drug

but not another could “evolve” to be resistant to the second drug suggesting that a heterogeneous
population of prion conformations simultaneously exists or prion conformations are not necessarily
irreversible and can continue to change.

95

1.32 Yeast Prions
Similar to the mammalian prion protein, some proteins in yeast can exist both in their soluble form
and in a self-propagating aggregate called a yeast prion.

96, 97

The characterized prions in yeast are not

toxic, but, instead, are epigenetically inherited, self-replicating, protein-only modes of information transfer
96

(Figure 1.1).

Prions exist in several species of yeast and are

10

Figure 1.1 Yeast prions are inherited epigenetically. Mating a [PRION+] haploid to a [prion-] haploid
results in [PRION+] diploids. The aggregated prion proteins in the [PRION+] haploid template the
monomeric prion proteins in the [prion-] haploid, resulting in aggregated prion proteins in the diploid.
These aggregates are then cytoplasmically inherited by all four haploid progeny following meiosis. Thus,
prion inheritance is an epigenetic, non-Mendelian mechanism.
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thought to be evolutionarily conserved.

98, 99

Although each prion is formed from a distinct determinant
100-103

protein, heterologous interactions between the prions have been demonstrated.

Yeast prions share several characteristics that are used as criteria when identifying a new yeast
prion. One is that yeast prions are reversibly curable.

104

Reversible curability means that colonies can

switch back and forth between the [prion-] and [PRION+] states in the absence of an associated genetic
change. Secondly, yeast prions can be induced by overexpressing the protein determinant of that
prion.

104

Finally, prion formation of a protein mimics a null mutation of that protein.

104

In that regard,

aggregation of yeast prion proteins acts as a molecular switch to turn off and on the function of that
protein. Additionally, prion proteins are composed of modular domains, one of which is the prion-forming
domain. This domain is required for prion formation and propagation and is separable from the domain
required for protein function.

105, 106

Yeast prions also share structural and mechanistic characteristics with disease-related amyloids
despite vast difference in protein primary sequence. For instance, structural studies of several yeast
prions suggest that the aggregated form is β-sheet rich and forms amyloid fibers in vitro, similar to PrP,
5

Aβ, polyQ, and other amyloidogenic proteins. Thus, yeast prions have proven valuable as a model
system to understand the effects of cellular and genetic factors on amyloid formation. One key difference
between yeast prions and other amyloids is that yeast prions are maintained and actively propagated.
The mechanism of prion aggregation must generate propagatable species that can be transmitted to
progeny during mitosis. These propagatable species are called propagons and are proposed to be
107, 108

soluble, amyloid oligomers that maintain the prion conformation.

To generate these propagons, the

large amyloid fibers need to be fragmented. The disaggregase chaperone Hsp104 is proposed to
fragment the large prion aggregates and, as such, most of the known yeast prions require Hsp104 for
propagation.

109

In concert with Hsp104, yeast prions are also regulated by various Hsp70 and Hsp40

chaperones. An interesting hypothesis, then, is that environmental factors indirectly regulate prion
propagation via molecular chaperones.
Another interesting phenomenon associated with yeast prions is the ability of the same primary
sequence to adopt multiple prion conformations, known as prion variants.

110, 111

Prion variants are similar

in theory to mammalian prion strains. Prion variants have been described for at least three separate

12

yeast prions and have been shown to be structurally and functionally distinct. Prion variants also respond
to chaperone levels differentially and may be preferentially selected for given a certain set of
environmental or cellular conditions.

[PSI+]
The [PSI+] prion results from the aggregation of the translation termination factor, Sup35.

112-114

Sup35 (eRF3) is a GTPase that interacts with Sup45 (eRF1) to form a translation termination complex to
recognize termination codons during translation.

115, 116

Sup35 is composed of three modular domains
112, 117

termed the N domain, the M domain and the C-terminal domain.

The C-terminal domain contains

the GTPase domain, is mostly α-helical, and alone, is sufficient to provide the essential function of
Sup35.

112, 116

The N domain of Sup35 constitutes the prion-forming domain of Sup35.

112, 118

The N

domain contains a glutamine and asparagine (Q/N) rich region encompassing residues 1-40, which is
crucial for nucleation of Sup35 aggregates, though some studies suggest that the sequence is less
important than the amino acid composition of the domain.

119-121

This suggests that proteins with Q/N rich

regions, regardless of sequence similarity, might also form amyloid.

121-123

Residues 41-97 of the N

domain are composed of 5 and a half repeating units of the peptide (P/QQGGYQQ/SYN) which resemble
124

the five “octarepeat” sequences (PHGGGWGQ) present in the amino terminus of PrP.
125, 126

replacement of these repeats destabilizes or eliminates [PSI+].
127

and confers stability and structure to the N domain.

Truncation or

The M domain is highly charged,

Structural studies suggest that while the C-

terminus of Sup35 is folded, the N-terminus is unstructured allowing it to better adopt the prion
conformation.

128

Recombinant Sup35, like other amyloid proteins, can form amyloid fibers in vitro.

129

Both the

PFD of Sup35, Sup35NM, and full-length Sup35 form fibers that are resistant to SDS, bind thioflavin T,
and can be seeded by the addition of preformed fibers supporting a nucleated conformational conversion
129, 130

model.

Analysis of Sup35 peptides suggests that these amyloid fibers are composed of parallel β-

sheets. Additionally, amyloid fibers of recombinant Sup35 can be introduced into [psi-] cells to generate
[PSI+] cells.

131

Hence, amyloid fibers formed from recombinant Sup35 are infectious and can provide

insight into the characteristics of infectious amyloid species.

13

The [PSI+] prion is important to study not only for its structural implications, but also because of
the unique function and phenotype it confers in cells. Since the [PSI+] prion is composed of Sup35, the
132

function of the translation termination complex is intimately connected to the presence of [PSI+].

When

cells are [psi-], Sup35 is monomeric and functional in efficient translation termination. On the other hand,
when cells are phenotypically [PSI+], Sup35 is aggregated and unable to fully interact with Sup45 causing
an increase in nonsense suppression. Increased nonsense suppression occurring in the presence of
[PSI+] can result in translation of normally silent regions of the genome.

133

[PSI+] cells have been shown

to have an advantage over [psi-] cells while growing in certain conditions, presumably because the [PSI+]
state offers variation through increased nonsense suppression.

134

This advantage is a fine balance

though, as overexpression of Sup35 in [PSI+] cells leads to toxicity because the increase in Sup35
aggregation sequesters Sup45 resulting in significant defects in translation termination.

135

Thus, the

[PSI+] prion may be beneficial for cell adaptability and survival, but regulation of the prion phenotype is
integral to preventing toxic gain-of-function.
Both intragenic and extragenic factors regulate Sup35 aggregation in vivo. Mutations in the PFD
can destabilize or inhibit [PSI+] while some mutations or truncations have no effect. Additionally, the
propagation of [PSI+] is regulated by chaperones, specifically, Hsp104.
is cured when Hsp104 is deleted.

109

109

As with all yeast prions, [PSI+]

Uniquely, [PSI+] is the only prion that is also cured by the

overexpression of Hsp104 suggesting that [PSI+] is extremely sensitive to changes in Hsp104 activity or
expression.
Variants of [PSI+] were initially identified based on their functional and phenotypic differences.
Two variants of [PSI+] have previously been described that display distinct levels of nonsense
suppression. Strong variants of [PSI+] are so named because they display high levels of nonsense
suppression which correlates with a very low amount of soluble Sup35.

110

On the other hand, weak

variants of [PSI+] exhibit less nonsense suppression correlative with an increased pool of soluble Sup35
136

(Figure 1.2).

When cells carrying strong and weak variants of [PSI+] are mated, the progeny are strong

[PSI+] suggesting that strong variants of [PSI+] out-compete weak variants for the available monomer
pool and thus propagate more efficiently.

137

Additionally, amyloid fibers formed in vitro have provided

valuable insight about the structural characteristics of prion variants. Several studies have shown that
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varying the temperature at which amyloid is assembled affects the conformation of the fiber formed as
well as the resulting [PSI+] phenotype when introduced into [psi-] cells.

138

Structural variants of Sup35

that contain a short amyloid core (~40amino acids) display faster kinetics of aggregation, are less
thermostable, and generate mostly strong [PSI+] variants when transformed into [psi-] cells.

138

Sup35

structural variants that contain a long amyloid core (~70 amino acids) display slower aggregation kinetics,
are highly thermostable, and generate mostly weak variants of [PSI+] when introduced to [psi-] cells.

138

Thus, a hypothesis developed whereby less stable strong variants of [PSI+] are more easily fragmented
and able to template monomer such that strong [PSI+] variants can out-propagate weak [PSI+] variants.
This recent hypothesis is still being investigated, but does suggest that Hsp104 and other chaperones
may play an important role in [PSI+] variant selection and propagation.

[RNQ+]
The [RNQ+] prion is formed from the aggregation of the protein Rnq1 whose monomeric function
in the cell is still unknown.

139

Rnq1, like Sup35, can be divided into modular domains. The N-terminal

domain is folded with function unknown. The C-terminal domain is Q/N rich and is necessary and
sufficient for [RNQ+] formation.

139

Rnq1 was initially identified as a prion candidate by a BLAST search

for Q/N rich proteins that were also able to aggregate in vivo.
on Hsp104 as deletion of Hsp104 cures [RNQ+].
140-142

Sis1.

139

139

Like [PSI+], [RNQ+] is also dependent

[RNQ+] is also dependent on the Hsp40 chaperone

Although the monomeric Rnq1 has no known function, the [RNQ+] prion has a function as

[PIN+] or a “[PSI+] inducible” element.

101

The [PIN+] hypothesis suggests that prions facilitate the

appearance of other prions via heterologous templating.
template monomeric

15

101, 103

Thus, as [PIN+], the [RNQ+] prion can

Figure 1.2 [PSI+] exists in conformationally distinct states. Strong and weak [PSI+] variants are
conformationally distinct and can be distinguished by differing amounts of soluble Sup35. The amount of
nonsense suppression is directly related to the amount of soluble Sup35, resulting in decreased
nonsense suppression associated with weak [PSI+] variants.

16

Sup35 aggregation and induce the [PSI+] phenotype. Interestingly, the [PSI+] prion can also induce the
formation of [RNQ+] as can the [URE3+] prion.

101

Therefore, the [RNQ+] prion is a component of a

complicated and interconnected prion network that is its own regulatory mechanism.
Definitive proof for Rnq1 as a prion protein was demonstrated when recombinant Rnq1 was
shown to form amyloid fibers in vitro and those fibers were capable of inducing [RNQ+] formation when
transformed into [rnq-] cells.

139, 143, 144

In fact, pre-formed fibers of Rnq1 amyloid can seed Rnq1

monomer demonstrating that alter Rnq1 amyloid formation follows the nucleated conformational
conversion model.

139

Similar to Sup35, mutations or truncations of both the PFD and the N-terminal non-

prion domain affect Rnq1 aggregation and regulate [RNQ+] formation.

145, 146

Changes in the amino acid

sequence not only regulate [RNQ+] formation, but also the ability of [RNQ+] to template Sup35.

147, 148

Not only do mutations affect the function of [RNQ+], but changes to the conformation in the
absence of mutations also differentially affect [PSI+] induction. Several variants of [RNQ+] were identified
and characterized by their level of [PSI+] induction. These variants termed low, medium, high, and very
high [RNQ+] for their ability to induce [PSI+] have also been differentiated by their ability to form
fluorescent foci.

101, 137, 149

Two fluorescent patterns were exhibited, multi-dot and single-dot fluorescence.

The low, medium, high, and very high variants of [RNQ+] demonstrated single-dot fluorescence while
multi-dot fluorescence was characteristic of only the high [RNQ+] variant. These variants also display
differences in stability and the amount of soluble Rnq1.

137, 150

1.4 Hsp104, an AAA+ ATPase Chaperone
Hsp104 is a AAA+ ATPase molecular chaperone in Saccharomyces cerevisiae. Hsp104 is a
member of the ClpA/ClpB family of proteins, chaperones that function in protein disaggregation and
151

degradation and is homologous to the bacterial chaperone ClpB.

The heat shock protein Hsp104 is

upregulated in response to stress and mediates protein disaggregation following heat shock.

151, 152

However, the disaggregase Hsp104 does not prevent protein aggregation, nor does it promote proteolysis
of protein aggregates like ClpA.

152

Instead, Hsp104 acts more like Hsp70 in that it modulates

resolubilization of proteins from insoluble aggregates.
109

plays an essential role in prion propagation.

152

Additionally, as already mentioned, Hsp104

All known yeast prions require Hsp104 for propagation.

17

109

The pre-eminent hypothesis for the mechanism of Hsp104 action is that Hsp104 disaggregates the prion
aggregates to generate the propagons for further propagation.

153

In order to perform the disaggregation function, Hsp104 forms a hexamer in response to ATP
154, 155

binding.

The hexameric state of Hsp104 can also be induced by high concentration of Hsp104
154, 155

and high salt concentrations.

155

The structure of Hsp104 was originally modeled off the structure of
156

ClpB determined by X-ray crystallography and cryo-EM (Figure 1.3).

Hsp104 is composed of five

functionally distinct domains including two nucleotide-binding domains (NBD1 and NBD2) connected by a
coiled-coil linker domain and flanked by N-terminal and C-terminal domains. The crystal structure of ClpB
suggested that the hexamer was a three-tiered structure (the N-terminal domain, NBD1, and NBD2) with
the middle domain projecting from the body of the hexamer.
157

middle domain

156

Despite debate over the position of the

, a recent cryo-electron microscopy structure of Hsp104 strongly suggested its
158

placement on the outside of the hexamer.

As an AAA+ ATPase, Hsp104 binds and hydrolyzes ATP to

generate energy for disaggregation but must form a hexamer to do so.
being hydrolyzed by Hsp104 and ADP inhibits ATP hydrolysis.

159

154, 159

Only ATP is capable of

Despite independent functions for each

domain, all of the domains cooperate to ensure synchronization of the hexamer subunits for efficient
disaggregation.

The N-terminal Domain (NTD)
The NTD of ClpB (residues 1-150) is mostly α-helical and highly mobile.

156

Deletion of the NTD

of ClpB was reported to maintain the same level of ATP hydrolysis and disaggregation activity as the full160

length ClpB and was suggested to be unnecessary for ClpB function.

However, additional studies

demonstrated that deletion of the ClpB NTD prevented maximum disaggregation activity, specifically
when co-chaperones were limiting suggesting that the NTD of
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Figure 1.3 Modeling of hexameric Hsp104 from the cryo-EM structure. The cryo-EM model of
Hsp104 (EMDatabank accession number 1630) was used to model the domains of Hsp104. Three tiers
can be observed in this model corresponding to the NTD (green residue), NBD1 (blue residue), and
NBD2 (red residue). The coiled coil linker domain is marked by a purple amino acid, and extends away
from the body of the hexamer. The CTD is marked by a residue colored yellow and sits on the C-terminal
face of Hsp104. This model was kindly provided by Dr. Francis Tsai for elucidation of Hsp104 mutants
characterized in this thesis.
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161

ClpB may provide a site of interaction for co-chaperones and may enhance disaggregation activity.

Furthermore, mutants in the NTD of ClpB that cross-linked the NTD to the body of the hexamer to restrict
mobility of the NTD reduced the disaggregation activity, substrate threading, and substrate-stimulated
ATPase activity.
163

substrates,

162

Several studies have demonstrated interactions between the ClpB NTD and

especially strongly aggregated proteins.

164

Thus, the NTD of ClpB is important for

interacting with both substrates and co-chaperones for efficient protein disaggregation.
In contrast, the role of the NTD in the disaggregation mechanism of Hsp104 is much less clear.
Deletion of the NTD of Hsp104 does not affect prion propagation or thermotolerance.

165, 166

Additionally,

mutations in the NTD or deletion of the NTD can enhance [PSI+] propagation and can compensate for
[PSI+] propagation defects in the presence of a mutant Hsp70.

165

Thus, the NTD of Hsp104 may be

similar to that of ClpB in that it enhances disaggregation activity to ensure prion propagation and is a site
of interaction for Hsp70s. Interestingly, deletion of the NTD does not support elimination of [PSI+] by
excess Hsp104.

165

Moreover, structural studies of Hsp104 suggest that deletion of the NTD results in

expansion of the central channel possibly suggesting that the NTD plays a role in preventing non-specific
polypeptide binding in the channel of Hsp104.

157

Therefore, despite being unnecessary for Hsp104

function, the NTD clearly still plays a role in prion and non-prion substrate disaggregation and may
instead serve as a “backup” to mediate efficient disaggregation.

Nucleotide-binding Domains (NBD1 & NBD2)
As a member of the Hsp100/Clp subfamily of AAA+ ATPases, the energy for the protein
disaggregation mechanism for Hsp104/ClpB is provided by ATP hydrolysis.

167

Hsp104/ClpB has two

NBDs, that in the ring-shaped hexamer, are stacked on top of each other. The ATP hydrolysis
mechanism can be generally described in a few over-simplified steps resulting from numerous studies
examining kinetics of several Hsp104 mutants. Within a single subunit in the Hsp104 hexamer (1) ATP
binds to NBD2 and stabilizes the hexamer (2) generating a conformational change that is propagated
through the middle domain to NBD1 where (3) ATP now binds while (4) ATP is hydrolyzed at NBD2
releasing ADP to (5) reverse the conformational change promoting (6) ATP hydrolysis at NBD1 to
complete the cycle.

168

This cycle is synchronous in the hexameric Hsp104 so that at any one time,
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multiple individual subunits in the hexamer are hydrolyzing ATP.

169, 170

From this general model of the

ATP hydrolysis mechanism, independent functions for each NBD can be recognized. For example, ATP
binding and hydrolysis at NBD2 was thought primarily to promote hexamerization and provide the energy
needed for the conformational change rather than significantly adding to the catalytic energy.
171

binding affinity of NBD2 for ATP is much higher than that of NBD1.

171

Thus, the

Conversely, ATP hydrolysis at

NBD1 provides the majority of the catalytic energy required for disaggregation.
NBDs are very highly conserved and have several distinct domains important for ATP
hydrolysis.

167, 172

The Walker A and Walker B motifs contain residues that directly interact with ATP. The

Walker A motif consists of the consensus sequence GXXXXGK[T/S] (where X is any amino acid) and the
lysine (K) residue in this motif is essential for ATP binding and hydrolysis.

159

In Hsp104, mutation of

these lysines, K218T and K620T, results in loss of ATP binding and hydrolysis at that domain.

159

The

double mutant, K218T/K620T, mimics a deletion of Hsp104. The K218T mutation results in loss of
function at NBD1 without altering the ability to oligomerize while the K620T mutation displays a
corresponding oligomerization defect.
propagation.

109, 151

154

Both of these mutations inhibit thermotolerance and [PSI+]

The Walker B motif also plays a role in ATP binding. The glutamate residue in the

Walker B consensus sequence, hhhhDE where h is a hydrophobic residue, is important for ATP
167, 173

hydrolysis.

Mutation of these residues in Hsp104 (E285Q/A and E687Q/A) does not prevent ATP

binding but inhibits ATP hydrolysis resulting in the commonly called “substrate trap” because substrates
are bound but unable to be released.

173, 174

The E285Q/A mutation is especially interesting because it

displays 300% ATPase activity of wild type supporting the hypothesis that NBD2 is a major contributor to
the catalytic energy.

174

Another conserved set of domains in the NBDs are the sensor 1 and sensor 2 domains. These
domains participate in ATP hydrolysis by interacting with the γ-phosphate of ATP. The sensor 1 domain
contains a highly important polar residue that when mutated, impairs ATP hydrolysis.

167, 171

In Hsp104,

mutation of these polar residues, T317A in NBD1 and N728A in NBD2, both impair ATP hydrolysis and
have been used to study the kinetics of the individual NBDs.

171

Both mutations inhibit [PSI+] propagation

and thermotolerance though N728A displays a more severe effect.

171

Thus, these mutations can impair

ATP hydrolysis without impairing ATP binding. The sensor 2 motif contains a conserved arginine residue
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that is also important for ATP binding and hydrolysis.

167

Mutation of the arginine residue in Hsp104

NBD2, R826M, impairs ATP binding as well as prevent [PSI+] propagation and thermotolerance.

175

Mutations in these two domains highlight the importance of ATP hydrolysis for the function of Hsp104. In
addition to the conserved arginine residue in the sensor 2 domain, another set of conserved arginine
residues are also extremely important for ATP hydrolysis and hexamer formation in response to ATP
binding. These arginine residues known as “arginine fingers” extend from one subunit into the ATP
binding domain of the neighboring subunit and coordinate ATP binding.
residues impairs ATP hydrolysis and hexamer formation.

176

167, 176

Mutation of these arginine

In fact, accurate positioning of the arginine

fingers has been used to validate structural models of Hsp104 as it has been shown that arginine finger
158, 177

residues are essential for ATPase and chaperone activities.

The purpose of ATP hydrolysis is to drive the disaggregation mechanism of Hsp104, and
therefore, both the ATPase activity and disaggregation should be coupled for maximum efficiency.
Several studies have shown that substrate binding is dependent on ATP binding at NBD1 and NBD2
though more strictly regulated by NBD1.

174, 178-180

by ATP hydrolysis, coupling the two cycles.

As expected, then, the release of substrate is triggered

174, 178, 180, 181

This coupling is optimized within the hexamer

such that asymmetry of ATP binding and hydrolysis among the NBDs in the six subunits promotes
continuous substrate binding and processing to prevent substrate release and incomplete
disaggregation.

170, 182

Additionally, substrate binding or interaction stimulates ATP hydrolysis of

Hsp104/ClpB, perhaps to ensure efficient processing of the substrate.

168, 183

To further complicate the

disaggregation mechanism, ATP hydrolysis and substrate binding and release are also coupled to cochaperone interactions which enhance Hsp104/ClpB functions.

166, 184

Thus, regulating substrate binding

and ATP hydrolysis provides optimal disaggregation activity and provides the foundation for threading of
substrates as the primary method of disaggregation.

Substrate Threading: A Mechanism of Disaggregation
The model of the hexameric structure of Hsp104/ClpB displays a narrow channel running through
the center of the hexamer that is open at both the N- and C-terminal faces of the hexamer.
channel is a conserved structural feature among the Clp proteins and Hsp100s.
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172, 185

156-158

This

The use of this

channel in protein disaggregation is most apparent in the disaggregation mechanisms of ClpA and ClpX
which bind to the protease ClpP at the C-terminus to degrade substrate proteins.

185

Translocation of

substrates through the central channel positions the substrate in the protease for degradation.

186, 187

The

application of the threading model to non-degrading chaperones like Hsp104/ClpB was made possible by
the identification of conserved pore loops that did not affect hexamerization or ATP hydrolysis, but
prevented aggregate refolding.

188-190

These channel loops contain the conserved domain sequence

GYVG where the tyrosine residue is specifically important.

190-193

residue in these loops prevents thermotolerance by Hsp104.

Mutation of the conserved tyrosine

192, 193

These loops are deep in the axial

channel and function to bind the substrate and translocate the substrate through the channel through a
series of conformational changes coupled to ATP binding and hydrolysis.

192, 193

The loops in the channel

act like levers, flipping up and down in the channel to move the aggregate down to the next set of leverlike loops.

192, 193

Asymmetrical loop function among the hexamer subunits ensures that the substrate is

constantly engaged in the channel to prevent loss of interaction between the chaperone and substrate.

194

The disaggregation mechanism of threading was further verified for Hsp104 and ClpB when a tripeptide
sequence encoding an interaction domain for ClpP was introduced into the C-terminal domain of Hsp104
173,

and ClpB such that any substrates threaded through the central channel would be degraded by ClpP.
195

These chimeras, termed HAP for Hsp104 and BAP for ClpB, have also been coupled with the

“substrate trap” mutation to identify aggregates that get trapped in ClpP, suggesting that these
173, 195

aggregates are disaggregated by the threading mechanism.

Use of the HAP chimera identified

Sup35 from [PSI+], but not [psi-], cells as a threading substrate of Hsp104. Indeed, mutation of the pore
loops either reduces or inhibits [PSI+] propagation. These data suggest that Hsp104 propagates the
prion by extraction of Sup35 molecules from the aggregate.

The Middle Domain (M-domain)
The M-domain of Hsp104, composed of residues 412-532, is a coiled-coil domain inserted
between NBD1 and NBD2 and is not well conserved among Hsp100/Clp chaperones. In fact, the
196

presence of this domain loosely correlates with a function in protein disaggregation.

Insertion of the

coiled-coil domain into the C-terminal region of NBD1 is often limited to members of the Hsp100 family

23

that function in protein disaggregation. The position of this domain in relation to hexameric Hsp104 is still
unclear as multiple structural models have been proposed which show vastly different placement for this
156, 157

domain.

From the cryo-EM reconstruction of hexameric ClpB, the M-domain was suggested to

project from the body of the hexamer similar to blades in a propeller.

156

Subsequent studies positioned

the M-domain inside the hexamer, intercalated between the NBDs of neighboring subunits and potentially
contacting substrates as they were threaded through the central channel.

157

However, this model also

resulted in the repositioning of the canonical arginine fingers. More recent data examining the role of the
arginine fingers demonstrated that the structure that correlates best with Hsp104 function is one in which
the M-domain is highly mobile and solvent-exposed.

197

Furthermore, examination of M-domain residues

by H/D exchange and cross-linking suggest that the M-domain interacts with NBD1 of the neighboring
subunit by nestling into the body of the hexamer.

198

The model of Hsp104 function, as discussed above, suggests that the M-domain is responsible
for driving hydrolysis at NBD1 through an intrasubunit signal transduction pathway.

168

When peptide

binds to the C-terminal domain, ATP binding and hydrolysis at NBD2 induces a conformational change in
the M-domain resulting in an increase in ATP binding at NBD1.

168

The peptide used for these studies

was lysine-rich, a region proposed to be important for normal Hsp104 substrate recognition. As such,
these data suggest that the M-domain is responsible for coupling substrate binding and ATP hydrolysis.
This mechanism has important implications for disaggregation activity as deletion of the M-domain or
172, 177, 192, 193

specific mutations can abrogate protein disaggregation.

Recent evidence suggested that M-domain cycles between distinct conformational states which
198-200

regulate the function of Hsp104/ClpB.

In the repressed state, the M-domain interacts with the

neighboring NBD1 through electrostatic interactions.

198, 199

Disruption of these interactions is proposed to

cause the M-domain to move away from the body of the hexamer and become accessible to co198, 199, 201

chaperones, though how the conformation switch is governed is still unknown.

Mutations which

prevent this interaction result in Hsp104 hyperactivity and are toxic to cells, especially under stressful
conditions.

198, 199

In contrast, mutations that stabilize the interaction of the M-domain with the neighboring
198, 199

NBD1 repress the function of Hsp104.

Though the mechanism of how the M-domain regulates

24

distinct activities of Hsp104 is still relatively unclear, data have shown that regulating this interaction is
essential not only for Hsp104 function, but also for cell viability.

198, 199, 201

The C-terminal Domain (CTD)
The CTD of Hsp104 is by far the least understood domain of Hsp104. For the Clp chaperones
that couple disaggregation activity with the protease activity of ClpP (ClpA and ClpX), the CTD is the
interface and interaction site for ClpP. The residues that encompass the ClpP binding site (IGF) have
been added to the CTD of Hsp104/ClpB to couple the protease to these chaperones indicating that the
CTD is the “exit” site for disaggregated polypeptides.
substrate binding site.

168

173, 195

However, the CTD has been proposed to be a

Additionally, the Hsp104 CTD contains an acidic motif (IDDDLD) at the extreme

C-terminus, which resembles the C-terminal cofactor binding motifs characteristic of eukaryotic Hsp70
and Hsp90 (VEEVD and MEEVD).

202

Through these domains, Hsp70 and Hsp90 interact with proteins

that contain TPR domains suggesting that the same may be true for Hsp104.
and Hsp90-interacting proteins, Sti1 and Cpr7, bind to the CTD of Hsp104.

203, 204

205-207

To this end, Hsp70-

In addition, deletion of

the CTD abrogates Hsp104/ClpB hexamerization and some mutations can cause defects in
thermotolerance.

160, 202, 208

The Effect of GdHCl
One of the agents that causes conversion of [PSI+] cells to [psi-] is the chaotropic agent,
guanidine hydrochloride (GdHCl).

209

While this effect was first demonstrated with the [PSI+] prion, it was

later shown to be a common property of all yeast prions.

104, 123, 139, 209

As GdHCl cures at only millimolar

concentrations and after only 12-16 generations of cell growth, GdHCl is a potent inhibitor of prion
propagation.

209, 210

Growing [PSI+] cells in media containing GdHCl does not affect existing Sup35

aggregates and does not prevent new Sup35 from joining Sup35 aggregates.

211, 212

However, GdHCl

does prevent the formation of new [PSI+] propagons suggesting that this prion-curing agent may inhibit
fragmentation of Sup35 aggregates. Indeed, GdHCl was shown to specifically inhibit the ATPase activity
of Hsp104.

213-215

A mutation of the NBD1 residue D184 can prevent GdHCl curing of [PSI+] cells

suggesting that GdHCl may act by directly binding and inhibiting Hsp104 activity.

25

214

This mechanism has

recently been further clarified by demonstrating that GdHCl exerts dual effects on Hsp104. First, GdHCl
inhibits Hsp104 by stabilizing the M-domain interaction with the hexamer and preventing efficient Hsp70
interaction.

200

Secondly, GdHCl binding to Hsp104 prevents continuous ATP turnover by local

conformational changes in the GdHCl binding site.

200

On the other hand, there is data that GdHCl affects

[PSI+] independent of Hsp104 suggesting that curing of [PSI+] by GdHCl may occur by several
independent methods and clearly still needs some investigation.

216

Hsp104 is essential for yeast prion propagation
As mentioned previously, most of the known yeast prions are dependent on the function of
Hsp104 as deletion or inhibition of Hsp104 prevents propagation of these yeast prions.

103, 109, 217

As the

essential regulator of yeast prions, much investigation has focused on the mechanism of Hsp104
interaction with prions. Furthermore, numerous mutations in all domains of Hsp104 have been
characterized which affect prion propagation by modifying various Hsp104 activities.

172, 218

Two different

models have been proposed to explain the role of Hsp104 in prion propagation that are rooted in the
ability of Hsp104 to remodel protein aggregates.
The first model hypothesizes that Hsp104 is involved in remodeling prion protein monomers to
catalyze formation of the amyloid conformation. The molecular basis of this mechanism is unclear, but
Hsp104 could promote the amyloid conformation by unfolding the monomer via the threading mechanism.
The unfolded monomer would then be primed for refolding into the altered, amyloid conformation.
Kinetically, Hsp104 would reduce the transition energy required to form the amyloid nucleus or enhance
joining to pre-existing aggregates. This model is supported by mainly in vitro data that showed
recombinant Hsp104 catalyzed the formation of amyloid fibers of recombinant Sup35NM.

219-221

This

conclusion was made based on the observation that addition of Hsp104 shortened the lag phase of
Sup35NM fiber formation.

219-221

An alternative conclusion from this observation is that Hsp104 remodels

off-pathway aggregates, which allows more efficient amyloid fiber formation. In fact, Hsp104 interacts
195

with Sup35 but only in the [PSI+] state

; an interaction between Hsp104 and monomeric Sup35 in vivo

has yet to be detected. Moreover, recombinant prion protein can form amyloid fibers in the absence of
Hsp104 in vitro.

130

26

The prion fragmenting hypothesis suggests that Hsp104 fragments large SDS-resistant
aggregates to generate oligomeric propagons. In order to efficiently propagate, prions need to be
dissociated to maintain a pool of propagons that are able to be transmitted to budding cells.

222

If

fragmentation does not occur, prion aggregates would both increase in size and reduce in number
impairing their ability to be inherited by daughter cells.

222

The disaggregation activity of Hsp104 is the

ideal feature to generate propagons to ensure prion propagation. Several studies report data that
supports this model as the primary role for Hsp104 in prion propagation.
Hsp104 results in an increase in aggregate size of Sup35.
210, 213

[PSI+] cells inhibits Hsp104 and cures [PSI+].

108, 136

136, 153, 210, 213, 223

First, inhibition of

As discussed, addition of GdHCl to

[PSI+] cells treated with GdHCl exhibit larger Sup35

aggregates, suggesting that GdHCl inhibition of Hsp104 prevents fragmentation of Sup35 aggregates.
153

136,

Additionally, [PSI+] cells grown in media containing GdHCl also decrease in propagon number as
136, 222

cells divide, further supporting a role for Hsp104 in prion fragmentation.

Furthermore, studies

examining how inhibition of Hsp104 affects Sup35-GFP aggregation suggest that Hsp104 does not affect
addition of the monomer to the aggregate, but rather, remodels existing Sup35-GFP [PSI+] complexes to
promote transmission.

153

Finally, addition of recombinant Hsp104 to Sup35 amyloid fibers in vitro has

demonstrated that Hsp104 is capable of disaggregating these fibers.

219-221, 224, 225

Though there is some

debate about how disaggregation of in vitro-made amyloid fiber occurs, these studies further support the
prion fragmentation mechanism and offer new insight into the structural components of this
mechanism.

219-221, 224, 225

Mutational analysis of Hsp104 suggests that optimal activity of all of the distinct properties of
Hsp104, hexamer formation, ATP hydrolysis, and substrate translocation, is required for efficient prion
172, 218

propagation

. In general, inhibition of any one of these activities often results in prion loss. For

example, the NBD mutations K218T/K620T, which abrogate ATP hydrolysis and hexamer formation, also
109, 152

inhibit prion maintenance and do so in the presence of wild type.

175, 226

prevents ATP hydrolysis but not hexamerization, cures [PSI+].

The N728A mutation, which

Additionally, mutation of the pore

loop tyrosine residues, Y257A and Y662A show a differential effect where Hsp104-Y257A only mildly
destabilizes [PSI+], while Hsp104-Y662A cures [PSI+] cells.

165, 195

Whole domain replacement with the

corresponding domains from ClpB showed that NBD1, NBD2, and the M-domain are required for prion

27

propagation while the NTD and CTD could be deleted or replaced with no effect on [PSI+] propagation.

165,

166

Strikingly, characterized mutations that inhibit thermotolerance also inhibit prion propagation, with
172, 218

a few exceptional mutations in the CTD.

On the other hand, mutations that inhibit prion propagation

do not always inhibit thermotolerance, suggesting that the disaggregation mechanism for prion substrates
and non-prion substrates is distinct.

172, 218

Additionally, these data suggest that the amount of

disaggregation activity required for thermotolerance is not as strict as for prion propagation. Slight
perturbations in Hsp104 function can have extreme effects on prion maintenance while having little to no
effect on thermotolerance. Indeed, recent data has shown that disordered aggregates like the type that
result from heat shock require less cooperative activity to be resolved than do ordered, prion
aggregates.

170

This study also shows that ClpB requires more cooperative activity among the hexamer to

disaggregate disordered substrates than does Hsp104, perhaps demonstrating a reason why ClpB
cannot substitute for Hsp104 in prion propagation.

170

Thus, substrate stability and structure are

contributing factors in the ability of Hsp104 to efficiently disaggregate a particular substrate.
Due to the conformational variation characteristic of individual yeast prions, one might predict that
not all yeast prions are similarly regulated by Hsp104. One very interesting example is that while deletion
of Hsp104 cures most of the known prions, only [PSI+] is cured by overexpression.

109, 139, 217

The

mechanism of [PSI+] curing by Hsp104 overexpression is still unclear as is the reason why only [PSI+] is
affected. One hypothesis for the mechanism of [PSI+] curing by overexpression of Hsp104 is that an
excess of Hsp104 dissolves prion aggregates to monomers.

227

One observation challenging this

hypothesis is that in the presence of excess Hsp104, aggregates of Sup35 increase in size.

136, 228

This

result contradicts the expected results if Hsp104 were to cause hyper-disaggregation of Sup35
aggregates. Another hypothesis, then, is that overexpression of Hsp104 leads to larger, nontransmissible aggregates that are “dead-end” products, though much is still unclear about this
mechanism.
To further investigate the underlying cause of the increased sensitivity of the [PSI+] prion to
Hsp104 expression levels, recent data investigates the regions in Sup35 that interact with Hsp104.

229

These data show that a specific 20 amino acid stretch in the highly charged M domain of Sup35 (129-

28

148) is a site for Hsp104 interaction. The authors speculate that a region specific for Hsp104 binding, like
this stretch found in Sup35, is absent in other prions, though no binding studies of Hsp104 with other
prion proteins have been reported. This hypothesis suggests that prions that expose regions of high
affinity for Hsp104 are more susceptible to dissociation by Hsp104. Thus, conformational variation
among different yeast prions may govern the interactions with Hsp104, and as a result, the ability of
Hsp104 to disaggregate individual yeast prions. Indeed, several Hsp104 mutants have been
characterized which cure [PSI+] but do not cure [RNQ+], though curiously, they all localize to a similar
region of Hsp104.

150, 230

In addition to the differences of separate yeast prions in their requirements for interaction with
Hsp104, individual conformational variants of the same prion also display distinct interactions with
Hsp104. For example, a weak variant of [PSI+] with a longer structural core and increased soluble pool
compared to a strong [PSI+] variant, is more susceptible to curing by overexpression of Hsp104.

108

Additionally, a mutation in NBD1 of Hsp104, E190K, which affects ATPase activity, can differentially affect
propagation of the [RNQ+] variants.

150

Moreover, a variant of [PSI+] has been characterized, which

depends on excess Hsp104 for efficient propagation.

231

This variant was identified as an induced [PSI+]

variant when Hsp104 and Sup35 were overexpressed simultaneously.

231

More recent data compare the

effect of Hsp104 on conformational variants of Sup35 aggregates formed at different temperatures in
vitro. Amyloid fibers of Sup35 formed at 4°C (NM4) that resulted in mostly strong [PSI+] when
transformed into [psi-] cells were more readily remodeled by recombinant Hsp104 than Sup35 aggregates
assembled at 37°C (NM37) that result in mostly weak [PSI+] variants after transformation into [psi-]
cells.

224

Remodeling of NM4 fibers by Hsp104 lead to prion-competent oligomers while the same amount

of Hsp104 remodeled NM37 fibers into non-templating structures.

224

Additionally, treatment of NM4 fibers

with Hsp104 before transformation into [psi-] cells resulted in an increased proportion of resulting strong
[PSI+] cells while treatment of NM37 fibers lead to a decrease in cells containing weak [PSI+] variants.
These data suggest that Hsp104 selectively amplifies certain [PSI+] variants based on its ability to
interact with those variants. Thus, not only does activity and expression of Hsp104 affect prion variant
propagation, but can also affect induction and selection of specific prion variants.

29

224

The role of Hsp104 in asymmetric inheritance
During progressive cycles of cell division, yeast cells accumulate age-related damages that affect
protein function, regulation of mitosis, and general cellular function.

232

To prevent these age-related

damages accumulating in the budding cell, including carbonylated or oxidatively damaged proteins, from
being inherited by the newly generated buds, damaged proteins and other factors are confined to the
mother cell in a process called asymmetric inheritance.

233

One factor central to the mechanism of

asymmetric inheritance is the sirtuin, Sir2, as deletion of Sir2, sir2Δ cells, results in an increase in the
amount of carbonylated protein aggregates in the new buds and a decrease in replicative lifespan.
Interestingly, overexpression of HSP104 in sir2Δ cells restores normal replicative lifespan.

235

234

In fact,

hsp104Δ cells also display a decrease in replicative lifespan compared to wild type cells suggesting a role
for Hsp104 in promoting damage asymmetry.

235

This process is dependent on the actin cytoskeleton and

Hsp104 appears to be part of the network linking the cytoskeleton to the process of asymmetric
inheritance.

235, 236

Co-expression of the HAP construct with ClpP displays defects in cell morphology and

the actin cytoskeleton, suggesting that cytoskeletal proteins are normal substrates of Hsp104.

236

Indeed,

some evidence suggests that Hsp104 interacts with the polarisome complex and the cytokinesis
machinery, and that deletion of certain components of both as well as deletion of Hsp104 can result in the
symmetric distribution of damaged proteins between the aging mother cell and the new bud.

236

The exact

role of Hsp104 in promoting asymmetric inheritance is not yet fully understood but offers a new way to
investigate the function of Hsp104 and perhaps add insight to its role in prion maintenance.

1.5 The Chaperone Network: Hsp104, Hsp70, Hsp40
In order to cover the variety of protein misfolding and aggregation issues, cells have evolved an
elaborate and highly cooperative network of molecular chaperones. In yeast and bacteria, a bichaperone
network composed of Hsp104/ClpB and the Hsp70 system are responsible for processing disordered and
stress-induced aggregates as well as highly structured and stable prion aggregates. The Hsp70 system
is composed of Hsp70s and Hsp40s in yeast and DnaK and DnaJ in bacteria, each with distinct functions
in protein folding and aggregate resolubilization.

30

Effects of Hsp40s on yeast prions
The primary functions of the Hsp40 chaperones are to direct the interaction of Hsp70s with
aggregate and misfolded substrates by binding directly to these substrates as well as stimulate ATP
hydrolysis in their Hsp70 partners. In yeast, there are 13 Hsp40 proteins and 41 in humans.
share a highly conserved J-domain critical for Hsp70 ATPase stimulation.

238

237

Hsp40s

In addition to the J-domains,

Hsp40s possess variable extra domains which allow targeting of Hsp70 chaperones to diverse cellular
239

targets.

The two most well-characterized Hsp40s in yeast are Ydj1 and Sis1, which each display

distinct substrate preferences as well as very different activities on prion propagation.
both physically associate with Sup35 aggregates
241

217

Ydj1 and Sis1

240

, but only Sis1 is essential for [PSI+] propagation.

Additionally, Sis1 is required for [RNQ+] and [URE3] propagation.

overexpression cures [URE3]

239

137

and some variants of [RNQ+].

140, 142, 241

166,

However, Ydj1

These data suggest opposing models

in prion propagation for the two Hsp40s, highlighting the distinct roles each plays in the cell. Additionally,
Ydj1 and Sis1 bind Rnq1 when it is in the [RNQ+] state though each has a separate binding site.

140, 242, 243

Thus, one hypothesis is that binding of each Hsp40 to [RNQ+] targets different Hsp70s to the prion
resulting in either propagation or curing. Interestingly, Sis1 was recently shown to enhance [PSI+] curing
in the presence of overproduced Hsp104.

244

How individual prions are regulated by differential Hsp40

binding and how the Hsp40s have differential effects is still relatively unclear.

Effects of Hsp70s on yeast prions
Hsp70s are conserved and essential chaperones that directly facilitate protein refolding by
binding to exposed hydrophobic regions of incompletely folded proteins.

245, 246

Binding to these

hydrophobic regions typically prevents aggregation and promotes efficient folding. Hsp70 functions by
cycling between ATP- and ADP-bound states to bind and release substrates.

247

In the ATP-bound state,

Hsp70 has low substrate affinity and rapid exchange while in the ADP-bound state, affinity for substrate is
high. Hsp70 has a slow intrinsic rate of ATP hydrolysis which can be stimulated by binding Hsp40s. At
one time, Hsp40s present bound substrate to Hsp70 and stimulate Hsp70 ATP hydrolysis to initiate
Hsp70 binding.

248

Yeast express six cytosolic Hsp70s, four are the essential Ssa subfamily (Ssa1-4) and

two are the ribosome-associated Ssb subfamily (Ssb1 & 2).

31

249

Efficient Hsp70 function also requires

nucleotide exchange factors (NEFs) to accelerate ADP release and subsequent rebinding of ATP. The
major NEFs in yeast are Fes1 and Sse1 (Hsp110).

250

The Ssa and Ssb Hsp70s have both been demonstrated to associate with Sup35 in the [PSI+]
state where Ssa1 is a major component (1 Ssa1:2 Sup35)

240

, however, the two chaperones demonstrate

opposite effects on the [PSI+] prion. For example, increased levels of Ssa1 prevent [PSI+] curing by
excess Hsp104 and with some variants of [PSI+], increase phenotypic expression.

251

Conversely, excess

Ssb1 increases [PSI+] curing by excess Hsp104 and inhibits phenotypic expression of some [PSI+]
variants.

252

Excess Ssa1 is proposed to result in an increase in the size of Sup35 aggregate, which then

counteracts the disaggregating effect of Hsp104.

253

Moreover, excess Ssa1 on its own can cure [PSI+]

and lead to an increase in aggregate size of specific [RNQ+] variants.

254

On the other hand, a mutation in

Ssa1 (Ssa1-21; L483W) decreases the number of [PSI+] propagons, thus destabilizing the [PSI+] prion.
Interestingly, several mutations in the NTD of Hsp104 can overcome the defect imposed by Ssa1-21 and
restore normal [PSI+] propagation. Clearly, the functions of Hsp70 and Hsp104 in prion propagation are
interdependent as mutations or changes in one can be compensated for by mutations changes in the
other. However, it is unclear if this mechanism holds true for prions in general as these mutations have
only been tested with [PSI+].
Not only do Hsp70s play a role in prion propagation, but the NEFs associated with Hsp70 also
show interesting prion phenotypes. For example, increased expression of the Hsp110 Sse1 strongly
increased de novo [PSI+] formation whereas deletion of SSE1 severely inhibited it.

255

Additionally,

overproduction of Sse1 led to very strong variants of [PSI+] while depletion of Sse1 resulted in only weak
[PSI+] variants.

255

Furthermore, the Hsp90 co-chaperone, which can also interact with Hsp70 and has

been shown to bind Hsp104, destabilized [PSI+] when overexpressed and stabilized [PSI+] when
256

depleted.

Undoubtedly, the mechanism of prion regulation by chaperone is complicated, resulting in

highly varied phenotypes among different Hsp70:Hsp40:NEF interactions and more work is needed to
understand these mechanisms.

The Bichaperone network: Hsp104, Hsp70, and Hsp40

32

Many studies have shown that the cooperation of the Hsp70 system and Hsp104/ClpB is required
for efficient solubilization of protein aggregates. Disaggregation of heat-aggregated proteins by the yeast
chaperone Hsp104 required the presence of Ssa1 and Ydj1 and similar data was shown for ClpB, DnaK,
and DnaJ in bacteria.

257, 258

In both organisms, Hsp70/DnaK is proposed to act upstream of

Hsp104/ClpB, promoting disaggregation by binding to aggregated substrates.

166, 259

The engineered

constructs, HAP and BAP, were able to degrade aggregated substrates in the presence of ClpP, but
strictly in an Hsp70/DnaK-dependent manner.

191, 195

These data suggested that Hsp70/DnaK were

required for the initial substrate binding and translocation by Hsp104/ClpB. Consistent with this
hypothesis, binding of substrates to the N-terminal pore loop of ClpB required DnaK
to the substrate required DnaJ.

190

and DnaK binding

260

Increasing evidence supports the binding of Hsp70/DnaK to the M-domain of Hsp104/ClpB during
the disaggregation process.

261

Indeed, a recent structural study using NMR has also shown specific

contacts between DnaK and the M-domain of ClpB.

262

Mixing domains of Hsp104 and ClpB

demonstrated that the M-domain from Hsp104 is required for interaction with Ssa1 and Ydj1, but
replacement with the M-domain from ClpB was able to couple Hsp104 to DnaK and DnaJ.

166, 177, 263

Surprisingly, Hsp104 and Ssa1 can also function with DnaJ, suggesting that the interface between
Hsp104 and Hsp70 is the species-specific factor.

257

Thus, the current proposed mechanism for the

bichaperone network is that Hsp40/DnaJ recruits Hsp70/DnaK to the aggregated substrate whereby
Hsp70/Hsp40/substrate then binds to the M-domain of Hsp104 and stimulates disaggregation of the
substrate by Hsp104/ClpB. Additionally, Hsp70 stimulation of the M-domain to depends on the
conformation of the M-domain such that the M-domain must be accessible and in the de-repressed
conformation for binding and stimulation to occur.

201, 264

Although the mechanism of protein

disaggregation by the bichaperone network is not entirely clear, recent structural studies have provided a
deeper understanding of this interaction and its effects on aggregated substrates.
If this bichaperone mechanism is true for protein aggregates, then, can it also be applied to the
mechanism of prion propagation? Initial studies suggest that, indeed, prion disaggregation may occur in
a similar fashion. One study showed that incorporation of Hsp70 and Hsp40 into amyloid fibers in vitro
made the fibers a better substrate for Hsp104 disaggregation.

33

265

Additionally, amyloid fibers that were

disaggregated by Hsp104 in the presence of Ssa1 retained more infectivity than fibers disaggregated by
Hsp104 alone.
of the fibers.

265

265

Furthermore, disaggregation of fibers in the presence of Ssb1 decreased the infectivity

This in vitro data mimics the [PSI+]-promoting (Ssa1) and [PSI+]-antagonizing (Ssb1)

phenotypes observed in vivo. More recently, Ssa1 was shown to be required for Hsp104 fragmentation of
Rnq1 fibrils in vivo.
remodeling them.

266

266

In the absence of Ssa1, Hsp104 was able to bind Rnq1 fibrils, but was incapable of

Additionally, excess Hsp104 outcompeted Ssa1 for binding to Rnq1 fibrils in vivo

suggesting a mechanism for the observed antagonism of excess Hsp104 curing of [PSI+] by excess
Ssa1.

266

1.6 Hsp104 in Models of Protein Aggregation Disorders
To date, no clear metazoan homolog or analog of Hsp104 has been identified. Initial attempts to
isolate a disaggregase by cellular fractionation have proven mostly unsuccessful. One study shows that
crude whole lysates of Caenorhabditis elegans are able to disaggregate and degrade Aβ fibers, but the
factor(s) responsible have yet to be identified.

267

It appears as if metazoan proteostasis focuses on

clearing aggregates by proteolysis and autophagy instead of disaggregation and renaturation. Given the
common structure of amyloid fibers and oligomers and the ability of Hsp104 to rapidly and efficiently
remodel yeast prions, the use of Hsp104 to remodel the mammalian disease-associated amyloid
structures is an attractive thereapeutic model to reverse amyloid aggregation.

30, 83, 172

Hsp104 has

previously been expressed in mammalian cell lines and has been shown to collaborate with human
Hsp70 and Hsp40 chaperones to refold thermally denatured firefly luciferase.

268

Several different disease

models have been generated to examine the ability of Hsp104 to interact with and disaggregate diseaseassociated amyloid substrates.
Expression of expanded polyQ tracts in yeast results in polyQ aggregation that is dependent on
269, 270

the [RNQ+] prion.

When cells are [RNQ+], expanded polyQ can aggregate and cause toxicity.

Overexpression of Hsp104 in these cells resulted in significantly reduced toxicity potentiated by small
heat shock proteins Hsp26.

269-271

As such, Hsp104 may be able to cooperate with small heat shock

proteins to disaggregate amyloid in other systems. Interestingly, small heat shock proteins have also
been shown to suppress Aβ toxicity suggesting that an interaction between Hsp104 and the small heat

34

shock proteins may be applicable to more than just polyQ disorders.

272

The co-expression of expanded

polyQ and Hps104 in C. elegans resulted in reduced inclusion formation and alleviation of developmental
defects.

273

Most remarkably, expression of Hsp104 in mouse models of Huntington’s disease prolonged

life span of these mice by 20% though the physical symptoms were not improved.
Hsp104 caused a significant decrease in the number of inclusions.

274

Additionally,

275

As another model for a disease-associated protein, overexpression of human α-synuclein in yeast
leads to toxicity and formation of cytoplasmic foci.

276

Unlike the effects on expanded polyQ,

overexpression of Hsp104 has no effect on α-synuclein toxicity.

271

However, the cytoplasmic foci that

form from aggregation of α-synuclein may not be amyloid-like aggregates. Similarly, in a C. elegans
model of Parkinson’s disease, Hsp104 also had no effect on toxicity.

277

In a rat model, however, when

Hsp104 and α-synuclein A30P were simultaneously expressed, Hsp104 reduced inclusion formation and
prevented neurodegeneration.

278

Nevertheless, several challenges remain to fully validate Hsp104 as a

potential therapy for Parkinson’s disease.
Finally, Hsp104 can interact with Aβ42 and can prevent formation of Aβ42 fibers in an ATPindependent manner.

279

However, Hsp104 is unable to disaggregate Aβ42 fibers in vitro. Although these

data show promising results for a therapeutic interaction between Hsp104 and Aβ42, no complementary
in vivo approaches have been reported. More recently, aggregates of mutant SOD1 were shown to be
disaggregted by Hsp104, and these observations may provide insight into the mechanism of amyotrophic
lateral sclerosis amyloid formation and disease progression.

280

1.7 Summary and Significance
Protein aggregation and amyloid deposition are common features of several protein
conformational disorders and investigating the mechanisms of amyloid aggregation has contributed
significantly to our understanding of these diseases. As non-toxic, epigenetic amyloid conformers, the
use of yeast prions has allowed investigation of the genetic and environmental factors which contribute to
amyloid formation. One class of amyloid regulating factors is the molecular chaperones, whose normal
function in preventing protein aggregation and misfolding make them ideal partners to ensure prion
propagation. Indeed, amyloid-associated protein conformational disorders are age-related and suggest

35

that changes in the chaperone network over time may contribute to cellular dysfunction and disease
pathology. Unfortunately, the very nature of the disease does not allow efficient investigation or treatment
of the factors promoting amyloid formation. In humans, detection of disease symptoms is often too late to
treat the disease and studying normal mouse models without artificially speeding up the aggregation
process would take years. Therefore, yeast prions and their regulation by the bichaperone network
provide an easily manipulated system in which to investigate amyloid aggregation and chaperone
function.
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Abstract
Amyloidogenic proteins aggregate through a self-templating mechanism that likely occurs via
oligomeric or prefibrillar intermediates. For disease-associated amyloidogenic proteins, such
intermediates have been suggested to be the primary cause of cellular toxicity. However,
isolation and characterization of these oligomeric intermediates has proven difficult, sparking
controversy over their biological relevance in disease pathology. Here, we describe an oligomeric
species of a yeast prion protein in cells that is sufficient for prion transmission and infectivity.
These oligomers differ from the classic prion aggregates as they are soluble and less resistant to
SDS. We found that the large SDS-resistant aggregates are required for the prion phenotype but
soluble, more SDS-sensitive oligomers contain all the information necessary to transmit the prion
conformation. Thus, we identified distinct functional requirements of two types of prion species
for this endogenous epigenetic element. Furthermore, the non-toxic, self-replicating amyloid
conformers of yeast prion proteins have again provided valuable insight into the mechanisms of
amyloid formation and propagation in cells.

Introduction
The amyloid hypothesis proposes that large, protease-resistant amyloid fibers underlie the toxicity
associated with several neurodegenerative diseases(Caughey and Lansbury, 2003; Chiti and Dobson,
2006). A definitive link between the amyloid aggregate and toxicity and neurodegeneration has not been
established(Haass and Selkoe, 2007). A recent alternative proposal posits that an intermediate in the
amyloid pathway is the primary toxic agent, while the large, insoluble aggregates may sequester
oligomers and perhaps aid in cell survival(Kirkitadze et al., 2002). Soluble oligomers of several
amyloidogenic proteins including amyloid-β, huntingtin, α-synuclein, and PrP have been detected both
from analysis of amyloid-forming recombinant proteins and in cell and mouse models(Conway et al.,
1998; Lasmezas et al., 1997; Lesne et al., 2006; Sajnani et al., 2012; Sanchez et al., 2003; Silveira et al.,
2005; Tzaban et al., 2002). These oligomers, characterized as putative intermediates in amyloid
formation, encompass a variety of sizes and structures that cause toxicity when introduced into disease
models(Klyubin et al., 2005; Sajnani et al., 2012; Silveira et al., 2005). Isolation of these dynamic, soluble
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oligomers has remained largely elusive and, as such, investigation of their role in amyloid formation has
proven challenging.

The yeast prion protein Sup35 forms self-perpetuating amyloid conformers that are transmissible and
infectious(Patino et al., 1996; Paushkin et al., 1996; Serio et al., 2000). To propagate the [PSI+] prion,
Sup35 aggregates must undergo remodeling by the chaperone Hsp104, which facilitates monomer
addition by severing amyloid structures to generate transmissible species, or propagons(Chernoff et al.,
1995; Kryndushkin et al., 2003; Satpute-Krishnan et al., 2007; Shorter and Lindquist, 2006). Until now, in
vivo studies have primarily reported on the role of Hsp104 in aggregate fragmentation(Ness et al., 2002;
Satpute-Krishnan et al., 2007). Interestingly, Hsp104 has also been shown to catalyze amyloid formation
in vitro, specifically impacting the formation of amyloid oligomers(Shorter and Lindquist, 2004). Moreover,
recent in vitro evidence identified Sup35 oligomers as intermediates during amyloid formation under some
conditions(Ohhashi et al., 2010). Here, we identify soluble, more SDS-sensitive oligomers of Sup35 as
prion propagons and show that Hsp104 plays a role in their maintenance.

Results and Discussion
We performed a screen to identify cellular changes that rescued cells from toxic overexpression of SUP35
in [PSI+] cells(Vishveshwara et al., 2009). As this toxicity is dependent on [PSI+], we expected to uncover
factors that affected Sup35 aggregation. One mutation identified, hsp104-R830S, caused [PSI+] cells to
appear phenotypically [psi-] by a readout of translation termination efficiency of a reporter that is
indicative of the functional, soluble state of Sup35 (Fig. 2.1A). Fluorescent imaging showed that Sup35 in
hsp104-R830S cells appeared diffuse (Fig. 2.1B), and by semi-denaturing detergent-agarose gel
electrophoresis (SDD-AGE), only monomeric Sup35 was detected in hsp104-R830S cells (Fig. 2.1C).
Strikingly, mating hsp104-R830S cells that appeared [psi-] to wild type HSP104 [psi-] cells produced
many diploids that were phenotypically [PSI+], as seen by increased nonsense suppression (Fig. 2.2).
Furthermore, sporulation of these diploids produced two [PSI+] and two [psi-] haploid progeny (Fig. 2.1D),
thereby indicating that prion-competent propagons had been maintained in hsp104-R830S cells that
resulted in cryptic [PSI+] (phenotypically undetectable). Indeed, transformation of hsp104-R830S cell
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lysates into wild type [psi-] cells demonstrated that these propagons were infectious and produced [PSI+]
cells. Out of 1,154 cells transformed, 45 were [PSI+] (3.9% infectivity). Control transformations of [psi-]
lysates into [psi-] cells resulted in only red colonies. Of the thousands of red colonies resulting from these
control transformations, over 400 were further analyzed and confirmed to be [psi-]. Thus, the infectious
propagon in hsp104-R830S cells is unable to cause observable nonsense suppression, but re-establishes
and maintains the [PSI+] phenotype in the presence of wild type HSP104.

Hsp104 normally functions to disaggregate non-prion aggregrates and promote cellular recovery from
stress(Glover and Lindquist, 1998). Therefore, we tested the activity of the Hsp104-R830S mutant with
other known substrates. Interestingly, the thermotolerance of hsp104-R830S cells resembled that of wild
type cells (Fig. 2.3A). Moreover, hsp104-R830S cells efficiently resolubilized heat-aggregated luciferase
(Fig. 2.3B). Hsp104 threads substrates through a central channel as a mechanism of
disaggregation(Tessarz et al., 2008). The Hsp104 variant, HAP, has been used to investigate threading
activity by coupling Hsp104 to the ClpP protease so that threaded substrates are degraded, resulting in
decreased viability(Tessarz et al., 2008). We created the HAP-R830S variant and found that the mutant
maintained threading activity (Fig. 2.3C). Hsp104 is an AAA+ ATPase. Mutations that inhibit ATP
hydrolysis or hexamerization typically prevent [PSI+] propagation(Glover and Lum, 2009). We purified
-1

Hsp104-R830S and measured a reduced initial rate of ATP hydrolysis of 0.1659±0.0308 nmol Pi·µg ·min
1

-1

-1

, as compared to the initial rate of wild type Hsp104 of 0.2975±0.412 nmol Pi·µg ·min , which is

comparable to previously published data(Tkach and Glover, 2004). We next analyzed the distribution of
Hsp104-R830S, relative to wild type Hsp104, using glycerol gradients and size-exclusion
chromatography. These analyses revealed that Hsp104-R830S forms unstable hexamers (Fig. 2.3D &
2.4). Together, these data reveal that the reduced activity of Hsp104-R830S impairs the maintenance of
the [PSI+] phenotype.

Next, we assessed the state of Sup35 in hsp104-R830S cryptic [PSI+] cells. We first performed
sedimentation analysis with hsp104-R830S cryptic [PSI+] lysates and found that Sup35 was soluble (Fig.
2.5A). Next, we subjected lysates of hsp104-R830S cryptic [PSI+] and HSP104 [psi-] cells to sucrose
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gradient fractionation. Monomeric Sup35 in [psi-] cells remained in the top fractions, while Sup35 from
hsp104-R830S lysates was detected further down the gradient, demonstrating the existence of some
oligomeric species (Fig. 2.5B). To understand how these oligomers relate to the large SDS-resistant
aggregates associated with the [PSI+] phenotype, we created a system to examine the effect of hsp104R830S on pre-existing Sup35 aggregates. We covered hsp104-R830S cryptic [PSI+] with wild type
HSP104 expressed from a glucose-repressible promoter such that cells grown in non-repressing
galactose allowed the propagation of [PSI+] and maintained SDS-resistant aggregates (Fig. 2.5C, Gal).
We then shifted the cells to glucose to repress wild type HSP104 (Fig. 2.6A) and performed SDD-AGE to
monitor the effect of hsp104-R830S on SDS-resistant Sup35 aggregates. Within twelve hours of wild type
HSP104 repression, monomeric Sup35 was apparent in hsp104-R830S cells. Within twenty-four hours,
SDS-resistant aggregates had disappeared (Fig. 2.5C). As expected, when hsp104-R830S pGALHSP104 cells were switched from glucose back to galactose to derepress wild type HSP104, they
became phenotypically [PSI+] (Fig. 2.6B). Therefore, despite the loss of SDS-resistant aggregates, the
propagons remained. Thus, the large SDS-resistant Sup35 aggregates are not strictly required for
transmission of the prion.

We therefore reasoned that a less stable subpopulation of Sup35 might be capable of prion transmission.
Indeed, that the addition of SDS to Sup35 prion aggregates results in smaller SDS-resistant polymers
suggests that some less SDS-resistant species exists within the large prion aggregates(Kryndushkin et
al., 2003). We investigated whether the soluble oligomers in hsp104-R830S cryptic [PSI+] cells were less
resistant to SDS, as has been reported for another prion (Taneja et al., 2007). We again performed SDDAGE on hsp104-R830S cryptic [PSI+] lysates but decreased the SDS concentration, and only then did we
observe the presence of oligomeric species (Fig. 2.5D). To determine how these species related to prion
propagons and the cryptic [PSI+] phenotype, we repeated the wild type HSP104 repression time course
with hsp104-R830S cells using a low SDS SDD-AGE. We observed the maintenance of less SDSresistant, oligomeric species throughout the time course (Fig. 2.5E), suggesting that the soluble, less
SDS-resistant oligomers are the transmissible propagons in hsp104-R830S cryptic [PSI+] cells.
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Although we observed the unstable, soluble oligomers in the absence of insoluble aggregates, it is likely
that both species exist in wild type cells, and the more SDS-sensitive, soluble oligomers are more readily
detectable in cells lacking insoluble aggregates. Therefore, we separated the Sup35 species in both
hsp104-R830S cryptic [PSI+] and wild type [PSI+] cells by sucrose gradient and performed protein
transformation to determine whether the soluble fractions contained infectious propagons. Both hsp104R830S and HSP104 cells contained soluble Sup35 oligomers that were infectious to [psi-] cells (Fig.
2.7A). While much of the Sup35 species from wild type lysates migrated to the bottom of the gradient
(35% of the total Sup35 which correspond to 54% of the infectivity), there were highly infectious oligomers
in wild type [PSI+] cells that did not migrate with the heavy-sedimenting aggregates. This soluble pool of
Sup35 contains 46% of the infectivity in wild type [PSI+] lysates. Curiously, the high-molecular weight
aggregates observed in hsp104-R830S cells were not very infectious, suggesting that these aggregates
are not the same high-molecular weight aggregates present in wild type [PSI+] cells and are not efficient
[PSI+] propagons. We then performed a simple solubility assay to separate wild type [PSI+] lysates into
soluble and insoluble fractions (see Fig. 2.5A) and then performed infectivity assays and SDD-AGE
analysis. Strikingly, we found much of the infectivity in the soluble fraction (32.8% of the total Sup35
which corresponds to 30% of the infectivity) from sedimentation analysis (Fig. 2.7B). Additionally, by
SDD-AGE, we found that there were no Sup35 oligomers resistant to 2% SDS in the soluble fraction (Fig.
2.7C). As such, these data support our hypothesis that insoluble aggregates are not strictly required for
prion transmission.

Propagons contain the variant-specific properties required for inheritance and propagation of distinct prion
phenotypes(Satpute-Krishnan and Serio, 2005; Tanaka et al., 2004). Therefore, the soluble oligomers in
hsp104-R830S cryptic [PSI+] cells should retain the properties necessary to propagate the parental
strong [PSI+] phenotype. If hsp104-R830S altered the prion structure, instead of cryptic [PSI+], weakened
nonsense suppression and enhanced mitotic loss could be expected. After crossing hsp104-R830S
cryptic [PSI+] cells to [psi-] cells, we compared the [PSI+] meiotic progeny to the parental strong [PSI+]
variant used initially in the screen. We found that the [PSI+] progeny were indeed strong [PSI+]
phenotypically (Fig. 2.7D). We then performed SDD-AGE analysis of the resulting [PSI+] haploids as
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compared to the strong [PSI+] and a weak [PSI+] variant(Bagriantsev and Liebman, 2004; Derkatch et al.,
1996; Kryndushkin et al., 2003). The SDS-resistant Sup35 aggregates in the [PSI+] progeny appear the
same as strong [PSI+] (Fig. 2.7E). We also noted that all the [PSI+] transformants from infection of
hsp104-R830S lysates into [psi-] cells were strong [PSI+]. Thus, Hsp104-R830S did not alter the
properties of the original variant phenotypically or biochemically, suggesting that there was no change in
prion structure.

We have shown, for the first time, the presence of soluble, prion-competent, less SDS-resistant oligomers
of Sup35 in vivo. The less SDS-resistant, soluble oligomers are sufficient for transmission of the prion
conformation, but are not sufficient to produce the nonsense suppression phenotype associated with
[PSI+]. We have also shown that the insoluble aggregates that characterize [PSI+] cells are not required
for prion transmission or infectivity. Furthermore, we have uncovered two novel features of yeast prion
propagons. First, they can be more SDS-sensitive, where previously only SDS-resistant aggregates of
Sup35 were shown to be infectious(Bagriantsev et al., 2008). This sensitivity parallels the previously
described PK-sensitive PrP species which can also transmit the prion(Sajnani et al., 2012). Second,
soluble oligomers were able to act as propagons in vivo. Oligomers of several amyloidogenic proteins
have been described and can cause toxicity in the absence of large aggregates(Haass and Selkoe,
2007). Indeed, our data correlate well with previous reports that visible Sup35 aggregates are lost in the
mother cell and yet the prion is faithfully propagated(Taguchi and Kawai-Noma, 2010). Perhaps the SDSresistant, insoluble Sup35 aggregates function as a reservoir for the continued renewal of transmissible
propagons. This role for SDS-resistant yeast prion aggregates mirrors the proposed role for amyloid
aggregates as traps for oligomers(Kirkitadze et al., 2002). As such, we clearly show separate functions of
two distinct aggregate species that are structurally-related components of the same prion propagation
pathway. A mutant in Hsp104 enabled us to initially tease out these species. We favor a model whereby
the decreased activity of hsp104-R830S results in reduced fragmentation of aggregates but our data do
not exclude the possibility that Hsp104 normally plays a role in generating the large insoluble aggregates.
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The soluble oligomers that exist in many conformational disorders are challenging to characterize due to
their dynamic and metastable nature. In addition, conflicting reports on the properties and structure of
oligomers complicate the elucidation of the important oligomeric species(Haass and Selkoe, 2007). The
properties and mechanisms associated with yeast prion propagons may be similar to those associated
with amyloidogenic proteins involved in self-propagating protein conformational disorders. Therefore,
investigating these features may lead to a better understanding of the function and structure of soluble,
self-templating oligomers, as well as the role of amyloid in disease.

Materials and Methods
Strains and Yeast cultivation
The yeast strains used in this study are derivatives of Saccharomyces cerevisiae 74-D694 and
were grown using standard culture techniques. YPD is rich yeast medium whereas SD is synthetic
medium lacking amino acids as needed to select for maintenance of plasmids or screen for a nonsense
suppression phenotype (SD-Ade). The strain used in the screen, 74-D694 [PSI+] can1Δ::MFA1pr-HIS3MFa1p r-LEU2 ade1-14 ura3-52 lys2Δ::KanMX4 pRS315CUP1-SUP35, was transformed with ten
independent plasmid pools of the mini-transposon (3XHA/lacZ(mTn3)) mutagenized library (kindly
provided by M. Snyder) and selected on media containing 350µM copper sulfate to induce expression of
SUP35. Candidates that rescued toxicity associated with increased expression of SUP35 were passaged
a second time on copper sulfate media and were examined for the effect on [PSI+] phenotypically by
color and genetically by mating to unmutagenized 74-D694 [PSI+] and [psi-] isogenic strains. Several
mutants, not linked to the transposon, were analyzed and determined to be in Hsp104 thru genetic
analysis. The mutant characterized here, hsp104-R830S, was recreated and these strains were used for
further characterization. Phenotypic assays are based on the amount of functional Sup35 to terminate
the premature stop codon in ade1-14, which results in the accumulation of a red-pigmented intermediate
in the adenine biosynthesis pathway(Liebman and Derkatch, 1999).
SDD-AGE protein analysis
Cells were lysed by beadbeating in Buffer A (25mM Tris-HCl pH 7.5, 50mM KCl, 10mM MgCl2,
1mM EDTA, 10% Glycerol plus mini EDTA-free protease inhibitors (Roche), Aprotinen (Sigma) and PMSF
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(Sigma)). Samples were treated at room temperature for 7 minutes in sample buffer containing 2% SDS
then electrophoresed through a 0.1% SDS, 1.5% agarose gel. The gels were subjected to western blot
with anti-Sup35 antibody. The experiments done with lower SDS concentrations contained 0.01% SDS in
the gel and between 0.05 and 0.1% SDS in the sample buffer, as indicated. Molecular weight markers
were not used because non-denatured protein aggregates were being analyzed.
Fluorescence Microscopy
Cells were transformed with pRS426CUP1-SUP35NM-GFP and grown in media lacking uracil.
50µM CuSO4 was added to logarithmically growing cells and grown for four hours to induce expression of
SUP35NM-GFP. Images of cells expressing Sup35NM-GFP, in water and at room temperature, were
captured on an Olympus Bmax-60F microscope containing a 1.35NA 100X UPlanApo objective lens,
spinning disc Confocal Scanner Unit (CSU10), and a Stanford Photonics XR-Mega10 ICCD camera.
Images were acquired using QED software and analyzed by Image J.
Protein Transformation
Recipient [psi-] cells from logarithmically growing cultures were spheroplasted with lyticase.
Samples from cell lysis, sedimentation analysis, and sucrose gradient fractionation were added to the
spheroplasts in 1M sorbitol along with a vector containing the URA3 gene for selection on media lacking
uracil. The cells were incubated at room temperature then recovered at 30°C. Media containing glucose,
sorbitol, and agar was added to the cells before plating the cells on sorbitol plates lacking uracil.
Transformants were replica plated to YPD plates, and individual colonies were picked from those YPD
plates and spotted onto YPD and both media lacking adenine and containing GdHCl for quantification of
infectivity.
Purification of Hsp104
Hsp104 was purified as previously described(Lum et al., 2004). Recombinant Hsp104 tagged
2+

with a 6x- Histidine tag was expressed in E. coli cells and affinity purified using a Ni -sepharose column.
Next, the 6x-Histidine tag was removed by cleavage with the TEV protease and the untagged Hsp104
was separated from the uncleaved, tagged Hsp104 by affinity purification. The untagged Hsp104 was
further purified using anion exchange via a Q-sepharose column. The pure Hsp104 collected from the Qsepharose column was then separated on an S-300 gel filtration column to isolate monomeric Hsp104.
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Purified, monomeric Hsp104 was pooled, concentrated, and frozen at -80°C. Multiple purification
preparations were used for all assays in repeat experiments.
ATP Hydrolysis Assays
ATP hydrolysis was monitored by the Malachite Green assay. 2µg purified Hsp104 was
equilibrated in buffer (40mM TrisHCl pH7.5, 175mM NaCl, 5mM MgCl2, 0.02% Triton X-100) at 37°C
before adding 5mM ATP (Sigma). During incubation of Hsp104 with ATP at 37°C, samples were taken
and free phosphate was measured by addition of Malachite green dye (Sigma). Color development
occurred over one minute and was terminated by the addition of 34% citric acid (Sigma). Absorbance
was measured at 650nm.
Glycerol Gradients
Purified protein at 75ug was incubated in buffer (20mM Tris pH 8, 100mM NaCl, 10mM MgCl2,
2mM EDTA, 10% glycerol) +/- ATP for 5 minutes on ice before loading onto linear glycerol gradients (1535%). The gradients were spun at 34,000 rpm for 18 hours in an SW55 rotor. Gradients were
fractionated and the fractions analyzed by SDS-PAGE and western blot with anti-Hsp104 antibody.
Size Exclusion Chromatography
Purified protein at 1mg/mL was incubated in buffer (50mM Tris pH7.5, 200mM KCl, 10mM MgCl 2,
2mM DTT, 2mM EDTA) +/- ATP for five minutes. The sample was applied to an S-300HR column and
fractions were collected. The concentration of Hsp104 was measured by Bradford analysis (Bio-Rad).
Thermotolerance Assays
Cells were grown to mid-log phase at 30°C. An equal number of cells from each sample were
aliquoted and pre-treated at 37°C for thirty minutes. Samples were heat shocked at 50°C for the
indicated amounts of time and then diluted five-fold before plating onto solid rich medium.
In Vivo Luciferase Refolding Assay
In vivo luciferase refolding assays were performed as previously described(Tipton et al., 2008).
Briefly, cells carrying pRS316GPD-Lux (kindly provided by B. Bukau) were pretreated at 37°C for one
hour to induce expression of HSP104, then heat shocked at 44°C for an hour. After fifty minutes of heat
shock, cycloheximide was added to prevent new protein synthesis. After heat shock, the cells recovering
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at 30°C were aliquoted at fifteen minute intervals and D-luciferin (Sigma) was added. Luminescence was
measured and plotted as a percentage of total luciferase activity before heat shock.
Hsp104 Shutoff Experiments
The diploid strains, HSP104/hsp104Δ::leu2 and HSP104/hsp104-R830S were transformed with
pRS416GAL-HSP104, sporulated, and dissected on CSM-Ura + 0.25% Galactose + 2% raffinose. Low
levels of galactose were used to avoid curing [PSI+] by overexpression of HSP104. Progeny were
selected that contained the plasmid and were pink in color as evidence that [PSI+] was maintained. Cells
were grown in CSM-Ura + 0.25% galactose + 2% raffinose for 48 hours before switching the cells to
glucose media lacking uracil to repress expression of the HSP104 plasmid. At six hour intervals, aliquots
of the sample were taken and both pelleted for SDD-AGE and plated on CSM-Ura + 0.25% galactose +
2% raffinose plates. SDD-AGE was performed as described above. Gels were transferred to PVDF
membrane and probed with anti-Sup35 antibody.
Sup35 Solubility Assays
Cells were lysed by beadbeating in buffer (10mM NaPO 4 pH 7.5, 250mM NaCl, 2% SDS, 1%
Triton X-100 plus mini EDTA-free protease inhibitors (Roche), and PMSF (Sigma)). Lysates were
subjected to ultracentrifugation at 100,000rpm in a Beckman TLA-100 rotor for one hour. The
supernatant was collected and the pellet resuspended in lysis buffer. Total, supernatant, and pellet
fractions were subjected to SDS-PAGE and western blot with anti-Sup35 antibody as well as protein
transformation.
Sucrose Gradients
Cells were lysed by beadbeating in Buffer A. Total protein was normalized to 1mg/mL and loaded
onto a 4mL linear sucrose gradient (15-60%) and centrifuged at 32,000rpm for either three or 22 hours.
In order to compare infectivity of soluble and insoluble Sup35 from HSP104 [PSI+] by sucrose gradient,
we increased the time of centrifugation to a time that reproducibly showed a large fraction of pelletable
Sup35. Thus, after a 22 hour spin, we are able to distinguish the soluble Sup35 and the insoluble Sup35
which migrates to the bottom of the gradient. Gradients were fractionated and the fractions were
analyzed by SDS-PAGE, western blot, and protein transformation.
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Figure 2.1 hsp104-R830S propagates cryptic [PSI+].
A, [PSI+], [psi-], and hsp104-R830S cells were spotted on media containing CuSO 4 to induce toxic
overexpression of Sup35, media lacking adenine (SD-Ade) to assess nonsense suppression of the
premature stop codon in ade1-14, and rich media (YPD). B, HSP104 [PSI+] and hsp104-R830S cells
containing pSup35NM-GFP were imaged by fluorescence microscopy. Scale bar represents 10µm. C,
Western blot of an SDS-containing agarose gel (SDD-AGE) shows Sup35 aggregate status in lysates of
indicated strains. This blot is one representative of three individual experiments. D, An example of two
tetrads where mating hsp104-R830S to [psi-] cells, both containing the ade1-14 mutation, resulted in
tetrads with two red (efficient translation termination, hsp104-R830S) and two light pink (increased
nonsense suppression, [PSI+] HSP104) haploids.
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Figure 2.2 hsp104-R830S haploids crossed to [psi-] haploids results in [PSI+] diploids.
The presence of phenotypically undetectable [PSI+] prion propagons was apparent when red hsp104R830S haploids were mated to wild type red [psi-] haploids. Though the hsp104-R830S haploids appear
[psi-] (red in color due to efficient translation termination of ade1-14), prion propagons are still present
that can efficiently template soluble Sup35 in the presence of wild type HSP104 to produce mostly pink
[PSI+] HSP104:hsp104-R830S heterogeneous diploids. Diploids from the cross were spotted onto YPD
plates and [PSI+] and [psi-] controls are labeled in the upper left corner of the plate.
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Figure 2.3 Analysis of Hsp104-R830S activity reveals the mechanism of altered activity.
A, Growth on YPD plates of the strains heat shocked at 50°C for times indicated. Untreated cells were
spotted before heat shock. B, HSP104 (black), hsp104-R830S (red), and hsp104Δ (orange) cells
expressing heat-aggregatable luciferase were heat shocked at 44°C while blocking new protein synthesis.
Luminescence during recovery at 30°C was plotted as a fraction of luminescence before heat shock.
Error bars represent the standard deviation. C, hsp104Δ cells carrying pRS315CUP1-ClpP, covered by
the indicated plasmids, were spotted on media containing CuSO4 to induce expression of ClpP. D,
Hsp104 (upper) and Hsp104-R830S (lower) incubated +/- ATP (red/black) separated on a glycerol
gradient by ultracentrifugation. Top of the gradient is fraction number 1. Fractions were analyzed by
SDS-PAGE and western blot. All experiments were repeated at least three times.
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Figure 2.4 Hsp104-R830S does not form efficient hexamers.
Recombinant Hsp104 (upper panel) and Hsp104-R830S (lower panel) were incubated either with ATP (♦)
or without ATP (◊) and applied to an S-300 size exclusion column. Fractions of the eluate were collected
and Bradford analysis (absorbance at 595nm) was performed to quantify the amount of Hsp104 protein in
each fraction. Both recombinant Hsp104 and Hsp104-R830S without ATP migrate mainly as monomers
or dimers. Incubation of wild type Hsp104 with ATP causes hexamers to form, but Hsp104-R830S
incubated with ATP is distributed across several fractions, suggesting an inability to efficiently hexamerize
(or maintain stable hexamers) in response to ATP binding. Proteins of known molecular weights,
thyroglobulin (669kDa) and aldolase (158kDa), were also applied to the column and their elution peaks
are labeled for reference.
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Figure 2.5 hsp104-R830S propagates SDS-sensitive soluble oligomers of Sup35.
A, Ultracentrifugation separated lysates into total (T), soluble (S) and pellet (P) fractions. B, Fractionation
of [psi-] and hsp104-R830S cryptic [PSI+] lysates separated by a three hour centrifugation through a
linear sucrose gradient. C, Hsp104 and hsp104-R830S cells carrying p416GAL-HSP104 grown in
galactose were switched to glucose to repress p416GAL-HSP104 and p416GAL-HSP104 was efficiently
repressed by 12 hours in glucose as shown by western blot in an hsp104Δ control (Fig. S3). Aliquots
were taken from galactose and between 12 and 72 hours in glucose and subjected to SDD-AGE. The
shift in aggregate distribution occurs when changing carbon sources. D, Lysates of the indicated strains
were analyzed by SDD-AGE. The HSP104 [PSI+] and [psi-] and hsp104-R830S samples were incubated
in sample buffer containing the indicated percentages of SDS. E, Same as (D) but samples were
subjected to SDD-AGE containing 0.01% SDS. All experiments were repeated at least three times and
protein molecular weight markers (kD) are indicated.
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Figure 2.6 Glucose represses expression of wild type HSP104 but [PSI+] propagons persist in the
absence of SDS-resistant aggregates.
(A) In order to establish a system whereby we could determine the effect of hsp104-R830S on preexisting [PSI+] aggregates, we transformed a plasmid expressing wild type HSP104 driven by the
galactose promoter (pRS416-GAL-HSP104) into heterozygous diploids expressing either wild type
HSP104 or hsp104-R830S and hsp104Δ on the chromosome. In order to determine if switching the cells
expressing pRS416-GAL-HSP104 to glucose efficiently repressed wild type HSP104, we performed a
western blot to detect the amount of Hsp104 expressed while growing in galactose (plasmid-borne wild
type HSP104 is expressed, Gal) and for various amounts of time after switching the cells to glucose
(plasmid-borne wild type HSP104 is repressed, 6-48 for wild type and hsp104-R830S and 6-24 for
hsp104Δ). We compared wild type HSP104 and hsp104-R830S cells containing pRS416-GAL-HSP104
to hsp104Δ cells containing pRS416-GAL-HSP104. After only six hours in glucose, we could detect no
Hsp104 in the hsp104Δ cells. This suggests that over the time course of our assay (Fig. 3C), wild type
HSP104 from the plasmid was efficiently repressed while growing in glucose. Total protein loading was
assessed by membrane stain. (B) We investigated the effect of hsp104-R830S on pre-existing
aggregates of Sup35 by both SDD-AGE (Fig. 3C & 3E) and by nonsense suppression phenotype (using
ade1-14) after repression of wild type HSP104. Briefly, cells (hsp104-R830S or hsp104Δ) carrying
galactose-inducible wild type HSP104 on a plasmid were grown in low galactose (0.25%) to maintain
[PSI+]. Cells were then switched to glucose media to repress wild type HSP104, grown for various times
in liquid glucose media (hours post shift to glucose), and then plated on media plates lacking uracil and
containing galactose (0.25%) to derepress wild type HSP104. The restoration of wild type HSP104
allowed for assessment of whether the cells contained any species capable of propagating [PSI+].
Throughout the time course tested, the hsp104-R830S cells were phenotypically [PSI+] on galactose
plates while the hsp104Δ cells had truly lost the prion phenotype (red in color indicating efficient
translation termination).
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Figure 2.7 Soluble oligomeric [PSI+] propagons are infectious and maintain the prion variant
structure.
A, Fractions of [PSI+] and hsp104-R830S cryptic [PSI+] lysates separated on a linear sucrose gradient by
a 22 hour ultracentrifugation step were analyzed by western blot and the amount of Sup35 (presented as
the percent of soluble Sup35) in each fraction was quantified by Image J and is indicated below each
fraction in the western blot. Equal volumes of each fraction were transformed into [psi-] cells. The
fraction of infected [PSI+] cells obtained from each gradient fraction is indicated for hsp104-R830S (black)
and HSP104 (grey) cells. The fraction of infected [PSI+] cells was generated by compiling the infectivity
data from four (HSP104) or five (hsp104-R830S) separate sucrose gradients and transformations. Sup35
in hsp104-R830S lysates appears to be more susceptible to proteolysis and frequently shows
degradation products. Protein molecular weight markers (kD) are indicated. B, Total, soluble, and
insoluble fractions of HSP104 [PSI+] lysates from sedimentation analysis were transformed into [psi-]
cells. The relative infectivity of the total, soluble, and insoluble fractions was calculated as above and is
indicated. Inset: A western blot for Sup35 in Total (T), Soluble (S), and Insoluble (I) fractions from one
sedimentation assay in this experiment with protein molecular weight marker (kD). Of the thousands of
red colonies resulting from transformation of the soluble and insoluble fractions from wild type [psi-] cells
as a negative control, further analysis verified that 48 from each fraction were [psi-] in each of three
independent experiments. C, Total (T), Soluble (S), and Insoluble (I) fractions of HSP104 [PSI+] lysates
from sedimentation analysis were analyzed by SDD-AGE. The soluble fraction is from the top of the
supernatant to prevent contamination from the pellet. This experiment was repeated three times. D, Two
representative tetrads from the mating of hsp104-R830S cryptic [PSI+] to [psi-] were spotted on YPD
(upper) and SD-Ade plates (lower) to assess the level of nonsense suppression. Strong [PSI+] (Control
A), weak [PSI+] (Control B), and [psi-] (Control C) strains were spotted for reference. E, The lysates of the
four white haploids from the tetrads in (C) were analyzed by SDD-AGE and compared to strong (St) and
weak (Wk) [PSI+] controls.
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Chapter 3: Regulation of the Hsp104 M-Domain Activity is Critical for Prion Propagation

Jennifer Dulle and Heather True
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Abstract
Molecular chaperones play a significant role in preventing protein misfolding and aggregation in
order to prevent toxicity and protein loss-of-function. Indeed, protein conformational disorders resulting
from the misfolding and aggregation of proteins and have been linked to changes in the chaperone
network. In yeast, molecular chaperones also play a role in prion propagation. Yeast prions are selfreplicating amyloid aggregates, which are proposed to play a functional role in yeast cell biology. Yeast
prion propagation requires the molecular chaperone Hsp104 to fragment prion aggregates to generate
propagons which can transmit the prion conformation to soluble prion protein monomers. Hsp104 is an
AAA+ ATPase involved in disaggregating stress-induced protein aggregates that is essential for yeast
prion propagation. Here, we show that the coiled-coil middle domain of Hsp104 is an integral part of the
prion propagation mechanism. We have generated mutations in the M-domain of Hsp104 which are
predicted to stabilize either the repressed or de-repressed conformation of the M-domain and have
characterized the effect of these mutations on Hsp104 activity. We show that mutations predicted to
stabilize the repressed conformation of the M-domain inhibit general chaperone activity. On the other
hand, de-repressed mutations have differential effects on ATP hydrolysis and disaggregation suggesting
that the M-domain is involved in coupling these two mechanisms. Furthermore, we show that changes in
the M-domain have more of an effect on weak [PSI+] variants whereas strong [PSI+] variants are less
susceptible to de-regulation of the middle domain. Additionally, changes in the M-domain differentially
affect of [PSI+] and [RNQ+] propagation, further supporting the hypothesis that these two prions vary in
their dependence and interaction with Hsp104. Thus, we provide evidence that regulation of the Mdomain of Hsp104 is critical for efficient prion propagation and that elucidating the role of the M-domain in
the mechanism of prion propagation is important for understanding propagation of individual prions as
well as prion variants.

Introduction
Protein aggregates pose a considerable challenge to cellular homeostasis. As such, protein
misfolding and aggregation are guarded against by molecular chaperones, which act as the cell’s first line
of defense by promoting proteostasis. In bacteria, fungi, and plants, the Hsp100 chaperones, together
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with Hsp70 and Hsp40 chaperones, are responsible for disaggregating protein aggregates and promoting
cell survival in response to cell stress[1,2]. The AAA+ ATPase Hsp104 is the primary disaggregase in the
yeast Saccharomyces cerevisiae[3,4]. Hsp104 is essential for cell survival post-heat stress
(thermotolerance) as well as recovery from various other stresses[4,5]. Like its bacterial homolog, ClpB,
the hexameric Hsp104 threads aggregated protein substrates through a central channel to be refolded by
Hsp70 chaperones[6,7].
In addition to its role in protein disaggregation, Hsp104 is also essential for yeast prion
propagation[8]. Prions in yeast are self-replicating, cytoplasmically inherited protein aggregates proposed
to play a role in cellular adaptation and survival[9,10]. Prions are amyloidogenic in nature, and the selfpropagating templates are cross β-sheet structures that are highly stable and resistant to high
temperature and detergents[11]. One of the best characterized yeast prions is formed from the reversible
aggregation of the translation termination factor, Sup35[12,13,14]. This prion, called [PSI+], has been
proposed to play a role in creating genetic diversity by promoting translation of normally silent regions of
the genome[15]. Interestingly, the de novo formation of [PSI+] is regulated by another yeast prion,
[RNQ+], resulting from the aggregation of the Rnq1 protein[16,17,18,19]. The proposed function for the
prion [RNQ+] is to act as an amyloid template for the conversion of monomeric Sup35 to the prion
conformation[16,18]. The formation of [PSI+] has been shown to increase cell viability under various
stresses suggesting that the formation and propagation of [PSI+] is an important biological process and
must be highly regulated[10,15,20]. As such, prion propagation and maintenance in yeast cells require
efficient fragmentation to generate prion-competent oligomers, or propagons, that can be transmitted to
daughter cells. Hsp104 is proposed to remodel prion aggregates to produce propagons, which as a result
generates more free fiber ends that appear to be required for additional monomer
templating[21,22,23,24]. Furthermore, Hsp104 has been implicated in the selection and propagation of
prion variants, or conformationally-distinct aggregates of the same protein sequence[25,26,27].
Alterations in the stability of prions, in the different variant structures, are proposed to govern their
interaction and fragmentation by Hsp104[25,28,29].
Structurally, Hsp104 can be divided into five functionally-distinct, yet cooperative, domains. The
N-terminal domain is not required for either prion propagation or thermotolerance, but has been proposed
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to be a site for substrate binding, as well as an interaction site for the Hsp70s and Hsp40s[30,31]. Two
nucleotide-binding domains, NBD1 and NBD2, bind and hydrolyze ATP to catalyze the disaggregation
mechanism and stabilize hexamer formation[32]. The role of the C-terminal domain is still not well
understood as it is unnecessary for prion propagation and thermotolerance yet both activities are affected
by mutations in this domain[30,33,34]. Finally, the linker region, or middle domain (M-domain), is
proposed to regulate both ATP hydrolysis and substrate disaggregation by coordinating the individual
actions of NBD1 and NBD2[30,35,36].
The M-domain is a coiled-coil insertion between NBD1 and NBD2 and is characteristic of Hsp100
chaperones that function as disaggregases, including the bacterial homolog, ClpB[37,38]. Biochemical,
genetic, and structural studies with both Hsp104 and ClpB suggest that the M-domain projects from the
body of the hexamer and makes contact with the NBD1 of neighboring subunits[39,40,41]. In both
Hsp104 and ClpB, the M-domain regulates ATP hydrolysis[40,42,43], is essential for substrate
disaggregation[44,45,46], and mediates the interaction between Hsp104 and the Hsp70
chaperones[44,47,48]. Recent data suggests that the M-domain of ClpB can occupy two distinct
functional states, repressed and de-repressed[43]. In the repressed state, the M-domain is nestled
against the body of the hexamer, maintaining contact with a neighboring NBD1. Interaction with Hsp70 is
proposed to promote a shift of the M-domain away from NBD1 to the de-repressed conformation, thereby
increasing the ATPase activity and, in turn, promoting substrate disaggregation[36,43]. ClpB mutations
that stabilize the M-domain in the repressed state prevent ATPase stimulation by substrate and decrease
substrate disaggregation[43]. On the other hand, mutations in ClpB that prevent binding of the M-domain
to NBD1 result in hyperactivity and cause toxicity in vivo[36,43]. Thus, the mobility of the M-domain plays
a significant role in regulating the activity of ClpB, and is presumed to play a similar role in Hsp104. As
such, elucidating the function of the M-domain in each aspect of Hsp104 activity is critical to
understanding how Hsp104 is able to disaggregate a broad range of substrates.
In the present study, we generated mutations in the M-domain of Hsp104 analogous to the
repressed and de-repressed mutations in ClpB and investigated their effect on thermotolerance and yeast
prion propagation. We found that M-domain mutants predicted to repress the mobility of the M-domain
prevent thermotolerance and prion propagation. Strikingly, mutations we hypothesized would de-repress
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Hsp104 M-domain function also result in prion elimination. Our data show that the M-domain regulates
Hsp104 disaggregase activity and suggest that changes in the mobility of the M-domain have significant
consequences for prion propagation.

Results
Hsp104 M-domain mutant, hsp104-V426I, causes sectoring [PSI+] phenotype
We performed a genetic screen to identify factors important for aggregation of the translation
termination factor Sup35, and the resulting propagation of the [PSI+] prion. To identify candidates, we
used a color-based phenotypic assay established to follow [PSI+] propagation. In this assay, a premature
termination codon is present in the ADE1 gene, ade1-14, which prevents completion of the adenine
biosynthesis pathway. Disruption of adenine biosynthesis causes the accumulation of a red-pigmented
intermediate and prevents these cells from growing on media lacking adenine. Suppression of the
premature termination codon leads to completion of the adenine biosynthesis pathway resulting in cells
that are phenotypically light pink or white when grown on rich media (YPD) and are able to grow on media
lacking adenine. When Sup35 is monomeric and functional (in non-prion containing [psi-] cells),
translation termination is efficient, and the ade1-14 cells appear red in color and do not grow on media
lacking adenine. Conversely, when Sup35 is in a prion state, it is aggregated and less functional, and the
[PSI+] colonies are ADE+ (light pink in color on YPD and able to grow on media lacking adenine). From
our screen, we identified a candidate that caused the [PSI+] cells to change from a light pink phenotype to
a sectoring color phenotype (Fig. 3.1A). When a fraction of the cells in a colony do not inherit [PSI+]
propagons, those cells become [psi-] and phenotypically red. All of the progeny resulting from those [psi-]
cells will also be [psi-] and this pattern of inheritance can result in a sectoring color phenotype. By
genetic testing, we discovered that this phenotype resulted from a point mutation in Hsp104. We
sequenced HSP104 in this mutant strain and identified the mutation as hsp104-V426I.
To determine whether this Hsp104 mutant was affecting the aggregation of Sup35 in [PSI+] cells,
we transformed the hsp104-V426I mutant strain with Sup35NM-GFP and analyzed the Sup35
aggregation pattern by fluorescence imaging. In hsp104-V426I cells, we observed cells that contained
fluorescent foci indicative of Sup35 aggregates as well as cells that displayed diffuse fluorescence similar
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to [psi-] cells (Fig. 3.1B). Interestingly, the hsp104-V426I cells with fluorescent foci contained a single or
a few large fluorescent foci, unlike the wild type [PSI+] cells, which contained multiple, small fluorescent
foci (Fig. 3.1B). Thus, we conclude that the mutant hsp104-V426I affects the aggregated state of the
prion determinant Sup35 reflecting the changes in the [PSI+] phenotype.

Hsp104-V426 is located in the coiled-coil M-domain
To determine how this mutation may be affecting Hsp104 function, we examined the structural
models of Hsp104 to determine where this residue is located[39,49]. We discovered that V426 appears
to be located in the first helix of motif 1 of the M-domain of Hsp104 and is analogous to the L424 residue
in ClpB. Recently, data on the structure and function of the M-domain of ClpB suggested that the L424
residue plays a role in mediating the mobility and position of the coiled-coil M-domain by contributing to
the interaction between the M-domain and NBD1 of the neighboring subunit. Another residue in the Mdomain of ClpB, Y503, has also been shown to regulate M-domain mobility[43]. The Y503 residue
interacts with NBD1, though it does so intramolecularly rather than interacting with the neighboring
subunit like L424. Mutation of this residue, Y503D, led to a pronounced decrease in KJE-dependent
(DnaK-DnaJ-GrpE, KJE) ClpB disaggregation activity[42]. More recently, ClpB-Y503D was shown to
increase the rate of substrate-stimulated ATP hydrolysis and cause toxicity when expressed in bacteria
grown at high temperatures[43]. Thus, the Y503D mutation in ClpB was proposed to be hyperactive by
stabilizing the de-repressed conformation of the M-domain. As such, we wondered if the Hsp104-V426I
mutation we identified in our screen might be disrupting the function of the Hsp104 M-domain in a similar
fashion. To further test this, we referred to two classes of ClpB M-domain mutants, repressed and derepressed, that had varying effects on the function of ClpB[43,50]. In a recent study, two repressed
mutants, ClpB-E432A and ClpB-D480C, and two de-repressed mutants, ClpB-K476C and ClpB-Y503D,
were analyzed for their affect on ClpB ATPase activity, disaggregation activity, and cell growth[43]. We
created the analogous mutations in the M-domain of Hsp104 to determine if the effects of these mutants
on disaggregase function are conserved between the chaperones. The analogous repressed Hsp104
mutations are predicted to be Hsp104-D434A and Hsp104-D484C. Likewise, Hsp104-K480C and
Hsp104-Y507D are analogous to the de-repressed mutations. We also generated Hsp104-V426C
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analogous to the ClpB-L424C mutation used to characterize the interaction of the M-domain with NBD1.
We first analyzed the biochemical properties and disaggregation activities of these mutants to determine
if they display similar functional effects as their counterparts in ClpB. Then, we analyzed the effect of
these mutants on the propagation of yeast two prions - [PSI+] and [RNQ+].

M-domain mutants display varying levels of ATPase activity and hexamer formation
One proposed function of the M-domain is to regulate ATPase activity by interacting with NBD1 of
the neighboring subunit in the hexamer and coordinating ATP binding and hydrolysis between NBD1 and
NBD2[40,42,51]. Both the repressed and de-repressed ClpB mutants showed basal levels of ATP
hydrolysis similar to wild type ClpB[43]. However, the de-repressed ClpB mutants had significantly higher
substrate-stimulated ATPase activity[43]. To determine if the analogous M-domain mutants in Hsp104
had a similar impact on the ATPase activity, we purified recombinant wild type Hsp104 and the M-domain
mutants and measured both the basal and substrate-stimulated ATP hydrolysis rates by the Malachite
Green assay[32]. Interestingly, Hsp104-V426I, the mutant identified in our screen that altered [PSI+]
propagation, maintained wild type rates of both basal and substrate-stimulated ATP hydrolysis (Fig. 3.2).
Hsp104-D434A, Hsp104-D484C, and Hsp104-V426C exhibited decreased basal levels of ATPase activity
as compared to wild type, while Hsp104-K480C and Hsp104-Y507D displayed higher rates of basal
ATPase activity (Fig. 3.2). Additionally, wild type Hsp104, Hsp104-V426I, Hsp104-V426C, Hsp104K480C, and Hsp104-Y507D all exhibited increased rates of ATP hydrolysis in the presence of substrate
(Fig. 3.2). Conversely, addition of substrate did not increase the ATP hydrolysis rate above the basal
level for Hsp104-D434A or Hsp104-D484C.
The ATPase activity of Hsp104 depends on the oligomeric state of the chaperone. Hsp104
mutants that inhibit hexamer formation also inhibit ATP hydrolysis[32]. Indeed, the M-domain has also
been implicated in hexamer formation[40]. We reasoned that the decreased rates of ATP hydrolysis for a
subset of the M-domain mutants might correlate with inefficient hexamer formation or a change in stability
of the hexameric state. To test this, we incubated the purified Hsp104 M-domain mutants with ATP and
then subjected the samples to ultracentrifugation on a linear glycerol gradient. Both Hsp104-D434A and
Hsp104-V426C, which displayed decreased rates of ATP hydrolysis, also displayed a decrease in stable
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hexamer formation (Fig. 3.3A). Hsp104-D484C appeared in two distinct populations: one that migrates
like wild type Hsp104 that represents the hexameric pool, and one that migrates similar to the lowmolecular weight species observed for Hsp104-V426C and Hsp104-D434A (Fig. 3.3A). Thus, the
apparent lack of efficient hexamer formation of these three mutants, Hsp104-D434A, Hsp104-D484C, and
Hsp104-V426C, likely contributes to the observed decrease in their ATPase activity. Alternatively,
Hsp104-V426I, Hsp104-K480C, and Hsp104-Y507D all form hexamers and sediment on the gradient like
wild type Hsp104 (Fig. 3.3B). Therefore, Hsp104-D434A, Hsp104-D484C, and Hsp104-V426C appear to
decrease the ability of the M-domain to regulate ATPase activity and hexamer formation, while Hsp104K480C and Hsp104-Y507D appear to cause hyperactivity, resulting in increased basal ATPase activity
and an apparent de-repressed state.

Hsp104-K480C and Hsp104-Y507D cause cell toxicity in a temperature-dependent manner
Since the repressed and de-repressed ClpB mutants showed a difference in cell viability at high
temperatures[43], we next tested if any of the Hsp104 M-domain mutants showed temperature-dependent
growth defects. We grew the mutant strains described above on media that selected for the plasmid at
25, 30, and 37°C. At 25 and 30°C, all the mutant strains grew as well as the wild type HSP104 cells (Fig.
3.4). At 37°C, however, both hsp104-K480C and hsp104-Y507D were unable to grow (Fig. 3.4). This
defect in growth at high temperature is similar to that of the analogous ClpB mutants, ClpB-K476C and
ClpB-Y503D, which were hypothesized to be hyperactive mutants that result in cellular toxicity [43,50].
For comparison, a vector-only control was also plated, and this strain shows normal cell growth.
Therefore, the toxicity associated with these mutant strains is not due to a lack of Hsp104 or a simple
loss-of-function, but suggests a toxic gain-of-function for these mutants that impairs cell growth. As this
toxicity is observed at 37°C which induces Hsp104 expression, we hypothesize that constitutive
expression of these two mutants is detrimental to cellular homeostasis resulting in decreased viability.
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M-domains mutants present varying levels of thermotolerance and non-prion aggregate
disaggregation
Hsp104 is required for cell viability following heat shock (thermotolerance)[5]. To confer
thermotolerance, Hsp104 must disaggregate non-prion substrates that aggregate as a consequence of
the heat stress. The M-domain of Hsp104 (and ClpB) is proposed to affect the disaggregation of
substrates by providing a site for an interaction with co-chaperones (Hsp70 and Hsp40 in yeast, DnaK
and DnaJ in bacteria)[42,47]. Thus, mutations in the M-domain which abrogate interaction with cochaperones may have a negative effect on the ability of the chaperone to disaggregate substrates.
Furthermore, as the ATPase activity and disaggregation activity are interdependent, mutations in the Mdomain that affect the regulation of ATPase activity may also affect the disaggregation mechanism.
Therefore, we investigated the disaggregation activity of the Hsp104 M-domain mutants in vivo by
analyzing their ability to confer thermotolerance to yeast, as well as their ability to disaggregate heataggregated luciferase. We first transformed an hsp104Δ strain with a plasmid expressing each of the Mdomain mutant Hsp104 genes, wild type HSP104, or an empty vector control. We then grew these
strains to mid-logarithmic phase at 30°C, moved them to 37°C to induce expression of Hsp104, then heat
shocked the strains at 50°C for various amounts of time before plating the cells to assess viability. We
found that, like the hsp104Δ strain, hsp104-D434A and hsp104-D484C cells were not thermotolerant (Fig.
3.5A). Alternatively, both hsp104-V426I and hsp104-V426C cells maintained wild type thermotolerance
ability (Fig. 3.5A). Interestingly, the two mutants with the highest ATPase activity, hsp104-K480C and
hsp104-Y507D, presented an intermediate level of thermotolerance, where the amount of
thermotolerance fell between that of wild type HSP104 and hsp104Δ strains (Fig. 3.5A).
We next tested the ability of the M-domain mutants to disaggregate heat-aggregated luciferase,
which has previously been shown to be a substrate of Hsp104[30]. The strains described above,
containing a plasmid expressing either wild type or mutant Hsp104, were transformed with a plasmid
expressing luciferase. These strains were grown for an hour at 37°C to induce Hsp104 expression then
heat shocked for an hour at 44°C to induce luciferase aggregation. After heat shock, the cells were
allowed to recover at 30°C and we took samples periodically to quantify the relative amount of
luminescence as a measure of the amount of luciferase resolubilized by Hsp104. As we saw in the
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thermotolerance assays, hsp104-D434A and hsp104-D484C cells resembled the hsp104Δ strain in that
there appeared to be no increase in the amount of resolubilized luciferase over time (Fig. 3.5B). In
contrast, hsp104-V426I, hsp104-V426C, hsp104-K480C, and hsp104-Y507D cells exhibited luciferase
recovery at about half the rate as that observed in wild type HSP104 cells. Thus, these data correlate
with the thermotolerance data and suggest that Hsp104-D434A, Hsp104-D484C, Hsp104-K480C, and
Hsp104-Y507D have defects in disaggregation. Alternatively, Hsp104-V426I and Hsp104-V426C appear
to affect the disaggregation of specific substrates.

Hsp104 M-domain mutants vary in their ability to propagate variants of the [PSI+] prion
Given the varying effects of the M-domain mutants on ATPase activity and disaggregation ability,
we next sought to ascertain the effect of the M-domain mutants on [PSI+] propagation. We first
demonstrated that Hsp104-V426I caused a defect in the propagation of one [PSI+] variant, strong [PSI+],
and resulted in sectoring colonies (Fig. 3.1A). To investigate the effect of the remaining M-domain
mutants on strong [PSI+] propagation, we transformed a strong [PSI+] heterozygous diploid containing
wild type HSP104 and hsp104Δ with a plasmid containing either wild type HSP104 or the M-domain
mutants. Instantly, we noticed that Hsp104-D434A was dominant and cured the [PSI+] diploids to
generate red [psi-] diploids (Fig. 3.6A). Next, the diploids were sporulated, and we selected haploids
harboring hsp104Δ and each wild type or mutant Hsp104 plasmid and analyzed them phenotypically to
assess [PSI+] propagation. By nonsense suppression, hsp104-V426I cells appeared to sector while
hsp104-V426C, hsp104-K480C, and hsp104-Y507D appeared darker pink, indicative of a weaker
nonsense suppression phenotype (Fig. 3.6A). In contrast, hsp104-D434A, and hsp104-D484C, appeared
to resemble the vector control, suggesting that these mutations do not propagate strong [PSI+] (Fig.
3.6A). We next performed SDD-AGE analysis on the haploids to determine the effect of the mutants on
Sup35 aggregate distribution and to confirm our analyses of the color phenotype. By SDD-AGE analysis,
hsp104-V426I, hsp104-V426C, and hsp104-K480C cells maintained aggregates of Sup35 while hsp104D434A, hsp104-D484C, and hsp104-Y507D cells did not (Fig. 3.6B).
The distribution of Sup35 aggregates in hsp104-V426C and hsp104-K480C cells is shifted
compared to wild type HSP104 strong [PSI+] cells, suggesting that cells expressing these mutants may
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be propagating a weak variant of [PSI+] in correlation with the decreased nonsense suppression
phenotype[24,52]. Therefore, we next tested if any of the mutants were capable of propagating a weak
[PSI+] variant. Using the same approach as for strong [PSI+], we transformed weak [PSI+] heterozygous
diploids expressing wild type HSP104 and hsp104Δ with plasmids expressing either wild type HSP104 or
the M-domain mutants. Similar to our observations with the strong [PSI+] diploid, hsp104-D434A
dominantly cured diploids carrying a weak [PSI+] variant (Fig. 3.6C). Since hsp104-D434A dominantly
cures two distinct variants of [PSI+], we propose that this mutation inhibits wild type Hsp104 function in
mixed hexamers. Interestingly, diploids expressing hsp104-K480C also appeared to decrease nonsense
suppression suggesting that hsp104-K480C might have a dominant curing effect on weak [PSI+] (Fig.
3.6C). Next, we sporulated the diploids and isolated hsp104Δ haploids expressing the wild type or
mutant HSP104 to assess the color phenotype. We observed that none of the Hsp104 M-domain
mutants were able to propagate the weak variant of [PSI+] (Fig. 3.6C). To confirm this phenotypic
observation, we performed SDD-AGE analysis and surprisingly found that hsp104-V426C cells contained
Sup35 aggregates (Fig. 3.6D).
Interestingly, despite several attempts to generate strong or weak [PSI+] haploids expressing
hsp104-Y507D, we were only able to isolate a single haploid expressing hsp104-Y507D from the strong
[PSI+] heterozygous diploid (Fig. 3.6B). In fact, this single haploid was unable to further grow beyond the
initial isolation (Fig. 3.6B). In addition to sporulating diploids, we also attempted to replace the wild type
HSP104 in a strong [PSI+] strain with hsp104-Y507D by co-expressing both wild type HSP104 and
hsp104-Y507D and then eliminating the wild type HSP104 plasmid. This method also proved
unsuccessful at isolating [PSI+] cells expressing hsp104-Y507D. From these data, we propose that
hsp104-Y507D is highly toxic in the presence [PSI+]. Consequently, we would predict that [PSI+] cells
that lost the prion and became [psi-] would still be viable in the presence of hsp104-Y507D. Intriguingly,
we were even unable to isolate any [psi-] cells expressing hsp104-Y507D after sporulation, suggesting
that the combination of either strong or weak [PSI+] and hsp104-Y507D is so potent that toxicity occurs
before cells have a chance to reverse the prion phenotype. Furthermore, expression of hsp104-Y507D in
hsp104Δ [psi-] [rnq-] cells showed no similar toxicity, suggesting that toxicity is dependent on Sup35
aggregation. Similar toxicity in the presence of [PSI+] has been observed for another M-domain mutant,
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hsp104-A503V, suggesting that prion-dependent toxicity is not specific for this one residue, but may be
caused by a deregulation of M-domain function[53].

M-domain mutants are able to propagate distinct variants of [RNQ+]
We next examined the ability of the M-domain mutants to propagate several variants of the
[RNQ+] prion. Similar to [PSI+], the [RNQ+] prion is also sensitive to changes in Hsp104 activity and
variants of [RNQ+] are differentially affected by changes in Hsp104 activity[54,55]. Several variants of
[RNQ+] exist that are characterized by their ability to induce the [PSI+] prion phenotype and the
aggregate pattern observed in cells by fluorescence[16,56]. [RNQ+] variants display either a single-dot
(s.d.) or multi-dot (m.d.) pattern of fluorescence describing the appearance of Rnq1-GFP aggregates in
[RNQ+] cells[56]. [RNQ+] variants that display s.d. fluorescence can facilitate the induction of [PSI+] at
low, medium, high, and very high rates upon Sup35 overexpression. On the other hand, the only
established m.d. variant of [RNQ+] exhibits a high rate of [PSI+] induction. We utilized these five
characterized [RNQ+] variants to ascertain the effect of M-domain mutants on conformational variants of
[RNQ+].
We utilized a plasmid shuffle technique to determine the effect of the M-domain mutants on the
[RNQ+] variants. Strains containing each [RNQ+] variant harbor a chromosomal hsp104Δ and are
complemented by the expression of wild type HSP104 from a plasmid. We transformed the plasmids
containing the M-domain mutants into these strains, then, selected for cells that eliminated the wild type
HSP104 by growing them on counter-selection media to determine the effect of the mutants on the preexisting [RNQ+] variants. Interestingly, we observe a differential effect of these mutants on the
propagation of the [RNQ+] variants. Of the M-domain mutants, hsp104-V426I and hsp104-K480C cells
were able to maintain all of the tested [RNQ+] variants (Fig.3.7). On the other hand, cells expressing
hsp104-D434A were [rnq-] in all of the tested variants of [RNQ+], suggesting that this mutant is a general
prion inhibitor. Interestingly, cells expressing hsp104-V426C and hsp104-Y507D were able to propagate
all but the s.d. medium and s.d. very high [RNQ+] variants, while hsp104-D484C cells propagate only the
s.d. low variant of [RNQ+]. Furthermore, all M-domain mutants, excepting hsp104-V426I, were
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characterized by a shift in the aggregate distribution of Rnq1 aggregates in all of the tested [RNQ+]
variants.

Discussion
Here, we present analysis of six Hsp104 M-domain mutants, which have differential effects on
chaperone function and cell viability. Initially, we identified Hsp104-V426I from a screen for factors that
affected [PSI+] propagation. We observed that hsp104-V426I cells had defects in [PSI+] propagation that
manifested as a sectoring [PSI+] phenotype. We have observed this phenotype before from other
Hsp104 mutants that have varying effects on Hsp104 structure and function (upublished data) but this
was the only mutation we identified that is located in the M-domain. The coiled-coil M-domain of Hsp104
is proposed to regulate ATPase activity, substrate disaggregation, and co-chaperone interactions[38].
We noted that the V426 residue in Hsp104 is analogous to the recently characterized L424 residue in
ClpB, which was shown to play a role in regulating the position and mobility of the M-domain in ClpB[43].
Previously, it was shown that the stability of the coiled-coil M-domain of ClpB depends on the leucine
zipper-like interactions between leucine and isoleucine residues and that mutation of these residues to
alanine caused significant changes in chaperone activity, ATP hydrolysis, and hexamer formation[57].
Perhaps, then, mutation of the valine at residue 426 to an isoleucine disrupts the normal isoleucineleucine interactions, resulting in slight destabilization of the M-domain. Although we do not have direct
evidence that the V426I mutation in the M-domain of Hsp104 alters the interaction of the M-domain with
the neighboring NBD1 domain, previous data from ClpB suggest that this residue may contribute to Mdomain positioning, and that mutation of this residue could disrupt interactions of the M-domain with
neighboring subunits within the hexamer.
In order to elucidate the effect of the V426I mutation on the function of the M-domain of Hsp104,
we examined the rates of ATP hydrolysis, hexamer formation, and thermotolerance and disaggregation.
We also examined these same properties among a set of mutations in the M-domain that in ClpB were
proposed to stabilize the repressed or de-repressed conformation of the M-domain resulting in changes in
the regulation of overall chaperone activity[43,50]. We generated the analogous mutations in Hsp104
and characterized their ability to form hexamers, hydrolyze ATP, and disaggregate protein substrates.
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We found that, in general, the M-domain mutants had similar effects on the activity of Hsp104 as they
displayed in ClpB.
Both Hsp104-D434A and Hsp104-D484C decreased overall ATPase activity and disaggregation
activity suggesting that prolonged occupation of the repressed state inhibits Hsp104 activity[43]. The Mdomain mutants Hsp104-K480C and Hsp104-Y507D increased the overall rate of ATP hydrolysis and
caused toxicity when cells were grown at higher temperatures indicative of the proposed effects of the derepressed conformation on M-domain function. Interestingly, our data for the rates of ATP hydrolysis of
Hsp104-K480C differed from a recent report in that we found an increase in the basal ATPase activity
compared to wild type Hsp104[41]. Interestingly, from biochemical characterization, both Hsp104-V426I
and Hsp104-V426C appear to stabilize neither the repressed nor the de-repressed conformation, as
those effects are characterized by the other analyzed mutants. Instead, we propose that the Hsp104V426I and Hsp104-V426C mutations result in a semi-repressed conformation that only moderately affects
the regulatory function of the M-domain. The difference in the ATP hydrolysis rates of Hsp104-V426I and
Hsp104-V426C suggest that the biochemical properties associated with the side chain of this residue are
important. A range of phenotypes associated with the identity of the mutated residue is also observed for
the Hsp104 M-domain residue D484. In a previously published report, mutation of D484 to a lysine
(D484K) was characterized by cellular growth defects and increased ATPase and chaperone activity,
which is the opposite of our data for Hsp104-D484C[36]. Interestingly, this study suggests that disruption
of the ionic interactions associated with Hsp104-D484 leads to hyperactivity while we show that disruption
of these ionic interactions can also lead to reduced activity[36]. Thus, the M-domain is finely tuned to
regulate various functions of Hsp104 and disruption of this balance can lead to severe consequences for
Hsp104 function.
Although several studies have examined the role of the M-domain in the regulation of protein
disaggregation and ATPase activity, much less is known about the effect of the Hsp104 M-domain
regulatory function on yeast prion propagation. Here, we show that mutations that disrupt M-domain
function also inhibit prion propagation. The repressed mutants, Hsp104-D434A and Hsp104-D484C,
inhibit propagation of both strong and weak [PSI+] variants. The M-domain mutant Hsp104-D434A is
even more pronounced as it inhibits wild type Hsp104 function to cause dominant curing of both variants
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of [PSI+]. Additionally, the de-repressed mutants Hsp104-K480C and Hsp104-Y507 appear to have
distinct effects on [PSI+] propagation despite similar biochemical properties. Hsp104-K480C is able to
propagate strong [PSI+] but has a semi-dominant curing effect on weak [PSI+]. These data correlate well
with observations that overexpression of Hsp104 cures weak [PSI+] variants more efficiently than strong
variants, though the mechanism of [PSI+] elimination by excess Hsp104 is not well understood[8,58,59].
Another hypothesis to explain the differences observed between weak and strong [PSI+] is that weak
[PSI+] variants are more dependent on Hsp70s and Hsp40s for efficient propagation, as varying levels of
Hsp70 expression can have greater effects on weak [PSI+] variants than strong variants[60]. Indeed,
Hsp104 acts in concert with Hsp70s and Hsp40s and the balance of this complex is important[1,61,62].
As the de-repressed M-domain mutants of ClpB were shown to have reduced interaction with the KJE
chaperones, and Hsp104-K480C is deficient in thermotolerance and luciferase refolding, perhaps a
reduced interaction of Hsp104-K480C with co-chaperones is responsible for the curing of the weak [PSI+]
variants.
Our biochemical data for Hsp104-V426I as a semi-repressed mutant correlate well with the
sectoring [PSI+] phenotype observed in hsp104-V426I cells. Unlike the repressed mutants, Hsp104D434A and Hsp104-D484C, which cure [PSI+], the semi-repressed Hsp104-V426I and Hsp104-V426C
maintain strong [PSI+], albeit inefficiently, and inhibit propagation of weak [PSI+]. Recently, a decreased
interaction of Hsp104 with weak [PSI+], as compared to strong [PSI+], was demonstrated in vitro[25], and
we have recently shown that decreased Hsp104 activity is sufficient to propagate strong but not weak
variants of [PSI+] (Dulle and True, unpublished data). Therefore, changes in the regulatory function of
the M-domain alter the ability of Hsp104 to stably propagate distinct [PSI+] variants.
In addition to changes in [PSI+] propagation, we also found differential effects of the M-domain
mutants on the propagation of conformational variants of the [RNQ+] prion. The repressed M-domain
mutants, Hsp104-D434A and Hsp104-D484C cannot propagate any tested variant of [RNQ+]. Although
we have previously characterized a mutant of Hsp104 that displays decreased activity but is still able to
propagate specific variants of [RNQ+], clearly a threshold of activity exists that is required for [RNQ+]
propagation[54]. Interestingly, the M-domain mutants Hsp104-Y507D and Hsp104-V426C are able to
propagate the two variants of [RNQ+] (s.d. medium and very high) but not the others while Hsp104-
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D484C could propagate the s.d. low variant of [RNQ+]. We have previously characterized mutations in
Hsp104, which showed differential propagation among the [RNQ+] variants[54]. One hypothesis for
differential prion variant propagation suggests that the stability of the prion variant dictates the interaction
with Hsp104[25]. However, the s.d. [RNQ+] variants have been shown to have similar stabilities,
suggesting that stability is only one contributing factor toward Hsp104 interaction[63]. Another
contributing factor may be the amount of soluble Rnq1 as the variants were shown to differ in the amount
of soluble Rnq1 with s.d. very high and s.d. low [RNQ+] containing the most[63]. However, our data also
suggest that medium [RNQ+], which contains less soluble Rnq1 than low and very high but more than
high, is also propagated differentially among the M-domain mutants. Curiously, the semi-repressed
mutant, Hsp104-D484C, shows a similar pattern of [RNQ+] variant propagation as the de-repressed
Hsp104-Y507D mutant. How these two mutants with different biochemical properties show the same
pattern of [RNQ+] propagation is as yet unclear. Furthermore, our data clearly demonstrates the
complexity of prion variant propagation and illustrates the need for further investigation to understand the
mechanism of interaction between chaperones and conformationally distinct prion variants.
The structure and function of the Hsp104/ClpB M-domain has been a subject of much
investigation and controversy in recent years. Various structural studies of ClpB and Hsp104 have
proposed significantly different models for M-domain position in relation the hexameric
structure[39,49,64]. More recent data suggest that the true placement of the M-domain may be a
combination of previous models. Specific residues in the M-domain are protected, suggesting that at
least part of the M-domain is tightly packed into the body of the hexamer[43,47,49]. Additionally, crosslinking and fluorescence quenching experiments suggest that the M-domain contacts residues in the
NBD1 either in the neighboring subunit or in the same subunit[43]. Furthermore, the flexibility of the Mdomain to break and re-form these contacts is integral to regulation of the chaperone function by the Mdomain[36,43,50]. The data in our study do not lend direct support any one structural model, but do
suggest that the M-domain of Hsp104 plays a key role in regulating the disaggregation of both prion and
non-prion substrates.
The M-domain has clearly been determined to play a significant role in regulating Hsp104/ClpB
function. Characterization of mutations in the M-domain demonstrates that this coiled-coil region affects
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all of the distinct activities that Hsp104/ClpB possesses, suggesting that this domain may be the master
regulator of Hsp104/ClpB function[35,36,42,43,44,47,50,53]. As such, elucidation of the M-domain
regulatory mechanism is vital to our understanding of the disaggregation mechanism of Hsp104/ClpB.

Materials and Methods
Strain and Plasmid Construction
All S. cerevisiae strains were derivatives of 74-D694 and were grown using standard culture
techniques. Strains were grown in YPD (1% yeast extract, 2% peptone, 2% glucose) or synthetic media
lacking amino acids with correlated with plasmid selection (0.67% yeast nitrogen base, 2% glucose).
Hsp104 mutants were cloned into the pRS313 vector for expression in vivo. Point mutations in
HSP104 were generated by bridge PCR (oligonucleotides listed in Supplementary Table One) using
pRS313-phs-HSP104 (kindly provided by B. Bukau) as the template. Bridge PCR and pRS313-phsHSP104 were digested with EcoRI and Bsu36I and ligated together. Hsp104 mutants were also cloned
into pProEx-HTb-HSP104 (kindly provided by J. Glover[34]) by the same digestion and ligation. The
pRS313-phs-hsp104-V426I plasmid was generated by PCR amplifying HSP104 from the EMS
mutagenized strain, then digesting and ligating as described.
The Lindquist lab characterized and kindly provided the strong [PSI+] variant[8,65]. The Liebman
lab characterized and kindly provided the weak [PSI+] variant[65]. The Sc4 and Sc37 [PSI+] variants,
made by transforming Sup35 fibers assembled at 4°C and 37°C into [psi-] cells, were made and kindly
provided by the Weissman lab[66]. To analyze the mutant pRS313-phs-HSP104 plasmids in the [PSI+]
variants, each variant was mated to an hsp104Δ (hsp104::leu2) strain and diploids were selected. The
mutant pRS313-phs-HSP104 plasmids were transformed into the heterozygous diploids, the diploids
were sporulated, and haploids were selected on media lacking histidine and leucine. Colonies were
verified as haploids by plating on A and α strains to determine mating type.
The [RNQ+] variant strains were kindly provided by the Liebman lab. To create strains carrying
both the mutant Hsp104 plasmids and the [RNQ+] variants, we created an HSP104 plasmid shuffle strain.
First, pRS316-phs-HSP104 (kindly provided by J. Weissman) was first transformed into each of the
[RNQ+] variants. HSP104 on the chromosome was deleted by transforming in the knock-out cassette
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pAG32-HygromycinB that had been PCR amplified to contain flanking sequences to HSP104
(oligonucleotide sequences in Supplementary Table One). Deletion strains were confirmed first by
selection on media lacking uracil and containing Hygromycin B (Invitrogen) then by colony PCR. These
strains were then transformed with each of the mutant pRS313-hsp104 plasmids, selected on media
lacking histidine and uracil, grown overnight in liquid media lacking just histidine, and then plated on
media lacking histidine and containing 5’Fluoroorotic acid (US Biologicals) to select for cells that had
dropped the pRS316-phs-HSP104 plasmid. Colonies that grew on media lacking histidine but not uracil
were selected.

EMS mutagenesis screen
The strong [PSI+] yeast strain was subjected to EMS mutagenesis as previously described[54].
Two cultures with viabilities of about 17% were plated to determine changes in color. Candidates were
selected based on color phenotype and were initially identified as mutations in HSP104 by back-crossing
to an hsp104Δ strain and analyzing the progeny for segregation of the prion-dependent nonsense
suppression phenotype. Genomic DNA was PCR amplified and sequenced to identify the point mutations
in HSP104.
SDD-AGE
Cells were lysed by disruption of the membranes with glass beads in Sup35 PEB buffer (25mM
Tris-HCl pH 7.5, 50mM KCl, 10mM MgCl2, 1mM EDTA, 10% Glycerol plus mini EDTA-free protease
inhibitors (Roche), Aprotinen (Sigma) and PMSF (Sigma)) or Rnq1 PEB buffer. Samples were incubated
in sample buffer at room temperature for seven minutes then separated on a 1.5% agarose gel. The
protein distribution was analyzed by western blot with anti-Sup35 antibody or antibody against Rnq1.
Hsp104 Purification
Recombinant Hsp104 was expressed and purified from E. coli cells as previously described[67].
After purification, the pool of recombinant Hsp104 was separated on an S-300 gel filtration column to
isolate Hsp104 monomers. Purified, monomeric Hsp104 was concentrated and frozen at -80°C.
ATP Hydrolysis Assays
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The Malachite green assay was used to measure the rates of ATP hydrolysis[32]. Purified
protein (2µg) was incubated with 5mM ATP in buffer (40mM TrisHCl pH7.5, 175mM NaCl, 5mM MgCl2,
0.02% Triton X-100) at 37°C. At each minute over a time course of 12 minutes, Malachite green dye was
added to the sample and the reaction stopped by the addition of 34% citric acid. The absorbance was
measured at 650nm and the concentration of free phosphate calculated based on a standard of KH 2PO4
and normalized to the sample containing no Hsp104.
Glycerol Gradients
Purified Hsp104 was centrifuged at 34k rpm for 18 hours through a 4mL linear (10-35%) glycerol
gradient. The gradients were fractionated and equal volumes of each fraction were analyzed by SDSPAGE and western blot using anti-Hsp104 antibody. Individual bands from each fraction were quantified
using Image J and reported as a percent of total Hsp104.
Thermotolerance
An equal number of cells from cultures of HSP104, hsp104-V426I, hsp104-V426C, hsp104K480C, hsp104-Y507D, hsp104-D434A, hsp104-D484C, and hsp104Δ were treated at 37°C for 30
minutes to induce HSP104 expression, then heat-shocked at 50°C. At 10, 15, 20, 25, and 30 minutes
during heat shock, samples were taken and spotted media lacking histidine in a five-fold dilution.
Luciferase Refolding
An hsp104Δ strain containing plasmids expressing HSP104, hsp104-V426I, hsp104-V426C,
hsp104-K480C, hsp104-Y507D, hsp104-D434A, hsp104-D484C, and an empty vector control were
transformed with pRS316-GPD-luciferase, a plasmid expressing luciferase (kindly provided by
B.Bukau)[6]. Cells were grown at 37°C for one hour, then heat-shocked at 44°C for one hour. Fifty
minutes into the heat shock, cycloheximide (Sigma) was added to the culture to block protein synthesis.
At various times during recovery at 30°C, 100 µL samples were taken and 50µL of 1mM beetle luciferin
(Promega) was added. Luminescence was measured on a Sirius luminometer. The resolubilization of
luciferase was calculated by dividing the measured luminescence at each time point by the measured
luminescence prior to heat shock and normalized to the luminescence measured immediately after heat
shock.
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Figure 3.1 A point mutation in Hsp104 destabilizes [PSI+]. A, Cells expressing hsp104-V426I or
HSP104 were plated onto rich media to illustrate the destabilizing effect this mutation has on [PSI+]. In
the presence of hsp104-V426I, [PSI+] is lost by a fraction of the buds, generating sectors of [psi-]
(phenotypically red) cells in the [PSI+] colony. B, The copper-inducible fluorescent protein, Sup35NMGFP, was transformed into hsp104-V426I and wild type [PSI+] and [psi-] cells. Fluorescence imaging
was done on an Olympus confocal microscope.
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Figure 3.2 Hsp104 M-domain mutants affect ATPase activity. The ATPase activity of recombinant
Hsp104, Hsp104-V426I, Hsp104-V426C, Hsp104-D434A, Hsp104-D484C, Hsp104-K480C, and Hsp104Y507D was measured by the Malachite Green assay after incubation with 5mM ATP either in the
absence (black) or presence (grey) of 0.25mg/mL β-casein. The amount of free inorganic phosphate in
each sample was calculated by comparison with a standard phosphate solution. For each protein, the
average initial rate of ATP hydrolysis is plotted. Each protein was measured in quadruplicate from two
separate purification preparations and error bars reflect standard deviation between the samples.
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Figure 3.3 The M-domain plays a role in hexamer formation. The oligomeric distribution of
recombinant Hsp104 (dark blue, A & B) and Hsp104-V426I (red), Hsp104-K480C (yellow), and Hsp104Y507D (green) (A) and Hsp104-V426C (orange), Hsp104-D434A (purple), and Hsp104-D484C (grey) (B)
was analyzed by ultracentrifugation through a linear glycerol gradient in the presence of 5mM ATP.
Equal fractions from the gradients were collected and analyzed by western blotting with anti-Hsp104
antibody. The amount of Hsp104 in each fraction was quantified by Image J and graphed as a fraction of
the total Hsp104. The gradients were repeated twice with recombinant protein from two separate
purification preparations.
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Figure 3.4 Hsp104-K480C and Hsp104-Y507D are toxic at high temperatures. Hsp104Δ strains
expressing wild type HSP104, hsp104-V426I, hsp104-V426C, hsp104-K480C, hsp104-Y507D, hsp104D434A, and hsp104-D484C from a HIS3-expressing plasmid were plated on media lacking histidine and
grown at 25, 30 or 37°C to assess temperature-dependent growth defects. A vector-only control is also
plated.
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Figure 3.5 M-domain mutants have differing affects on the ability to disaggregate non-prion
substrates. A, hsp104Δ strains expressing wild type HSP104, hsp104-V426I, hsp104-V426C, hsp104K480C, hsp104-Y507D, hsp104-D434A, and hsp104-D484C from a HIS3-expressing plasmid were heatshocked to measure the mutants’ ability to function in thermotolerance. The mutant and wild type cells as
well as an empty vector control (Vector) were heat-shocked at 50°C for various amounts of time then
plated on media lacking histidine to assess viability. The spottings represent a five-fold serial dilution. B,
The same hsp104Δ strains containing a plasmid expressing luciferase and expressing wild type HSP104
(red), hsp104-V426I (purple), hsp104-V426C (light blue), hsp104-K480C (yellow), hsp104-Y507D (green),
hsp104-D434A (orange), hsp104-D484C (pink), or an empty vector control (dark blue) were grown at
37°C to induce Hsp104 expression then heat-shocked at 44°C for an hour to induce luciferase
aggregation. At fifty minutes into heat shock, cycloheximide was added to the cells to block new protein
synthesis. At various times during recovery, samples were taken, luciferin was added, and the
luminescence was measured. The graph represents the amount of luciferase recovered as a fraction of
the total luciferase before heat shock. Three separate samples for each mutant were analyzed and error
bars reflect standard deviation between the samples.
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Figure 3.6 M-domain mutants differentially affect propagation of strong and weak variants of
[PSI+]. A, Strong [PSI+] diploids or haploids were transformed with plasmids expressing HSP104,
hsp104-V426I, hsp104-V426C, hsp104-D434A, hsp104-D484C, hsp104-K480C, hsp104-Y507D or an
empty vector control (EV) and spotted on media selecting for the plasmid. Each column is a five fold
dilution. B, Strong [PSI+] haploids expressing HSP104, hsp104-V426I, hsp104-V426C, hsp104-D434A,
hsp104-D484C, hsp104-K480C, or hsp104-Y507D, as indicated, were subjected to SDD-AGE analysis
and western blot with antibody against Sup35. This is one representative of three separate experiments.
C, Weak [PSI+] diploids or haploids were transformed with plasmids expressing HSP104, hsp104-V426I,
hsp104-V426C, hsp104-D434A, hsp104-D484C, hsp104-K480C, hsp104-Y507D or an empty vector
control (EV) and spotted on media selecting for the plasmids. Each column is a five fold dilution. D,
Weak [PSI+] haploids expressing HSP104, hsp104-V426I, hsp104-V426C, hsp104-D434A, hsp104D484C, hsp104-K480C, hsp104-Y507D, or an empty vector control were subjected to SDD-AGE analysis
and western blot with antibody against Sup35. This is one representative of two separate experiments.
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Figure 3.7 M-domain mutants differentially propagate [RNQ+] variants. Strains containing the
[RNQ+] variants, s.d. low, medium, high, and very high and m.d. high, expressing HSP104, hsp104V426I, hsp104-V426C, hsp104-D434A, hsp104-D484C, hsp104-K480C, hsp104-Y507D, or an empty
vector control (EV) were subjected to SDD-AGE analysis and western blot with antibody against Rnq1.
Each SDD-AGE is on representative of at least three separate experiments.
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Abstract
The molecular chaperone network plays a critical role in the formation and propagation of self-replicating
yeast prions. Not only do individual prions differ in their requirements for certain chaperones, but
structural variants of the same prion can also display distinct dependences on the chaperone machinery,
specifically Hsp104. The AAA+ ATPase Hsp104 is a disaggregase required for the maintenance of most
known yeast prions. As a key component in the propagation of prions, understanding how Hsp104 differs
in its interactions with specific variants is crucial to understanding how prion variants may be selected or
evolve. Here, we investigate two novel mutations in Hsp104, hsp104-G254D and hsp104-G730D, which
allow us to elucidate some mechanistic features of Hsp104 disaggregation and its requirement for activity
in propagating specific prion variants. Both Hsp104 mutants propagate the [PSI+] prion to some extent,
but show a high rate of prion loss. Both Hsp104-G254D and Hsp104-G730D display reduced
biochemical activity, yet differ in their ability to efficiently resolubilize disordered, heat-aggregated
substrates. Additionally, both mutants impair weak [PSI+] propagation, but are capable of propagating
the more stable strong [PSI+] variant to some extent. One of the Hsp104 mutants also has the ability to
propagate one variant of the [RNQ+] prion. Thus, our data suggest that changes in Hsp104 activity limit
substrate disaggregation in a manner that depends more on the stability of the substrate than the nature
of the aggregated species.

Introduction
Prions are self-templating, amyloidogenic protein aggregates. In mammals, prions are
associated with several neurodegenerative diseases, including scrapie in sheep, chronic wasting disease
1, 2

in deer and elk, and Creutzfeldt-Jacob disease in humans.

In the budding yeast Saccharomyces

cerevisiae, prions are non-toxic, epigenetic elements of inheritance, but they do share many
3-5

characteristics with mammalian prions and other disease-related amyloidogenic proteins.

The yeast
6,

prion [PSI+] results from a self-propagating aggregated state of the translation termination factor Sup35.
7

Aggregation of Sup35 results in partial loss-of-function that leads to an increase in global nonsense
8

suppression. Consequently, the ability to generate [PSI+] cells, coupled with the reversible or
metastable nature of this prion mechanism, and has been proposed to be advantageous due to the ability
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9, 10

to alter phenotypes through the [PSI+]-dependent translation of normally silent regions of the genome.
Interestingly, the appearance of the [PSI+] prion appears to be regulated by the presence of another
11-15

yeast prion, called [RNQ+] (or [PIN+]) which is the aggregated form of the Rnq1 protein.

Though the

soluble protein Rnq1 (in [rnq-] cells) has no known function, the prion state of Rnq1, [RNQ+], functions to
promote the de novo induction of [PSI+], and is often required for the aggregation of other amyloidogenic
16

proteins in yeast.

Although the prion conformation is self-templating, the maintenance of prions in yeast relies on
the molecular chaperone network to produce aggregates that can be transmitted from mother to daughter
cells. The AAA+ ATPase chaperone Hsp104 is a disaggregase required for propagation of both [PSI+]
11, 17-19

and [RNQ+], as well as all other recognized yeast prions.

Hsp104, in concert with Hsp70 and

Hsp40 chaperones, also functions to resolubilize proteins that aggregate as a consequence of various
20, 21

environmental stresses.

Hsp104 has five distinct domains and is functional as a hexamer that
22-24

contains a central pore used for threading substrates.

The N-terminal domain is proposed to play a

role in substrate recognition and may also be a site for interaction of co-chaperones, though the N25

terminal domain is not required for either thermotolerance or prion propagation.

The two ATP-binding

domains (NBD1 and NBD2), connected by a coiled-coil linker domain, both bind and hydrolyze ATP to
26, 27

power the disaggregation mechanism.

Lastly, the function of the fifth modular domain, the C-terminal

domain, is still mostly unclear, though some data have implicated this domain as having a role in
28, 29

substrate interaction and processing.

The proposed role of Hsp104 in prion propagation is to fragment prion aggregates in order to
generate the smaller heritable species, or propagons.

30-32

Consequently, deletion of Hsp104 eliminates

both [PSI+] and [RNQ+], and several mutants in each domain of Hsp104 have been characterized that
12, 17, 33-36

affect [PSI+] and [RNQ+] propagation.

Interestingly, [PSI+] is especially sensitive to changes in

the Hsp104 system as the overexpression of Hsp104 eliminates [PSI+] to generate [psi-] cells, whereas
12, 17, 37, 38

Hsp104 overexpression does not eliminate [RNQ+].
37, 39, 40

amyloid formation of prion proteins in vitro.

Hsp104 has also been shown to catalyze

Furthermore, maintenance of prions by Hsp104 is

aided by Hsp70 and Hsp40 co-chaperones, and overexpression or deletion of these chaperones can
41-47

affect prion propagation.
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Yeast prions exist as an array of self-propagating structures, known as prion variants (analogous
to “prion strains” in mammalian prion nomenclature). Although formed from the same protein sequence,
prion variants maintain distinct structures having varying stabilities and causing different cellular
phenotypes, much like mammalian prion strains result in variation in disease pathology.

48-52

Prion

variants have been described for both [PSI+] and [RNQ+]. [PSI+] variants are characterized by the
amount of nonsense suppression they confer, which is related to the ability of the aggregate to template
monomeric Sup35.

53-55

Weak variants of [PSI+] maintain an increased pool of monomeric Sup35 relative

to strong [PSI+] variants. As such, weak [PSI+] variants show less nonsense suppression (more folded,
soluble Sup35 means more translation termination). Additionally, distinct Sup35 amyloid structures have
been generated using denatured, recombinant protein (usually using just the prion-forming domain, also
49, 50

called “NM”) by simply changing the temperature at which amyloid fibers are formed.

From structural

studies of in vitro formed amyloid, Sup35 aggregates with a shorter protected amyloid core are less stable
and give rise to a strong [PSI+] phenotype when [psi-] cells are infected with these aggregates, while
49, 50, 56

fibers with longer, more stable cores tend to give rise to weak [PSI+] phenotypes upon infection.

Recent data suggest that the longer, more stable core associated with the weaker [PSI+] variants is more
57, 58

refractory to Hsp104 activity or interaction.

In contrast, the shorter core of strong variants is more

labile to Hsp104 disaggregation, resulting in the generation of more propagons in strong [PSI+] cells, and
57

thus increased conversion of monomeric Sup35.

As such, strong [PSI+] variants present a stronger

nonsense suppression phenotype as compared to weak [PSI+] variants, and are better able to propagate
when challenged with fluctuations in Hsp104 activity.
Variants of [RNQ+] were first identified in vivo and were characterized by their differential ability
to facilitate formation of the [PSI+] prion.

15, 59

These variants were named low, medium, high, and very
15

high [PIN+] to indicate their rate of [PSI+] induction.

These [PIN+]/[RNQ+] variants were further

described by their patterns of fluorescence when Rnq1 was tagged with GFP.

60

Two distinct phenotypes

were observed: cells that contained multiple, small fluorescent foci termed multi-dot (m.d.), and cells that
contained a single, large fluorescent focus termed single-dot (s.d.). [RNQ+] variants that induced [PSI+]
at low, medium, high, and very high rates were all found within the microscopic s.d. pattern, while only
one m.d. [RNQ+] variant was characterized and it induced [PSI+] at a high rate. Further investigation of
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these established [RNQ+] variants showed that a distinct region of the Rnq1 protein was required for
propagation of certain variants, suggesting that [RNQ+] variants, like [PSI+], may also differ in their core
61

region.

Similar to Sup35, Rnq1 fibers display distinct characteristics when generated under various
62

conditions in vitro,

though structural studies to elucidate the amyloid core of these [RNQ+] variants have

not yet been done. Additionally, much less is understood about the interaction between [RNQ+] and
Hsp104 and how changes in Hsp104 activity affect propagation of specific [RNQ+] variants.
Here, we characterize two novel mutations in Hsp104 that we identified as causing a defect in
[PSI+] propagation. We show that these mutations decrease select activities of Hsp104, resulting in
diminished disaggregation activity of specific substrates. Finally, we find that defects in [PSI+] and
[RNQ+] propagation are specific for certain prion variants, thereby providing further evidence for the
hypothesis that Hsp104 may interact more efficiently with less stable [PSI+] variants than more stable
variants, and that this may also hold true for variants of [RNQ+].

Results
Point mutations in HSP104 cause a defect in the maintenance of [PSI+]. We performed a
mutagenesis screen in order to identify factors required for the propagation of a specific variant of the
[PSI+] prion. To identify such factors, we used a colony color based phenotypic assay commonly used to
track [PSI+] prion propagation. In this colorimetric assay, a premature stop codon in the ADE1 gene,
ade1-14, blocks the completion of the adenine biosynthesis pathway and results in the accumulation of a
red-pigmented intermediate. Disruption of the pathway at this point also results in the inability of these
cells to grow on media lacking adenine. Cellular changes that afford an increase in nonsense
suppression of the premature stop codon in ade1-14 can result in production of sufficient Ade1 protein to
generate light pink or white colonies and allow for growth on media lacking adenine. Such an increase in
nonsense suppression can be generated by reduced function of the translation termination complex
8

(eRF1 and eRF3, or Sup45 and Sup35, respectively). This can occur either by mutation of either
termination factor or by conversion of wild type Sup35 into a prion state. When Sup35 is monomeric and
fully functional in [psi-] cells, the premature stop codon in ade1-14 is recognized, resulting in colonies that
are red in color on rich media and cannot grow on media lacking adenine. When Sup35 is aggregated in
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[PSI+] cells, however, the nonsense codon is suppressed and the [PSI+] cells appear white on rich media
and can grow on media lacking adenine.
In addition, structural variants of the [PSI+] prion present a range of color phenotypes indicative
of the amount of soluble Sup35 characteristic of those variants. For example, because of the relative
increase in soluble Sup35, weak [PSI+] strains harboring ade 1-14 are pink in color on rich media. In our
screen, we expected to find mutants that affected [PSI+] propagation by a change in color phenotype
from the light pink indicative of strong [PSI+] in our parent 74-D964 strain. Interestingly, in addition to
mutations that completely inhibited [PSI+] propagation, we found a subset of mutations that partially
inhibited [PSI+] inheritance. These mutants displayed a sectoring color phenotype on rich media (Fig.
4.1A). Color sectoring within a [PSI+] colony results when a fraction of the budding daughter cells lose
the prion, thereby producing sections of the colony that are [psi-] and phenotypically red. We identified
two point mutations in the chaperone Hsp104 that demonstrated an interesting effect on the inheritance of
[PSI+] unlike the curing phenotype that is often characterized. These mutants, which we sequenced to
identify as hsp104-G730D and hsp104-G254D, presented varying levels of sectoring and [PSI+] loss (Fig.
4.1A). We recreated both mutants in an unmutagenized [PSI+] 74-D694 strain by double homologous
recombination to verify the phenotypic effects and used these strains for all subsequent analyses.
In order to determine how the mutants affected the biochemical properties of Sup35 in [PSI+]
cells, we first performed SDD-AGE (semi-denaturing with detergent agarose gel-electrophoresis)

63

and

analyzed the SDS-resistant Sup35 species. In hsp104-G254D and hsp104-G730D cell lysates, we found
that the size of the Sup35 aggregate distribution was increased, as was the amount of Sup35 monomer
(Fig. 4.1B). From these data, one could hypothesize that these Hsp104 mutants are unable to efficiently
fragment Sup35 aggregates, resulting in larger aggregates that cannot be as easily passed on to
daughter cells. In addition, less propagons would also result in decreased monomer addition and a larger
pool of monomeric Sup35. Alternatively, the mutants could be propagating a weak variant of [PSI+] which
would be predicted to show the same change in aggregate pattern.

Strong [PSI+] propagons are maintained in both hsp104-G254D and hsp104-G730D. The SDD-AGE
analysis of the mutant strains (Fig. 4.1B) showed an increase in both high-molecular weight species and
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30

Sup35 monomer, which is characteristic of weak [PSI+] variants.

However, the original [PSI+] variant in

the screen was strong [PSI+]. Thus, we used a genetic test and phenotypic test to analyze whether the
mutants appeared to be propagating a different variant of [PSI+] or if the variant propagated in the
sectoring colonies still appeared to be strong [PSI+]. As the mutants are recessive, we could readily
analyze the properties of the variant by mating the sectoring hsp104-G254D and hsp104-G730D cells to
wild type [psi-] cells, sporulating diploids, and analyzing resultant haploid progeny phenotypically and
biochemically. Mating [PSI+] hsp104-G254D and [PSI+] hsp104-G730D cells to wild type [psi-] cells
resulted in diploids that were light pink, and more similar to the strong [PSI+] parent than the mutant
haploids (Fig. 4.2A). Sporulation of the diploids resulted in tetrads with two stable [PSI+] haploids and
two sectoring/ weaker [PSI+] haploids. For both heterozygous diploids, the two haploid progeny that
expressed wild type HSP104 resembled strong [PSI+] phenotypically, by both color and growth on media
lacking adenine (Fig. 4.2B). Finally, we performed SDD-AGE analysis on cell lysates from full tetrads
obtained from the heterozygous diploids and compared the aggregate distribution of the wild type
HSP104 haploids to lysates from control cells containing the parental strong [PSI+] variant. The
biochemical analyses correlated with the colorimetric phenotypes: all the wild type haploids propagated
Sup35 aggregates that resembled those from control strong [PSI+] cell lysates (Fig. 4.2C). In sum, our
phenotypic and biochemical analyses suggest that the underlying structure of Sup35 aggregates is
retained in [PSI+] cells harboring the hsp104-G254D and hsp104-G730D mutations; however, when
these mutations are present as the only copy of Hsp104 in the cell they are unable to efficiently propagate
the prion to maintain the strong [PSI+] phenotype.

Hsp104 missense mutant proteins are defective in ATP hydrolysis and efficient hexamer
formation. As the increased size of the Sup35 aggregates in hsp104-G254D and hsp104-G730D cells
could suggest a fragmentation defect of Hsp104, we next investigated whether these mutations affected
ATP hydrolysis. We purified recombinant wild type Hsp104, Hsp104-G254D, and Hsp104-G730D
proteins from E. coli cells. We then tested the ability of Hsp104-G254D and Hsp104-G730D to hydrolyze
ATP by monitoring release of inorganic phosphate using the Malachite Green assay.
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The G254D

mutation is in NBD1 and G730D is in NBD2 and as such, may be involved in ATP binding or hydrolysis.
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As compared to wild type Hsp104, both mutants had significantly reduced ATPase activity (Table 4.1).
Surprisingly, these results contradict previous results in the literature, which demonstrate that mutants of
17, 33

Hsp104 that display similarly low levels of ATP hydrolysis often cure [PSI+].

As ATP hydrolysis is dependent on the ability of Hsp104 to form hexamers,

64

we next
65

investigated whether these mutants were capable of oligomerizing in the presence of nucleotide.

Using

glycerol gradient fractionation in the presence of ATP, we found that Hsp104-G254D and Hsp104-G730D
do form hexamers, though appear to do so less efficiently than wild type, as there was a slight shift in the
peak of Hsp104-G254D and Hsp104-G730D toward the top of the gradient (Fig. 4.3). In the absence of
ATP, wild type Hsp104 and the mutant proteins remain monomeric (data not shown). Thus, the reduced
ATP hydrolysis of both Hsp104-G254D and Hsp104-G730D may correlate with their inefficient
hexamerization ability.
We reasoned that if the majority of the mutant were in the hexameric state, we might observe wild
type levels of ATPase activity from the mutants. Hsp104 has previously been shown to hexamerize even
in the absence of ATP when incubated in a buffer containing low salt (<20mM).

64

Therefore, we again

measured hydrolysis of ATP by the Malachite green assay, this time in a low salt (15mM NaCl) buffer to
promote hexamerization. In low salt buffer, we found that the NBD2 mutant, Hsp104-G730D, displayed
ATPase activity similar to wild type (Table 4.1). Hsp104-G254D, however, did show an increase in ATP
hydrolysis in low salt buffer, but not to the same extent as Hsp104 or Hsp104-G730D, suggesting the
hexamer defect of Hsp104-G254D may not be the only cause of the reduced rate of ATP hydrolysis.

Low activity mutations in HSP104 vary in their ability to disaggregate non-prion substrates. In
addition to its role in prion propagation, Hsp104 is also necessary for cell survival following acute heat
shock.

21

With the aid of Hsp70 and Hsp40 co-chaperones, Hsp104 resolubilizes proteins that aggregate
20

as a result of heat or other stresses and is crucial for cellular recovery from such stresses.

Therefore,

we tested the ability of Hsp104-G254D and Hsp104-G730D to provide thermotolerance. We first pretreated cells at 37°C to induce Hsp104 expression, and then heat-shocked HSP104, hsp104Δ, hsp104G254D, and hsp104-G730D cells at 50°C for various times as indicated, before plating on rich media to
determine the relative viability. We found that both wild type HSP104 and hsp104-G254D were
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thermotolerant, but hsp104-G730D cells were not, and resembled the hsp104Δ strain (Fig. 4.4). Thus,
despite having lower ATPase activity, Hsp104-G254D was more active in thermotolerance assays than
Hsp104-G730D, suggesting that the mechanism of disaggregation is de-coupled from the ATP hydrolysis
activity for these two mutants.

hsp104-G254D and hsp104-G730D do not propagate weak [PSI+]. Recently, it has been shown that
some mutations in Hsp104 that reduce ATPase activity can impair the propagation of weak [PSI+]
66

variants, but not strong [PSI+] variants.

Accordingly, we next tested the ability of hsp104-G254D and

hsp104-G730D to propagate weak [PSI+] variants. We mated hsp104-G254D [psi-] and hsp104-G730D
[psi-] cells to two previously characterized weak [PSI+] variants and examined the diploids and haploid
progeny phenotypically and biochemically.

49, 53

In both weak [PSI+] variants, the heterozygous diploids

displayed decreased nonsense suppression as compared to the wild type weak [PSI+] parent (Fig. 4.5A).
These data suggest that both hsp104-G254D and hsp104-G730D were inhibiting weak [PSI+]
propagation, even in the presence of wild type HSP104. After sporulation, we observed two distinct
patterns of inheritance in the haploid progeny. Resultant tetrads were either all red and [psi-], or
segregated 2:2 weak [PSI+]:[psi-] (Fig. 4.5B) where the [PSI+] progeny segregated with the wild type
HSP104. Loss of the [PSI+] phenotype, even in the wild type haploids, is consistent with the increased
mitotic loss of weak [PSI+] we observed in the diploids. Presumably, the reduced activity of Hsp104G254D and Hsp104-G730D prevent weak [PSI+] propagation and also partially inhibit wild type Hsp104
from stably propagating weak variants. Next, we chose tetrads that maintained weak [PSI+] in the wild
type haploids for SDD-AGE analysis and found that the variant propagated resembled the weak [PSI+]
parent (Fig. 4.5C). Thus, hsp104-G254D and hsp104-G730D do not irreversibly decrease the ability of
wild type HSP104 to propagate weak [PSI+] variants and do not appear to alter the prion variant structure
by phenotypic assays.

hsp104-G730D propagates a known variant of [RNQ+]. Like [PSI+], the [RNQ+] prion is also
12

dependent on Hsp104 for its maintenance.

To determine if the prion propagation defect observed in

hsp104-G254D and hsp104-G730D cells was specific to [PSI+], we tested the ability of both mutants to
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propagate several established [RNQ+] variants. After mating [psi-] hsp104-G254D and [psi-] hsp10459

G730D cells to the s.d. low, medium, high, very high, and m.d. high variants of [RNQ+]

and sporulating

the diploids, we performed SDD-AGE on the hsp104-G254D and hsp104-G730D haploids to determine
the [RNQ+] state of the cells. Interestingly, we found one variant of [RNQ+], the m.d. high variant, that
was propagated, at least to some extent, in hsp104-G730D cells (Fig. 4.6). None of the s.d. variants
could be propagated by hsp104-G730D, and hsp104-G254D did not propagate any of the [RNQ+]
variants tested (data not shown). Thus, similar to recent reports for [PSI+], these data may suggest that
the m.d. [RNQ+] variant is less stable than the s.d. [RNQ+] variants and thus more refractory to changes
in the activity or interaction with Hsp104.

Discussion
Here, we identify two novel mutations in Hsp104, Hsp104-G254D and Hsp104-G730D, which
affect Hsp104 activity in a substrate- and prion variant-specific manner. Cells carrying the NBD1 mutant,
hsp104-G254D, or the NBD2 mutant, hsp104-G730D, display high mitotic loss of the strong variant of
[PSI+]. Phenotypically, hsp104-G730D displays a high degree of sectoring while hsp104-G254D exhibits
fewer sectoring colonies but more completely [psi-] (red) colonies. Despite both showing marked
reductions in ATP hydrolysis activity under physiological conditions, the mutants differ in their ability to
disaggregate a broad range of substrates, though both are unable to propagate weak variants of [PSI+].
The hsp104-G254D mutant is active in thermotolerance, but is defective in the propagation of all tested
variants of [RNQ+]. On the other hand, Hsp104-G730D expressing strains are unable to resolve
disordered aggregates but, curiously, can propagate at least one variant of the [RNQ+] prion to some
extent.
Manipulation of the chaperone network has long been known to regulate prion propagation and
formation.

17, 20, 27, 67

Hsp104 is a general prion regulator

26, 68, 69

; deletion of Hsp104 eliminates all of the

known yeast prions and dependence on Hsp104 is often one of the criteria used when identifying new
yeast prions.

18, 70-72

Therefore, we were not surprised when several candidates from our mutagenesis

screen for factors involved in [PSI+] propagation were identified as mutations in Hsp104. Several
interdependent features of Hsp104 contribute to its overall function in substrate disaggregation, and
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understanding the effect these features have on each other is not simple. For example, as an AAA+
ATPase, hydrolysis of ATP provides the primary energy for the disaggregase ability of Hsp104 and yet we
identified two mutations, Hsp104-G254D in NBD1 and Hsp104-G730D in NBD2, that still disaggregate
substrates despite having significantly lower rates of ATP hydrolysis. Interestingly, reducing the ATPase
73, 74

activity of Hsp104 was previously shown to enhance substrate disaggregation.

However, the

increased disaggregation ability extended only to disordered substrates; decreased ATPase activity
66, 73

instead impaired prion remodeling.

On the other hand, a highly characterized mutation in the Walker

B motif in NBD1, E285A/Q, hydrolyzes ATP at a rate much higher than wild type (300-500%), but fails to
support either thermotolerance or prion propagation.

33

Therefore, ATP hydrolysis is not always a reliable

indicator for substrate disaggregation ability.
One hypothesis proposed suggested that disordered substrates are less stable and thus require
less overall force by Hsp104 to be disaggregated.

66

High temperature and other stresses result in the

increased exposure of hydrophobic regions in proteins, leading to the formation of unstable,
heterogeneous protein aggregates. Unlike these stress-induced aggregates, prions are highly ordered,
stable protein aggregates that are typically resistant to denaturation by detergents and high temperatures.
Mutations in Hsp104 that promote thermotolerance but are not sufficient for prion propagation have been
33

previously described.

Interestingly, hsp104-G730D cells can propagate strong [PSI+] and m.d. high

[RNQ+], but are unable to function in thermotolerance. Additionally, mutations in the C-terminal domain
including K774E, L814S, L840Q, and 22 or 38 residue deletions of the C-terminus cause a loss of
26, 29, 33

thermotolerance but these mutants are able to propagate [PSI+] to some extent.

These previously

characterized mutants are similar to Hsp104-G730D in that they exhibit reduced ATP hydrolysis and
show defects in hexamerization.

29

As yet, no function has been ascribed to the Hsp104 C-terminal

domain, though some data suggest it is a site of substrate interaction.

28

The hypothesis that Hsp104 is better able to remodel less stable aggregates can also be applied
57

to the broad range of prion variants.

Despite having the same sequence, prion variants compose

distinct structures that vary in stability and hence, may vary in their interaction with Hsp104. Hsp104 has
previously been shown to play a role in prion variant selection.

75

Continued expression of high levels of

Hsp104 resulted in propagation of a [PSI+] variant dependent on overexpression of Hsp104.

120

76

Additionally, recent data show that, like with disordered aggregates, less stable variants of [PSI+] are
57

more efficiently remodeled by Hsp104 despite equal binding affinities for Hsp104.

At low

concentrations, Hsp104 catalyzed the generation of prion-competent seeds of strong variants but was
unable to remodel weak variants. Therefore, the decreased activity of our Hsp104 mutants may
specifically inhibit weak variants of [PSI+] in vivo due to the inability to interact with or remodel this
specific amyloid structure or any structure that is more stable. Moreover, expressing the mutant
concurrently with wild type, as seen in the diploids, caused mitotic loss of weak [PSI+] variants, thereby
supporting previous results indicating that weak variants require a high level of cooperativity between
66

hexameric subunits to propagate.

In addition to causing unstable strong [PSI+] propagation, hsp104-G730D is also able to
propagate m.d. high [RNQ+] to some extent. The m.d. high [RNQ+] variant has been shown to be less
61, 76

thermal-stable than the s.d. [RNQ+] variants.

We have previously published another mutation in

Hsp104, E190K, which also had a differential effect on the propagation of the [RNQ+] variants. Like
hsp104-G730D, hsp104-E190K was unable to maintain the s.d. variants, but was able to propagate m.d.
34

high [RNQ+].

Additionally, both hsp104-G730D and hsp104-E190K showed defects in both [PSI+]

propagation and thermotolerance. Our data from these two mutants suggest that variants of the [RNQ+]
prion may be regulated by Hsp104 in a manner similar to the mechanisms elucidated for [PSI+].
Interestingly, the m.d. [RNQ+] variant that is the most resistant to alterations in Hsp104 activity also
facilitates a high rate of [PSI+] induction. It’s interesting to theorize that changing environmental
conditions may cause fluctuations in Hsp104 activity that in turn control the appearance and
disappearance of prions, and as such, the environment may influence prion-dependent phenotypic
variation, adaptability and survival in different conditions. Therefore, discerning Hsp104’s mechanism of
disaggregation, as it applies to distinct prion variants, is critical to understanding how prions appear,
disappear, and evolve.
As our understanding of self-propagating prions continues to develop, so too does the knowledge
that the biological phenomenon of protein-only heritability is highly complex. In addition to mutations in
the primary sequence affecting aggregation and propagation, we now understand that the same primary
sequence can adopt multiple conformations, and these conformations differ in stability, heritability, and
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function. How a single protein sequence can adopt multiple conformations is a biological phenomenon
that is still relatively unclear. Just as gene expression is regulated by an intricate network of transcription
factors and promoter elements, prion variant propagation is regulated by a network of chaperones and in
some cases, other prions. Understanding how changes in the chaperone network regulate prion variant
formation and propagation will broaden our understanding of the mechanisms of prion variant generation,
selection, and evolution.

Materials and Methods
Strain and Plasmid Construction
S. cerevisiae strains used in this study were derivatives of 74-D694 and were grown and
manipulated using standard techniques. Yeast strains were either grown in rich media (1% yeast extract,
2% peptone, 2% glucose) or synthetic media lacking amino acids corresponding to plasmid selection
(0.67% yeast nitrogen base, 2% glucose) or nonsense suppression analyses. Diploids were generated
by mating haploids containing selectable plasmids and were verified by growth on minimal media and
plating on haploid tester strains. Haploid progeny from diploids were isolated by micromanipulation and
verified by phenotypic assays and mating type testing.
Hsp104 mutants from the original mutagenized strains were PCR amplified and cloned into the
pRS306 integrating vector. The mutants were integrated into a clean 74-D694 background by the popin/pop-out method and verified by DNA sequencing. The pProEx-Htb-Hsp104 purification plasmid has
previously been described.

29

Hsp104 mutations were cloned into pProEx-Htb-Hsp104 by restriction

digest with BamHI and Bsu36I followed by ligation and sequencing to verify the mutation.
The “strong” and “weak” [PSI+] variants were characterized and kindly provided by the Chernoff
17

and Liebman labs.

The Sc37 [PSI+] variant was made by transforming Sup35NM fibers generated at
49

37°C into [psi-] cells. These strains were made and kindly provided by the Weissman lab.

The [RNQ+]

variant strains were characterized as specific [PIN+] strains initially, but later confirmed to be [RNQ+], and
were kindly provided by the Liebman lab.

59, 60

To analyze the Hsp104 mutants in both [RNQ+] and [PSI+]

variants, each variant was mated to both hsp104-G254D [psi-][rnq-] and hsp104-G730D [psi-][rnq-] cells
and diploids were selected. The diploids were sporulated and dissected by micromanipulation.

122

EMS Mutagenesis Screen
A strong [PSI+] yeast strain was subjected to EMS mutagenesis as previously described.

34

Two

cultures with viabilities of about 17% were plated to determine changes in color. Candidates were
selected based on color phenotype and were initially identified as mutations in HSP104 by back-crossing
to an hsp104Δ strain and analyzing the progeny for segregation of the phenotype. Genomic DNA was
PCR amplified and sequenced to identify the point mutations in HSP104.
SDD-AGE
SDD-AGE analysis was performed as previously described. Cells were lysed by beadbeating in
PEB buffer (25mM Tris-HCl pH 7.5, 50mM KCl, 10mM MgCl2, 1mM EDTA, 10% Glycerol plus mini EDTAfree protease inhibitors (Roche), Aprotinen (Sigma) and PMSF (Sigma)). Samples were incubated in
sample buffer at room temperature for seven minutes then separated on a 1.5% agarose gel. The protein
distribution was analyzed by western blot with anti-Sup35 antibodies or anti-Rnq1 antibodies.
Hsp104 Purification
Recombinant Hsp104 was expressed in E. coli cells and purified as previously described with one
23

further separation step added.

Briefly, Hsp104, tagged with a 6xHis tag on the N-terminus, was first

isolated on a Nickel-sepharose column, the 6xHis tag was cleaved off using the TEV protease, and
Hsp104 was re-applied to the Nickel-sepharose column to separate the untagged Hsp104. Untagged
Hsp104 was then applied to an anion exchange Q-sepharose column followed by an S-300 size exclusion
column to isolate monomeric Hsp104 from any aggregated Hsp104 species. Untagged, monomeric
Hsp104 was stored at -80°C.
ATP Hydrolysis Assays
64

ATP hydrolysis was measured by the Malachite green assay as previously described.

Briefly,

2µg of purified protein was incubated in buffer (40mM TrisHCl pH7.5, 175mM NaCl, 5mM MgCl 2, 0.02%
Triton X-100) with 5mM ATP at 37°C. At various times, Malachite green dye was added to the sample for
one minute and the reaction was stopped by the addition of 34% citric acid. The dye absorbance was
determined at 650nm and the amount of free phosphate calculated based on a standard of KH 2PO4.
Glycerol Gradients

123

Purified Hsp104 was applied to a 4mL linear (10-35%) glycerol gradient and centrifuged at 34k
rpm for 18 hours in a SLA-600 rotor. Gradients were fractionated and equal volumes of each fraction
were analyzed by SDS-PAGE and western blot using an anti-Hsp104 antibody. Individual bands from
each fraction were quantified using Image J and reported as a percent of total Hsp104.
Thermotolerance
An equal number of cells from cultures of HSP104, hsp104-G254D, hsp104-G730D, and
hsp104Δ grown to mid-log phase were pre-treated at 37°C to induce HSP104 expression then heatshocked at 50°C. At the indicated time intervals, samples were taken and spotted on rich media in a fivefold serial dilution.
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Figure 4.1. hsp104-G254D and hsp104-G730D strains show inefficient [PSI+] propagation.
(A) hsp104-G254D and hsp104-G730D cells display a sectoring [PSI+] phenotype as a result of
inefficient [PSI+] inheritance. (B) Lysates of sectoring hsp104-G254D and hsp104-G730D cells with
strong [PSI+] cells ([PSI+]) and [psi-] cells ([psi-]) as controls were analyzed by SDD-AGE analysis
followed by western blot and blotting for Sup35. These results were reproduced at least three times. An
example of the shift is shown. The general loss of the lower aggregate species and the decrease in
aggregated Sup35 is reproducible. The appearance of monomeric Sup35 on SDD-AGE western blots is
more variable, even with controls, for unknown reasons.
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Figure 4.2 hsp104-G254D and hsp104-G730D cells propagate the original strong [PSI+] variant.
(A) hsp104-G254D and hsp104-G730D cells (G254D and G730D, respectively) and diploids from the
mating of hsp104-G254D and hsp104-G730D to wild type [psi-] cells (WT/G254D and WT/G730D) were
spotted on rich media (YPD) and media lacking adenine (SD-Ade). Strong [PSI+] and [psi-] cells are
spotted for comparison. The second spot in each row is a five-fold dilution of the first spot. (B) Full tetrads
from the sporulation of the diploids in (A) were spotted for each mutant as indicated. Each haploid
progeny in the tetrad is labeled, A-D. Strong [PSI+] and [psi-] are spotted for color comparison. The
second spot in each row is a five-fold dilution of the first spot. (C) A representative tetrad from (B) was
analyzed by SDD-AGE analysis and western blot. The letters A-D correspond to the haploids with the
same label in (B) and weak [PSI+] (Weak), strong [PSI+] (Strong) and [psi-] were analyzed for
comparison. SDD-AGE analysis was performed four times with haploids from both hsp104-G254D and
hsp104-G730D cells.
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Table 4.1 Hsp104 mutants display defects in ATP hydrolysis under physiological salt conditions
Physiological*

Low†

WT

0.225 ± 0.0397

0.732 ± 0.0543

G254D

0.0325 ± 0.00177

0.211 ± 0.00177

G730D

0.00583 ± 0.00439

0.677 ± 0.0321

-1

-1

Numbers represent the average initial rate (nmol·µg ·min ) of ATP hydrolysis for WT Hsp104, Hsp104-G254D,
and Hsp104-G730D. ATPase assays were measured by the Malachite Green assay. Rates were calculated from
three separate experiments from two different preparations of purified protein.
*Buffer contains 150mM NaCl
†
Buffer contains only 15mM NaCl
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Figure 4.3 Hsp104-G254D and Hsp104-G730D mutant proteins form hexamers in vitro.
Hsp104 (blue), Hsp104-G254D (green), and Hsp104-G730D (red) were incubated with 5mM ATP for 10
minutes then subjected to ultracentrifugation through a linear (10-35%) glycerol gradient. Equal volume
fractions were collected and the amount of Hsp104 protein in each fraction was analyzed by SDS-PAGE
and western blot. Individual bands were quantified and the amount of Hsp104 in each fraction was
plotted as a percent of the total Hsp104 protein. The graph shows the data from one assay. This assay
was performed three times and all gave similar results.
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Figure 4.4 hsp104-G254D and hsp104-G730D display different levels of non-prion disaggregation.
The thermotolerance of HSP104, hsp104Δ, hsp104-G254D, and hsp104-G730D cells was tested. Cells
were first grown at 37°C in liquid culture to induce HSP104 expression, heat-shocked at 50°C for 10 to 30
minutes as indicated, and then spotted on rich media. Control cells (No Heat) were plated without heat
shock. Thermotolerance assays were repeated four times and all showed similar results.
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Figure4.5 Neither hsp104-G254D nor hsp104-G730D can propagate weak [PSI+].
(A) Cured hsp104-G254D [psi-] and hsp104-G730D [psi-] cells, weak [PSI+], the weak [PSI+] variant
Sc37(from transformation of [psi-] cells with Sup35NM fibers formed at 37°C), and the diploids from the
matings of the weak [PSI+] cells to the mutants were spotted on YPD. The second spot in each row is a
five-fold dilution of the first spot. (B) Diploids of the mutants crossed to weak [PSI+] (Weak/Mut in (A))
were sporulated and 16 tetrads dissected. Two representative tetrads on YPD are shown. Each haploid
is labeled A-D. (C) Diploids of weak [PSI+] crossed to the mutants (Weak/Mut in (A)) and a representative
tetrad from these heterozygous diploids were subjected to SDD-AGE and western blot analysis to
determine Sup35 aggregate distribution. SDD-AGE analysis was performed twice using four distinct
tetrads.
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Figure 4.6 hsp104-G730D can propagate multi-dot high [RNQ+].
hsp104-G730D cells weremated to s.d. low (low), medium (med), high (high), very high (v.high) and m.d.
high (m.d. high) [RNQ+] and then sporulated. The hsp104-G730D haploid progeny from four separate
tetrads of each variant mating, along with the unmated [RNQ+] variants as controls (WT), were analyzed
by SDD-AGE and western blot.
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Chapter 5: Conclusions and Future Directions
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5.1 Hsp104-R830S and soluble Sup35 oligomers future directions
Summary
1

Yeast prions are self-replicating, protein-only epigenetic elements that are non-toxic. To be
efficiently propagated, prions must be fragmented to generate smaller, prion-competent propagons that
are easily transmissible to the budding cells.

2, 3

Propagons must also maintain the structural information

of the prion in order to faithfully propagate the prion to the soluble prion protein in the newly budded cell.
The generation of these propagons requires the AAA+ ATPase chaperone Hsp104.

2-4

In Chapter 2, I

investigate a point mutant of Hsp104 that propagates soluble, more SDS-sensitive oligomers of Sup35
that are sufficient for transmission of the prion state but are incapable of conferring the nonsense
suppression phenotype associated with [PSI+]. The novel properties of the soluble, prion-competent
Sup35 oligomers can provide insight into the mechanisms of prion formation and propagation. The
following section will describe some experiments designed to utilize them.

Structural analysis of soluble Sup35 oligomeric propagons
Our findings in chapter 2 represent the first identification of soluble oligomers of a prion protein in
vivo. From protein transformation experiments where we transformed [psi-] cells with these soluble
oligomers, we discovered that these oligomers could transmit the prion state to a soluble pool of
monomer. Several studies have hypothesized that propagons in yeast are a soluble oligomeric species,
but until now, these structures have always been transient and have yet to be characterized structurally.
One future experiment is to characterize these amyloid oligomers by several structural methods to
investigate how these structures differ from the large aggregates that confer the [PSI+] phenotype. For
example, structural data of the amyloid aggregate is difficult to achieve due to its large bulky structure.
However, we have shown from matings of hsp104-R830S cells containing soluble Sup35 oligomers to
[psi-] cells that these oligomers retain the same amyloid core as the parental [PSI+] strain. Perhaps, now,
given their soluble nature and small size these structures are more amenable to various structural
techniques such as NMR. Furthermore, these oligomers be analyzed by EM and AFM to determine if
they share ultrastructural features with the intermediate protofilaments identified of Aβ aggregation.
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These oligomers could also be used in single-molecule studies to investigate the templating or joining
mechanism.
In addition to the correct structure, propagons also need to interact with molecular chaperones for
efficient propagation. One area of chaperone involvement that is the least characterized is in prion
formation. When prion monomers template into the β-sheet rich conformation, they first have to unfold
and many prion proteins have natively unfolded or destabilized domains already present. One very
important job of molecular chaperones is to bind unfolded or exposed domains to prevent aggregation.
Interestingly, overexpression of the Hsp70 chaperone Ssa1 leads to increased [PSI+] production, while
the overproduction of another Hsp70, Ssb1, results in increased [PSI+] loss from excess Sup35. What
these mechanisms are and why they are opposing is still unclear. We should use the oligomers to probe
the role of chaperones in the formation of prions by looking at chaperone binding, oligomeric stimulation
of chaperone activity, and specific chaperone domains or activities that may be required for an
interaction.

Analyze the role of oligomeric intermediates for the [RNQ+] prion
In order to determine if oligomeric intermediates are a general property of yeast prions, future
5

experiments should examine the role of oligomers in the propagation of the [RNQ+] prion. In our
experiments, we only closely looked at the Sup35 species in hsp104-R830S cells. By solubility assays,
hsp104-R830S cells were able to maintain [RNQ+]. Similar to wild type [PSI+] cells, wild type [RNQ+]
cells may also contain oligomeric species sufficient for transmission of the [RNQ+] state. Wild type
[RNQ+] cells should be separated by sedimentation and the soluble and insoluble fractions transformed
into [rnq-] cells to determine if any infectious species exist in the soluble fraction. Subsequently, wild type
[RNQ+] lysates should be separated by sucrose gradient fractionation and analyzed by western blot and
protein transformation into [rnq-] cells. Since [RNQ+] does not have an easily observable phenotype like
[PSI+] does, a Rnq1 reporter developed in our lab should be used to quantify the infectivity of specific
soluble or oligomeric species. The RRP construct is a chimera of the Rnq1 prion-forming domain and the
middle and C-terminal domains of Sup35 and can be used as a phenotypic readout of the [RNQ+] state.
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Analyze the role of oligomeric intermediates in the propagation of conformational variants
Recombinant Sup35 can form distinct amyloid structures in vitro when assembled under different
temperatures.

6, 7

Structural variation is also the basis for prion variants observed in cells, such as weak
8-10

and strong [PSI+] and the low, medium, high, and very high variants of [RNQ+].

One hypothesis is

that the formation of amyloid oligomers is also conformation-dependent and may only occur under certain
conditions, as seen for Sup35 and PrP.

11-13

Therefore, the presence of amyloid oligomers in variants of

the [PSI+] and [RNQ+] prions should be assessed. Again, this could be done by separating soluble
oligomers from SDS-resistant aggregates by sucrose gradients and sedimentation assays and using the
species isolated to infect [psi-] or [rrp-] cells and quantify the amount of infectivity. By SDD-AGE and
14,

solubility assays, weak [PSI+] maintains an increased soluble pool of Sup35 compared to strong [PSI+].
15

Perhaps this soluble pool is not simply functional monomer, but a mix of oligomeric species, of which

some may be highly infectious.

Determine the domains of Sup35 involved
Although we were able to separate the soluble oligomeric species from large aggregates in wild
type HSP104 cells, we originally identified these propagons in a point mutant of Hsp104. We could use
this mutant again to help identify domains and regions of Sup35 important for oligomer formation. For
example, we have seen that full-length Sup35 is capable of forming soluble propagons but what about the
PFD of Sup35 alone? Investigating the mechanism of Hsp104-R830S on distinct Sup35 domain deletion
or truncations mutants not only provides information about Sup35 regions involved in amyloid formation,
but also gives insight into the interaction between Hsp104 and Sup35. I would propose using a plasmid
shuffle technique to replace full-length Sup35 with various Sup35 deletions and truncations and
measuring the amount of soluble oligomers. Additionally, measuring the amount of infectious soluble
oligomers by protein transformation may provide insight into which regions of Sup35 are important in
forming infectious structures.
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Investigation of a “dead-end” substrate
In Figure 2.4, the sucrose gradient of lysates from hsp104-R830S cells showed that Sup35
species migrated just as far as Sup35 from the wild type cells. The difference between these species
was in their levels of infectivity. High molecular weight species from hsp104-R830S cells were not
infectious suggesting they might be examples of “dead-end” substrates or non-heritable amyloids. I
propose that these structures should be isolated as well and compared by structural techniques like EM
or sensitivity to denaturants or proteases to their counterparts in the wild type cells to determine
differences between infectious aggregates and non-infectious aggregates.

Conclusions
We found that soluble, prion-competent oligomers exist in wild type [PSI+] cells and are highly
infectious. These oligomers have mostly remained elusive because of their transient and unstable
nature. Here, we have identified a mutation in Hsp104 which propagates these oligomers allowing a
more stable system within which to investigate the structure and mechanism of these structures.

5.2 Hsp104 M-domain Future Directions
Summary
Hsp104 is composed of five functionally distinct domains that each contribute to the overall
function of the disaggregase chaperone. The middle domain (M-domain) is a coiled-coil whose position
in the hexamer has been a matter of much debate.

16-18

Recent studies have suggested that this domain

plays a role in regulating the function of the whole chaperone. The M-domain of ClpB was proposed to
alternate between two conformational states, repressed and de-repressed.

19

The repressed M-domain is

stabilized against the body of the hexamer through an interaction with the NBD1 of the neighboring
subunit. The de-repressed state, however, is unattached from the body of the hexamer and accessible to
co-chaperones. We found that mutations that were predicted to promote the repressed state inhibited
Hsp104 function. These mutations inhibited ATPase activity, disaggregation activity, and were not able to
form efficient hexamers. Conversely, mutations proposed to induce the de-repressed state stimulated
ATPase activity but exhibited reduced disaggregation activity. Interestingly, the mutants exhibited
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variation in their ability to propagate prions, suggesting that de-regulation of the function of the M-domain
can cause defects in yeast prion propagation.

The Interaction of the M-domain with Co-chaperones
One of the proposed roles for the M-domain of Hsp104 and ClpB is as a site for co-chaperone
interaction. Hsp104 and the co-chaperones, Hsp40 and Hsp70, often have opposing effects on [PSI+]
propagation. Perhaps, then, reducing or increasing the levels of co-chaperones may complement the
defects in [PSI+] propagation observed from these M-domain mutants. A comprehensive genetic
experiment to delete (or reduce in the case of the essential chaperones) or overexpress each cochaperone with each mutant would enhance our knowledge of the interactions between the M-domain
and the co-chaperones as well as the role of Hsp70 chaperones in prion propagation.

Structural Studies of M-domain mutants
As yet, no evidence has been reported on the movement of the M-domain of Hsp104 and
whether it can actually alternate between the repressed and de-repressed states similar to what has been
reported for ClpB.

19

One way to investigate this question would be to create cysteine mutants of the

predicted pairs and perform both cross-linking and FRET studies. Both methods would provide
information on the interactions between the predicted residues and would provide evidence for the model
of alternating repressed and de-repressed conformations.

Hsp1040Y507D and [PSI+]
Despite repeated efforts, I was unable to isolate more than one cell that contained both Hsp104Y507D and [PSI+]. Clearly, antagonistic interactions of Hsp104-Y507D and [PSI+] led to toxicity but how
this occurs is unknown. One way to investigate this mechanism is by using a shutoff system, much like
the one we employed in Chapter 2. Expression of hsp104-Y507D in [PSI+] cells containing wild type
HSP104 is not toxic. Therefore, a plasmid with wild type HSP104 driven by a repressile promoter could
be used to maintain viability before adding the repressing agent, such as glucose for the galactose
promoter or doxycycline for the tetracycline-repressible promoter. As wild type Hsp104 is repressed, the
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activity of Hsp104-Y507D and [PSI+] in the cell could be investigated by numerous methods to look at the
Sup35 aggregates themselves or protein aggregation or defects in translation. Thus, this system could
be used to understand how co-expression of Hsp104-Y507D and [PSI+] are toxic.

Conclusions
From our data, we find that the function of the M-domain is very important for proper Hsp104
function. De-regulation of this domain can either cause a loss-of-function or a toxic gain-of-function.
Investigating the function of the M-domain will elucidate the mechanisms of disaggregation and ATPase
substrate stimulation in addition to co-chaperone interactions.

5.3 Low Hsp104 Activity Mutants Future Directions
Summary
The optimal activity of the molecular chaperone Hsp104 is dependent on several variables
including ATPase activity, hexamer formation, and ability to bind and translocate substrates. Mutations in
Hsp104 that inhibit these features often inhibit chaperone activity. As Hsp104 is essential for yeast prion
propagation, changes in Hsp104 expression or activity can have severe consequences for prion
maintenance. However, several conformational variants exist which are not as sensitive to changes in
Hsp104 activity. For example, the [PSI+] prion is cured by overexpression of Hsp104, but the [RNQ+]
prion is not. Clearly conformational features of the prion substrates play a role in their interaction with
Hsp104.
Here we show two novel mutants of Hsp104 which inhibit Hsp104 activity but are still capable of
propagating certain variants of both [PSI+] and [RNQ+]. These mutants have very low ATPase activity
and do not form stable hexamers and appear not to be functional. However, enough activity is
maintained for unstable prion propagation. What are the differences in requirements for prion and nonprion substrates in their interaction with Hsp104? Furthermore, how are specific conformations
maintained but not others? The ability of Hsp104 to efficiently propagate some prion variants and not
others is a mechanism not well understood.
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Changes in Hsp104 activity alter propagation of specific variants
Classically, much of the mutational analysis done with Hsp104 has been focused on the [PSI+]
prion. And yet, the [PSI+] prion cannot form without the presence of [RNQ+] suggesting that the
interaction of Hsp104 with the [RNQ+] prion is as equally important. Many of the mutations that affect
Hsp104 ATPase activity or disaggregation activity should be re-evaluated in the context of [RNQ+] and
variants of [RNQ+] which show differences in their ability to induce [PSI+]. Furthermore, variants of
[PSI+] exist that are more susceptible to changes in Hsp104 activity and the interaction of Hsp104 with
these weak variants should be further investigated.

Conclusions
Investigating how different aggregated structures respond to changes in Hsp104 activity will
elucidate mechanisms of protein disaggregation. Furthermore, structural studies of the substrates of
Hsp104 will provide insight into why some structures appear dominant or more likely to aggregate. All in
all, investigating the interaction between Hsp104 and various substrates will provide insight into the
physical characteristics of protein folding.
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The formation and maintenance of prions in the yeast Saccharomyces cerevisiae is highly regulated by the cellular chaperone
machinery. The most important player in this regulation is Hsp104p, which is required for the maintenance of all known
prions. The requirements for other chaperones, such as members of the Hsp40 or Hsp70 families, vary with each individual
prion. [RNQ+] cells do not have a phenotype that is amenable to genetic screens to identify cellular factors important in prion
propagation.Therefore, we used a chimeric construct that reports the [RNQ+] status of cells to perform a screen for mutants
that are unable to maintain [RNQ+].We found eight separate mutations in Hsp104p that caused [RNQ+] cells to become [rnq-].
These mutations also caused the loss of the [PSI+] prion. The expression of one of these mutants, Hsp104p-E190K, showed
differential loss of the [RNQ+] and [PSI+] prions in the presence of wild type Hsp104p. Hsp104p-E190K inefficiently propagated
[RNQ+] and was unable to maintain [PSI+]. The mutant was unable to act on other in vivo substrates, as strains carrying it
were not thermotolerant. Purified recombinant Hsp104p-E190K showed a reduced level of ATP hydrolysis as compared to
wild type protein. This is likely the cause of both prion loss and lack of in vivo function. Furthermore, it suggests that [RNQ+]
requires less Hsp104p activity to maintain transmissible protein aggregates than Sup35p. Additionally, we show that the L94A
mutation in Rnq1p, which reduces its interaction with Sis1p, prevents Rnq1p from maintaining a prion and inducing [PSI+].

Introduction
Prions are proteins that can form a self-propagating aggregated
state. In mammals, prions are a causative agent of neurodegenerative disease.1 In yeast, however, prions act as an epigenetic mode
of inheritance. The prion-forming proteins in yeast are involved
in a variety of cellular processes, including nitrogen catabolism,
translation termination and chromatin modification.2-4 One
of the yeast prions, [PSI+], provides a potential mechanism to
respond to environmental stresses.5-8 Interestingly, [PSI+] is regulated by another prion, [RNQ +], whose presence increases the
rate of [PSI+] appearance.9-12 However, [RNQ +] is not required
for the maintenance of [PSI+]. Thus, the maintenance of [RNQ +]
is critical for the formation of [PSI+] and its adaptive effect on
the cells.
The maintenance of yeast prions is regulated by the cellular
chaperone machinery.13,14 A crucial player in this regulation is the
AAA+ ATPase Hsp104p that is essential for the survival of acute
heat shock.15,16 Hsp104p is a disaggregase and has been shown
to dissociate aggregated proteins both in vivo and in vitro.15,17,18

Like its bacterial homolog ClpB, the active form of Hsp104p is
a ring-shaped hexamer with a pore in the center.19 Interestingly,
Hsp104p can be divided up into five functionally distinct
domains. Although the N terminus is generally dispensable for
function, the amino and carboxy termini are likely involved
in substrate binding.20,21 The two nucleotide binding domains
(NBDs) coordinate to hydrolyze ATP to ADP and this enzymatic activity is required for Hsp104p function in prion maintenance.22-25 Finally, the M domain lies between the two NBDs and
is thought to coordinate the activities of the NBDs by propagating a conformational change in response to binding or hydrolysis
of ATP.23,26,27 Due to the discrete nature of the domains, a variety
of mutations have been described in each domain of Hsp104p
that affect prion propagation.20,25,28-31
One model of Hsp104p function in prion biology posits
that Hsp104p has two roles in prion maintenance: generation
of transmissible material (seeds) from prion aggregates and
conversion of monomer into a prion-competent form.17,32-34 A
complete loss of Hsp104p activity eliminates (cures) all known
yeast prions.3,4,11,25,35 However, increasing Hsp104p activity by
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Here, we describe a screen for cellular factors that affect the
propagation of the [RNQ +] prion. Using a chimeric reporter for
the [RNQ +] status of the cell, we found several novel alleles of
HSP104 that are unable to propagate both [RNQ +] and [PSI+].
Interestingly, one of the alleles shows differential rates of curing of [RNQ +] and [PSI+] in the presence of wild type Hsp104.
Additionally, we show that Rnq1p-L94A, which has a decreased
interaction with Sis1p, aggregates non-specifically and cannot
support [PSI+] induction.
Results

Figure 1. RRP reporter reveals [rnq-] cells after EMS mutagenesis. (A)
[RNQ+] cells carrying the RRP reporter were mutagenized with EMS to
approximately 14% viability and plated on YPD to assess color nonsense
suppression of ade1-14. Left panel shows colonies prior to EMS treatment
while right panel shows colonies after EMS treatment. (B) Solubility of
Rnq1p in mutagenized cells. Following EMS mutagenesis, the red colonies
were lysed and the lysate was fractionated into soluble and insoluble
components by ultracentrifugation. The total (T), soluble (S) and insoluble
pellet (P) were subjected to SDS-PAGE, transferred to PVDF and probed
with an anti-Rnq1p antibody. The strain is indicated above the blot with
[RNQ+] and [rnq-] controls shown on the left. An example of a mutagenized strain that remained [RNQ+], Red4, and one that converted to [rnq-],
Red8, are shown.

overexpressing the disaggregase cures only the [PSI+] prion and
does not affect [RNQ +] or any other yeast prion.3,4,9,11,25,35 This
indicates that Hsp104p has both general effects on all known
yeast prions and specific effects on the [PSI+] prion, at least when
overexpressed.
Other members of the cellular chaperone machinery also
show differential effects on prion propagation. For example,
overexpression of the Hsp70 family member Ssa1p cures [URE3]
but not [PSI+].36 Excess Ssa1p does, however, reduce the curing
of [PSI+] by Hsp104p overexpression and promote [PSI+] formation.37,38 Overexpression of the Hsp40 member Ydj1p cures the
[URE3] prion but affects only certain variants of [PSI+] and
[RNQ +].35,39,40 Deletion of either of two different Ssa1p nucleotide
exchange factors, SSE1 or FES1, cures [URE3] but not [PSI+],
though the deletion of SSE1 weakens [PSI+]-mediated nonsense
suppression.41,42 Moreover, Hsf1p, which regulates the expression of heat shock proteins, influences [PSI+] formation. Hsf1p
contains two activation domains and deletion of the N-terminal
activation domain inhibits [PSI+] formation while deletion of the
C-terminal activation domain promotes [PSI+] formation.43 This
suggests two classes of interaction with [PSI+] by proteins regulated by Hsf1p.
Rnq1p has been shown to interact with both Ssa1p and the
Hsp40 family member Sis1p.44,45 The propagation of [RNQ +] can
be abolished by mutations within Sis1p.33,44,46,47 Sis1p depletion
cures [RNQ +], [PSI+] and [URE3], albeit with varying efficiency,
which may indicate different requirements for its activity in prion
maintenance.48
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EMS mutagenesis reveals genes necessary for the maintenance
of [RNQ +]. We developed a system to identify cellular factors
important in the propagation of [RNQ +]. The phenotypes associated with [RNQ +], insolubility of the Rnq1 protein and an
increase in the induction rate of [PSI+], are not amenable for use
in a high-throughput screen. Therefore, we used the RRP reporter
to assay the [RNQ +] status of the cells. As described previously,50
RRP consists of a fusion of the Rnq1p prion forming domain
(PrD) and the C-terminal translation termination domain of
Sup35p. In [rnq- ] cells, RRP is soluble and able to promote faithful termination of translation. In [RNQ +] cells, RRP aggregates
and is unable to promote faithful translation termination. We
used a strain that has the ade1-14 allele for a sensitive readout of
nonsense suppression. This allele harbors a premature stop codon
that is read through when RRP is aggregated. Therefore, [rnq- ]
cells expressing RRP are adenine auxotrophs and appear red on
rich medium (YPD) due to the accumulation of an intermediate in the adenine biosynthesis pathway. [RNQ +] cells expressing
RRP are adenine prototrophs and appear light pink on YPD.
We used EMS to create an unbiased set of mutants that are
unable to maintain [RNQ +]. A strain that was light pink due to
expression of RRP in a [RNQ +] background was mutagenized
with EMS to approximately 14% viability and plated on YPD.
Following plating on YPD, some of the colonies turned red, indicating a deficiency in adenine biosynthesis, possibly as a consequence of the loss of RRP-associated nonsense suppression (Fig.
1A). Of the approximately 150,000 colonies screened, 312 colonies turned red on YPD. These 312 colonies were re-plated onto
YPD to determine if the red phenotype was stable. 40 of these
colonies remained red following two passages on YPD, indicating a stable phenotype.
The red phenotype created by the EMS mutagenesis could
result not only from the loss of the [RNQ +] prion but also from
a variety of different mutations affecting adenine biosynthesis or translation termination. Therefore, we wanted to select
those red mutants that had, in fact, converted from [RNQ +] to
[rnq- ]. The solubility of the Rnq1 protein was analyzed by western
blot following high speed centrifugation of cell lysates. In [rnq- ]
cells, Rnq1p remains in the soluble fraction while in [RNQ +] cells
Rnq1p is found in the insoluble fraction. The solubility of Rnq1p
in the 40 stable red colonies was assayed. Of these 40 mutants, 14
showed soluble Rnq1p, indicating that [RNQ +] had been cured
(Fig. 1B and data not shown).
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Genetic linkage indicates the [rnq- ] phenotype is caused
by single mutations. Next, we assessed the genetic properties of
the red mutants. We mated the 14 [rnq- ] mutants to a wild type
[RNQ +] strain. We then assayed the solubility of Rnq1p in the
resulting diploids as described above. Three of the diploids showed
soluble Rnq1p, indicating that the diploids were [rnq- ] and that
the mutant phenotype was dominant over wild type (data not
shown). The remaining eleven mutants had insoluble Rnq1p in
the diploids, indicating that [RNQ +] was propagating in the cells
and that the mutations were recessive (data not shown).
To determine if the loss of [RNQ+] was caused by a single genetic
lesion we employed a genetic test. The [RNQ+] diploids generated
above were sporulated to obtain haploid progeny. Single mutations
should segregate in a 2:2 ratio and produce two [rnq- ] cells and two
[RNQ+] cells. Multiple mutations would create a variety of ratios
due to random segregation. The haploid progeny acquired from
the sporulation of the recessive mutants were analyzed for their
[RNQ+] status using the solubility assay described above. Eight of
the recessive mutants generated the 2:2 ratio of [rnq- ] to [RNQ+]
cells, indicating a single mutation (Fig. 2A and data not shown).
The remaining three mutants showed other ratios of [RNQ+] to
[rnq- ] haploid progeny, suggesting that multiple mutations had possibly been acquired.
Due to the ability of the three dominant mutations to cure
[RNQ +] in the diploid, all four haploid progeny will be [rnq- ],
regardless of whether the phenotype is caused by one or more
loci. However, the haploids can then be backcrossed to a wild
type, [RNQ +], haploid strain and the [RNQ +] status of the resulting diploids analyzed. Single gene traits should produce a 2:2
ratio of [RNQ +] diploids to [rnq- ] diploids. The haploid progeny
from the dominant mutants were analyzed in this manner. Only
one of the dominant mutations produced the 2:2 ratio indicative
of a single gene trait (Fig. 2B). One of the dominant mutants
failed to sporulate and, therefore, could not be analyzed in this
manner, while the third produced variable ratios indicative of a

Figure 2. Curing of the [RNQ+] prion is caused by mutation at a single
genetic locus. (A) Biochemical analysis of recessive mutations that cure
[RNQ+]. The red [rnq-] cells carrying recessive mutations created by EMS
were mated to a strain carrying wild type Rnq1p in the [RNQ+] state. The
resulting diploids were sporulated and the solubility of the Rnq1 protein
from individual haploids was analyzed as described in the legend of Figure
1. A single representative tetrad is shown. A minimum of eight tetrads
were tested for each mutant. (B) Analysis of dominant mutation that cure
[RNQ+]. The red [rnq-] cells carrying dominant mutations created by EMS
were mated to a strain carrying wild type Rnq1p in the [RNQ+] state. The
resulting diploid was sporulated and haploid progeny of this cross were
then backcrossed to strains carrying wild type Rnq1p in the [RNQ+] state.
The resulting diploids from these matings were lysed and fractionated
as above. Three tetrads were tested and a single representative tetrad is
shown.

multi-locus trait. We chose to focus on the mutants whose phenotypes were caused by alteration of a single locus.
Missense mutations in HSP104 cure [RNQ +]. We set out
to identify the specific mutations that cured the [RNQ +] prion.
Since inactivation of the cellular disaggregase Hsp104p is known
to cure all yeast prions it was an obvious candidate for our

Figure 3. The EMS-induced mutations that cure [RNQ+] are in HSP104. (A) HSP104 was deleted in the mutant strains as indicated in the methods. The
resulting Dhsp104 strains were mated to a strain carrying wild type Rnq1p in the [RNQ+] state. The resulting diploids were sporulated and the solubility of
Rnq1p from individual haploids determined by well trap assay as described in Materials and Methods, transferred to PVDF and probed with an anti-Rnq1p
antibody. Two representative tetrads are shown. A minimum of four tetrads were tested for each mutant. (B) Diagram of mutations in Hsp104p that cure
[RNQ+]. The general domain structure of Hsp104p is indicated above the diagram. NTD, N-terminal domain; NBD1, nucleotide binding domain one; M
domain, middle domain; NBD2, nucleotide binding domain two; CTD, C-terminal domain. Mutations found in strains cured of [RNQ+] are indicated below the
diagram.
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Figure 4. The identified mutations in Hsp104p cure [PSI+]. Haploid [rnq-]
progeny from a cross between the mutant strains and a wild type strain
(SUP35) were mated to a wild type [PSI+] strain. The resulting diploids
were sporulated and the haploid progeny plated on YPD. Representative tetrads from four mutants are shown. Hsp104-E689K shows a 2:2
inheritance of [RNQ+] to [rnq-] colonies which is indicative of a recessive
trait. Hsp104p-A297T and Hsp104p-A502T also show a 2:2 inheritance.
Hsp104p-E190K shows a 0:4 inheritance of [RNQ+] to [rnq-] colonies
which indicates a dominant trait. A minimum of eight tetrads were
analyzed for each mutant.

mutants.3,4,11,25,35 To determine if our mutants were in Hsp104p,
we deleted the HSP104 gene in each of our mutants. The resulting Dhsp104 mutants were then mated to a [RNQ +] strain. These
diploids were sporulated and the [RNQ +] status of the haploid
progeny was assessed by a Rnq1p well-trap assay (Fig. 3A and
data not shown). For this assay, lysates from the haploid cells were
resuspended in sample buffer containing 1% SDS and incubated
at room-temperature. Insoluble Rnq1p in [RNQ +] strains resists
solubilization by SDS and does not enter the separating gel when
subjected to electrophoresis, but soluble Rnq1p enters the gel and
can be detected by western blot. All of the HSP104 deletions produced a 2:2 ratio of [RNQ +] to [rnq- ] haploids, indicating that
the mutations caused by EMS were in HSP104.
We sequenced HSP104 from each of the mutant strains and
found that eight of the single gene mutants carried a single missense mutation in the gene while one carried a nonsense mutation
(Fig. 3B). The missense mutations found were as follows: A178T,
E190K, A297T, A502T, G619D, A660T, E689K and T726I. The
G619D mutant was dominant for the curing of [RNQ +]. Of these
mutations, T726I, has been previously described.26 Additionally,
a different mutation in G619, G619V, has also been described
and both T726I and G619V have been shown to affect prion
maintenance.26,28,54 The other mutations found in this screen are
novel.
HSP104 missense mutations cure [PSI +]. Because Hsp104p
is also required for the propagation of [PSI+], we tested whether
the mutations also affected the [PSI+] prion. In order to isolate
haploids containing both the HSP104 mutation and SUP35, we
mated the original mutant strain which contained the mutant
HSP104 and RRP to a [RNQ +] strain that contained wild type
HSP104 and SUP35. We used western blot analysis to identify
spores containing wild type Sup35p that had become [rnq- ] due
to the presence of the mutant HSP104 (data not shown). RRP
is recognized by polyclonal antibodies raised against Sup35p
and can easily be distinguished from wild type Sup35p by its
larger size. The [rnq- ] strains carrying wild type Sup35p will also
carry the HSP104 mutation. We then backcrossed these strains
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to a [PSI+] [RNQ +] strain. We dissected the resulting diploids
and analyzed the degree of nonsense suppression of their haploid progeny in order to determine their [PSI+] status (Fig. 4 and
data not shown). Each of the mutants that cured [RNQ +] was
also able to cure [PSI+], indicating that the mechanism of curing
by the mutants is not specific to [RNQ +] but likely affects prion
propagation in general. Surprisingly, Hsp104p-E190K, which
was recessive for the curing of [RNQ +], appeared to be dominant for the curing of [PSI+] (Fig. 4). All of the other mutations
showed the same dominant or recessive effects on the curing of
both [RNQ +] and [PSI +].
Hsp104p-E190K cures [RNQ +] slowly in the presence of
wild-type Hsp104p. To further investigate the E190K mutation,
the mutant strain was recreated by the pop-in/pop-out method
in an unmutagenized version of 74-D694. Interestingly, initial
results indicated that HSP104-E190K was dominant for curing
[PSI+] but recessive for curing [RNQ +]. Further analysis, however, suggested that [RNQ +] was cured in a dominant fashion as
well. We hypothesized that Hsp104p-E190K was less efficient at
curing [RNQ +] than [PSI+] in the presence of wild type Hsp104p.
Two other mutations of Hsp104, P557L and L462R, are known
to cure [PSI+] but not [RNQ +].29 Of these two, Hsp104p-L462R
looked cured by the lack of Rnq1p-GFP fluorescent foci but was
confirmed [RNQ +] by SDD-AGE and mating to [rnq- ]. Therefore,
Hsp104p-L462R was suggested to weaken or destabilize [RNQ +]
but not cure it.29 To determine if Hsp104p-E190K was similar
to either of these two mutants, we transformed haploid [RNQ +]
cells expressing wild type Rnq1p with a plasmid that expresses
Hsp104p Hsp104p-E190K. We then tested the transformants for
the [RNQ +] prion by well-trap assay. Of the 24 transformants
tested, all but two had become [rnq- ] (Fig. 5A). The two remaining [RNQ +] transformants were grown in selective medium for
22 generations and then retested for soluble Rnq1p (Fig. 5B).
Both had become [rnq- ]. This is consistent with our hypothesis
that Hsp104-E190K shows inefficient curing of [RNQ +] in the
presence of wild type Hsp104p.
In order to gain more insight into the slow curing of [RNQ +]
by Hsp104p-E190K, we looked at the effect of Hsp104p-E190K
on prion strain variants of [RNQ +]. Three strain variants of
[RNQ +] have been identified that induce [PSI+] with differing
frequencies.40 The three [RNQ +] variants we used were previously
characterized as low, medium and high [PIN+] ([PSI+] inducibility) and are so named for their increasing ability to induce [PSI+]
in the presence of moderate overexpression of Sup35p. We transformed haploid cells of low, medium and high [PIN+] with a plasmid expressing Hsp104p, Hsp104p-E190K, or a vector control.
We then immediately analyzed the transformants that grew for
the state of [RNQ +] by a solubility assay (Fig. 5C). Contrary to a
previous report that showed differences in the amount of soluble
Rnq1p in these variants, our vector control revealed that all three
variants had only insoluble Rnq1p.40 This discrepancy could be
due to the difference in the solubility assays with which Rnq1p
was measured but our assay consistently shows no soluble Rnq1
protein in the lysates from these strain variants. As expected,
overexpression of Hsp104p did not cure [RNQ +] in any of the
variants. Interestingly, the expression of Hsp104p-E190K in the
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presence of wild type Hsp104p resulted in significant Rnq1 protein in the soluble pools of the three variants. In the low [PIN+]
strain, the majority of the protein had shifted to the soluble pool
while in the high [PIN+] strain, the majority of Rnq1p stayed in
the insoluble fraction. In the medium [PIN+] strain, the distribution between soluble and insoluble was approximately equal.
Thus, the efficiency of [RNQ +] curing by Hsp104p-E190K is
dependent on the strain variant of [RNQ +].
Hsp104p-E190K does not support thermotolerance. Since
our data suggest that there is a difference in handling various substrates by Hsp104p-E190K, we next asked whether the
mutant was defective in recognition and processing of other substrates in vivo. As Hsp104p is required for resistance to lethal
heat shock, we tested whether the strain carrying the Hsp104pE190K mutant was thermotolerant. Strains expressing either
wild type Hsp104p, Hsp104p-E190K, or no Hsp104p at all were
first exposed to a sublethal heat stress (37°C) to induce HSP104
expression and then exposed to a lethal heat stress (50°C). Strains
expressing wild type Hsp104p were able to recover from a 20
minute heat shock while the Dhsp104 strains showed significant
cell death (Fig. 6). The strain expressing Hsp104p-E190K was
also unable to survive lethal heat stress and appeared similar to
the deletion (Fig. 6). This indicates that the in vivo function of
Hsp104p in resolubilizing essential proteins aggregated by heat
stress is compromised by the E190K mutation.
E190K forms hexamers but has a defect in ATP hydrolysis. As the maintenance of prions is closely tied to the levels of
Hsp104p, we wanted to determine if the steady state expression
of the Hsp104p-E190K mutant is similar to that of wild type.
Lysates from logarithmically growing cells were analyzed by western blot using an antibody against Hsp104p. Hsp104p-E190K
was expressed to a similar level as wild type Hsp104p (Fig. 7A).
To determine the reason why Hsp104p-E190K is unable to
support prion propagation and is defective in protecting the cells
from heat stress, we examined two biochemical properties of
Hsp104p, hexamer formation and ATPase activity. To test the
ability of Hsp104p-E190K to form hexamers, we expressed and
purified recombinant wild type Hsp104p and Hsp104p-E190K
from E. coli. Purified protein was analyzed by size exclusion
chromatography under conditions that promote hexamer formation.54 The mutant protein eluted in a similar volume as both the
wild type Hsp104 protein and a 670 kDa standard, indicating
that under these conditions, the mutant is able to form hexamers
(Fig. 7B and data not shown).
Given that Hsp104p-E190K forms hexamers, we wanted to
see whether it is able to hydrolyze ATP as efficiently as the wild
type protein. To test this, the purified protein was incubated with
a fixed concentration of ATP. At various time points, the amount
of free Pi produced by the hydrolysis of ATP to ADP was measured. While Hsp104p-E190K did show hydrolysis of ATP, it did
not hydrolyze ATP as well as wild type Hsp104p (Fig. 7C). This
provides a likely explanation for its defect in both thermotolerance and prion propagation.
Rnq1p-L94A is unable to propagate the [RNQ +] prion.
Our screen uncovered novel mutations in Hsp104p but failed to
uncover other novel factors required for the maintenance of the
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Figure 5. E190K cures [RNQ+] slowly in the presence of wild type
Hsp104p. (A) Well-trap assays of cells containing both wild type Hsp104p
and the E190K mutant. A strain carrying wild type Hsp104p was
transformed with a plasmid expressing the E190K mutant. Lysate from
individual transformants was subjected to a well trap assay as detailed in
Materials and Methods, transferred to PVDF membrane, and blotted with
an anti-Rnq1p antibody. (B) Strains carrying both wild type Hsp104p and
the Hsp104p-E190K mutant lose [RNQ+] over time. The strains from (A)
that remained [RNQ+] were grown in selective media for the number of
generations indicated (# gen), lysed, and the [RNQ+] status was determined
by [RNQ+] solubility assay as described in Materials and Methods. (C)
The rate of [RNQ+] curing differs among [PIN+] prion strain variants. The
strain variants of [RNQ+] (high, med, low [PIN+]) which have endogenous
wild type Hsp104p were transformed with an empty plasmid (Vector) or
a plasmid containing either wild type Hsp104p (WT) or Hsp104p-E190K
(E190K). Transformants were scraped off plates, lysed and subjected to a
full solubility assay as described in Materials and Methods, transferred to
PVDF membrane and blotted with an anti-Rnq1p antibody. Three separate
transformations were analyzed and all showed similar results. Total, T;
soluble, S; insoluble pellet, P.

[RNQ +] prion. Had our screen been to saturation, we would have
predicted it to reveal point mutations in SIS1, which is required
for [RNQ +] propagation, as well as mutations in RNQ1 itself that
abolish prion propagation. The domains of Sis1p required for
the propagation of [RNQ +] have been described.44 We recently
performed a screen for mutations in Rnq1p that disrupt prion
propagation with the same RRP reporter and [RNQ +] dependent
phenotype used here.50 Interestingly, we identified mutations
that allow [RNQ +] to propagate but affect the ability of [RNQ +]
to induce [PSI+]. None of those mutations affected the interaction with Sis1p, however, as detected by co-immunoprecipitation
(Bardill JP and True HL, unpublished data). Recently, one binding site for Sis1p on Rnq1p was identified and a mutation in
Rnq1p that severely reduces the interaction with Sis1p has been
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Figure 6. Hsp104p-E190K does not allow for the yeast to recover from acute heat shock. Following 30 minutes of pre-treatment at 37°C, liquid cultures
containing identical numbers of cells of the indicated genotypes were heat-shocked at 50°C for the time indicated. Following heat shock, the cells were serially diluted and spotted onto YPD.

described.58 We created this mutation in Rnq1p, L94A, to ask
whether the alteration in the interaction with Sis1p at this site
would affect the propagation of the [RNQ +] prion.
We created the L94A mutation in a Rnq1p-expressing plasmid and analyzed its ability to maintain the [RNQ +] prion.
Expression from the native RNQ1 promoter was undetectable
by western blot, so we used a GPD promoter which produced
Rnq1p-L94A at steady state levels approximately equal to wild
type Rnq1p (data not shown). This plasmid was used to replace
wild type Rnq1p by plasmid shuffle in either a [RNQ +] or [rnq- ]
cell. The solubility of the Rnq1p-L94A mutant was then assayed.
Wild type Rnq1p fractionates into either the insoluble or soluble
fraction when shuffled through a [RNQ +] or [rnq- ] strain, respectively (Fig. 8A). Rnq1p-L94A also fractionated into the insoluble
fraction when shuffled through a [RNQ +] strain. However, the
mutant was also insoluble when shuffled through a [rnq- ] strain,
indicating that the aggregation of Rnq1p-L94A is non-specific
(Fig. 8A). Furthermore, we crossed the strain carrying Rnq1pL94A to a [rnq- ] strain and found that the haploid progeny carrying the wild type RNQ1 remained [rnq- ] (data not shown). This
suggests that the aggregates from the mutant L94A strain were
unable to transmit the aggregate structure and are thus not prionlike. We also tested the ability of Rnq1p-L94A to induce [PSI+].
Following overexpression of Sup35p, cells containing Rnq1pL94A showed a severe reduction in the ability to induce [PSI+]
(Fig. 8B). These data indicate that the interaction of Rnq1p with
Sis1p is important for the maintenance of the [RNQ +] prion as
well as [PSI+] induction.
Figure 7. Hsp104-E190K is deficient in hydrolyzing ATP but not in forming hexamers. (A) Expression analysis of Hsp104p-E190K. Lysate from
strains grown to an OD600 of 1.0 were normalized by Bradford analysis,
subjected to SDS-PAGE, transferred to PVDF and blotted with an antiHsp104p antibody. Equal loading was confirmed by probing the same blot
with anti-Pgk1p antibody. (B) Hsp104p-E190K forms hexamers. Recombinant purified Hsp104-E190K was run through a Sephacryl S-300 column in
the presence of ATP. Fractions were collected and analyzed by SDS-PAGE
followed by western blot with anti-Hsp104p and the bands quantified by
densitometry. The percent of total protein in each fraction was calculated.
The positions of eluted standards are indicated above the graph. The
molecular weight of the standards is thyroglobulin-670 kDa (T), catalase-250 kDa (C), bovine serum albumin-66 kDa (B). (C) ATP hydrolysis by
Hsp104p-E190K. The assays were performed in buffer A at 37°C. At various time points the amount of free Pi in the reaction of either Hsp104p
(circles) or Hsp104p-E190K (squares) was calculated as compared to a
standard of KH2PO4 concentrations.
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Discussion
Here we describe six novel mutations within HSP104 that cure
both the [RNQ+] and [PSI+] prions. Five of these mutations are
located in one of the nucleotide binding domains and one was
found in the M domain. One of the Hsp104p mutants, E190K,
displays differential kinetics for curing [PSI+] and [RNQ+] in the
presence of wild type Hsp104p. Furthermore, Hsp104p-E190K
shows varying kinetics within [RNQ+] variants that suggests
Hsp104 may function differently in different prion strain variants. Hsp104p-E190K is unable to support thermotolerance on its
own and shows reduced ATPase activity, suggesting that [RNQ+]
requires less Hsp104p activity to propagate the prion state than
[PSI+].
To our knowledge this represents the first screen for cellular
factors that affect [RNQ +] propagation. The phenotypes typically
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associated with the [RNQ +] prion, aggregation of Rnq1p and
[PSI+] inductions, are not readily amenable to large scale screens.
However, as the nonsense suppression of RRP is dependent on
the cells being [RNQ +],50 it constitutes an excellent system to
screen for factors that affect [RNQ +] propagation.
Our screen for mutants that are unable to propagate [RNQ +]
only uncovered mutations within HSP104. Hsp104p is the only
known protein required for the propagation of all known yeast
prions.3,4,11,25,35 Furthermore, over thirty different mutations have
been discovered in Hsp104p that affect prion propagation.20,25,28-31
These mutations are found throughout the protein and may interfere with Hsp104p activity at a variety of different steps including
substrate recognition, hexamer formation and nucleotide hydrolysis. Thus, there are many targets within Hsp104p that can be
altered and cause the loss of prion propagation. Generally, the
mutations that cure [PSI+] cause the cells to lose the thermotolerance phenotype. However, this is not always a complete loss of
thermotolerance.28 This indicates that thermotolerance and prion
propagation are genetically separable.
The majority of the mutants found in this screen were in either
NBD1 (A178T, E190K, A297T) or NBD2 (G619D, A660T,
E689K, T726I). A loss of ATPase activity from either of these
domains or the inability to form hexamers generally results in
defects in the propagation of [PSI+]. Of the two domains, NBD1
appears to provide the majority of the ATPase activity required
for disaggregation activity.23,59 While NBD2 has a low rate of
hydrolysis, nucleotide binding to NBD2 regulates the formation
of hexamers as well as the rate of hydrolysis of NBD1.22-24 As an
example of the importance of these two domains, the K218T and
K620T mutations which lie within the Walker A motifs of NBD1
and NBD2, respectively, have been shown previously to impair
ATPase activity.54 Thus, in our screen the mutants in NBD1 and
NBD2 likely alter the ATPase activity or oligomerization ability
of the protein to produce the loss of prion phenotypes. This conclusion is supported by the decreased rate of ATP hydrolysis of
Hsp104p-E190K as compared to wild type Hsp104p.
The final mutation we identified was in the M domain (A502T).
Deletions within this middle domain abrogate the function of
Hsp104p27 as this domain likely plays a role in transducing the
allosteric signal from NBD2 to NBD1. Thus, the A502T mutation we identified likely disrupts the coordination between the
domains, reducing the ATPase activity and inhibiting the overall
disaggregation ability of the protein. Interestingly, the mutation
A503V has differential effects on [PSI+] and [RNQ +].60 It causes
toxicity in [PSI+] strains and affects aggregate size but does not
affect [RNQ +] propagation.60
Due to its differential effects on curing [RNQ +] and [PSI+] in
the presence of wild type Hsp104, we extended our analysis of the
E190K mutant. While it is competent to form hexamers, it shows
significantly decreased ATPase activity in vitro as compared to
wild type Hsp104. The in vivo function of the mutant is also
compromised as it cannot support thermotolerance. Given that
it appeared to have no defect in hexamer formation, the mutant
likely forms mixed hexamers with wild type Hsp104p. This
mixed hexamer may have enough activity to temporarily propagate [RNQ +] but not [PSI+]. Our data indicate that aggregates
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Figure 8. Rnq1p-L94A aggregates but does not maintain [RNQ+] or
facilitate [PSI+] induction. (A) Rnq1p-L94A was expressed as the only copy
of Rnq1p in either a [RNQ+] or [rnq-] strain by plasmid shuffle. Lysate from
these strains were fractionated into total (T), soluble (S) and insoluble
pellet (P) by high speed centrifugation and subjected to SDS-PAGE. A
western blot was performed with anti-Rnq1p antibody. [RNQ+] status of
original plasmid shuffle strain is indicated to the left of the blot. (B) Wild
type Rnq1p was replaced with Rnq1p-L94A by plasmid shuffle in a [RNQ+]
strain. The plasmid-shuffled strain was transformed with a plasmid that
overexpresses Sup35p and plated on YPD. [PSI+] was scored by the appearance of light pink sectoring on the colonies. Three independent transformants were scored for [PSI+] induction. Approximately 200 colonies
were analyzed for each and a total of four [PSI+] colonies were obtained.
The graph indicates the percentage of sectoring cells with wild type set
to 100%. Error bars indicate standard error of at least three separate
replicates.

of Rnq1p may require less Hsp104p activity to propagate than
aggregates of Sup35p. Interestingly, too much Hsp104p activity cures [PSI+ ] but not [RNQ + ].11,25 Thus, [RNQ + ] appears
to persist through a broader range of Hsp104 activities. This
may be one reason why [RNQ + ] cells are found in nature while
[PSI+ ] cells are not.61 Allowing [RNQ + ] to persist over a broader
range of conditions may also benefit the yeast as the presence
of the [RNQ + ] prion dramatically increases the appearance of
[PSI+ ].10-12,62 Further investigations into the different regulation
of yeast prions will lead to a better understanding of their biological function.
In further characterizing the effect of E190K on [RNQ +] by
looking at the high, medium and low [PIN+] variants, we found
that the mixed hexamers of wild type and Hsp104p-E190K differ in their ability to recognize and/or propagate the [RNQ +]
variants. Previous data suggests that medium and low [PIN+]
have different aggregate structures than high [PIN+].63 While
Hsp104p-E190K is not the first Hsp104p mutant to show differential curing of [PSI+] and [RNQ +],29 it is the first Hsp104
mutant that demonstrates a difference in recognition between
the variants of [RNQ +]. Interestingly, the overexpression of the
Hsp40 co-chaperone Ydj1p showed differential curing of the
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[RNQ +] strain variants, suggesting that the whole chaperone network is involved in recognizing distinct structures.40
Another Hsp40, Sis1p, is essential for the propagation of
[RNQ +] and interactions between Sis1p and Rnq1p have been
proposed to generate the infectious seeds required for [RNQ +]
propagation.33,44 The Rnq1p-L94A mutation dramatically
reduces the ability of Rnq1p to bind Sis1p but does not completely abolish binding.58 Our data indicate that the reduction in
Sis1p binding prevents the protein from effectively maintaining
a prion. It appears that Rnq1p-L94A aggregates non-specifically,
indicating that the interaction with Sis1p promotes the formation
of ordered aggregates. These non-specific aggregates are unable to
induce [PSI+], suggesting the aggregation of Rnq1p alone is not
sufficient to promote [PSI+] induction.
Materials and Methods
Strain and plasmid construction. All S. cerevisiae strains were
derived from 74-D694. Standard culturing and manipulation
techniques were used for both yeast and Escherichia coli.49 Yeast
strains were grown in either a rich medium, YPD (1% yeast
extract, 2% peptone, 2% glucose), or a synthetic medium (0.67%
yeast nitrogen base, 2% glucose) lacking the appropriate amino
acids to select for plasmids. Haploid spores were generated from
diploid parents and isolated by micromanipulation.
RRP has been described previously.50 pPROEx Htb Hsp104
has previously been described.21 A fragment containing the E190K
mutation was amplified using the oligonucleotides 5'-TTC TTT
CAA AGG CAC CAT CC and 5'-CGG GAT CCA CCC TTG
AAT CGA ATC AGC A. This product was digested with BglII
and EcoRI and ligated into a BglII/EcoRI fragment of pPROEx
Htb Hsp104 to generate pPROEx Htb Hsp104-E190K. HSP104
was cloned into pRS316,51 by digesting pPROEx Htb Hsp104
with BamHI and XhoI and ligated into a BamHI/XhoI fragment
of pRS316. Sequence carrying the E190K mutation was excised
from pPROEx Htb Hsp104-E190K on a BglII and EcoRI fragment and ligated into a cognate fragment of pRS316-Hsp104 or
pRS306-Hsp104 to create pRS316-Hsp104-E190K and pRS306Hsp104-E190K, respectively. Single mutants were also cloned
with bridge PCR. The N-terminus of RNQ1 was amplified with
the oligonucleotide 5'-GGG GAT ATC ATG GAT ACG GAT
AAG TTA ATC TCA GAG G-3' and an oligonucleotide specific
to the mutant. The reverse complement of the mutant specific
oligonucleotide was then used along with the oligonucleotide
5'-CCC GTC GAC TCA GTA GCG GTT CTG GTT GCC
G-3' to amplify the C-terminus of RNQ1. This produced full
length RNQ1 carrying the desired mutation which was digested
with EcoRV and SalI and ligated into pRS313 that contained the
RNQ1 promoter on an EcoRV/EcoRI fragment and the RNQ1
terminator on a SalI/XhoI fragment. For GPD-Rnq1-L94A, an
EcoRV/SalI fragment was removed from the pRS313-Rnq1-L94A
mutant and cloned into a EcoRV/SalI fragment of p413-GPD.
EMS mutagenesis. Overnight cultures of [RNQ +] cells
expressing RRP were washed twice in 50 mM potassium phosphate buffer pH 7.0 and then resuspended in buffer. The cells
were normalized to 5 x 107 cells/ml and incubated with ethyl
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methyl sulfonate (EMS) at a final concentration of 3% (v/v).
Mutagenesis was halted at various time points by the addition of
an equal volume of 10% Na 2S2O3. The treated cells were extensively washed with H2O and their viability was determined by
plating assay. A culture with approximately 14% viable cells was
plated on YPD to assess color.
Analysis of [RNQ +] status. The [RNQ +] status of the cells
was biochemically assessed in one of two ways.52 For a full
solubility assay, yeast cells were lysed with glass beads in buffer containing 100 mM Tris-HCl pH 7, 200 mM NaCl, 1 mM
ethylendiaminetetraacetic acid (EDTA), 5% glycerol, 0.5 mM
dithiothreitol (DTT), 50 mM N-ethylmaleimide (NEM), 3 mM
phenylmethanesulphonylfluoride (PMSF) and complete Mini
protease inhibitor cocktail (Roche). Following lysis, an equal volume of RIPA buffer (50 mM Tris-HCl pH 7, 200 mM NaCl, 1%
Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl
sulfate (SDS)) was added to the lysate and cell debris was cleared
by a brief centrifugation. This cleared lysate is the total protein.
Insoluble protein was pelleted by centrifugation at 80,000 RPM
(27,000 xg) in a Beckman TLA-100 rotor for 30 minutes. The
supernatant containing the soluble protein was removed and
the pellet was resuspended in a 1:1 mix of lysis buffer and RIPA
buffer. Total, supernatant and pellet fractions were subjected to
SDS-PAGE, transferred to PVDF membranes and probed with
an anti-Rnq1p antibody.
Well trap assays were performed as previously described.52
Cells were lysed with glass beads in buffer containing 50 mM
Tris-HCL pH 7.5, 50 mM KCl, 10 mM MgCl2 and 5% glycerol
supplemented with an anti-protease solution (Sigma), 10 mM
PMSF, 50 mM NEM. Lysate was incubated in sample buffer
(100 mM Tris-Cl pH 6.8, 1% SDS, 10% glycerol, 0.1% bromophenol blue) for seven minutes at room temperature. Treated
lysates were subjected to SDS-PAGE, transferred to PVDF and
blotted with an anti-Rnq1p antibody.
Thermotolerance assays. Thermotolerance assays were
performed as previously described.53 Equal numbers of yeast cells
in logarithmic growth were resuspended in liquid medium. The
resuspended cells were pretreated at 37°C for 30 minutes and
then shifted to 50°C for various periods of time. Following heat
shock, the cells were incubated on ice for 2 minutes. The cells
were then serially diluted and spotted onto YPD.
Hsp104p purification. His6 -Hsp104p and His6 -Hsp104pE190K were expressed and purified from E. coli BL21(DE3)
as previously described.21 Polyhistidine-tagged Hsp104p and
Hsp104-E190K were isolated by affinity chromatography on
Ni-NTA sepharose. The histidine tag was cleaved with TEV
protease and the untagged protein further purified by anion
exchange chromatography. The fractions were analyzed by SDSPAGE, pooled and frozen at -80°C.
ATPase activity assay. Characterization of Hsp104 ATPase
activity was performed in Buffer A (40 mM Tris, pH 7.5, 175
mM NaCl, 5 mM MgCl2, 0.02% Triton X-100) as reported.54
The reactions were performed at 37°C with either 1 μg Hsp104p
or 5 μg Hsp104-E190K and 5 mM ATP (Sigma). At various time
points during the reaction, Malachite Green Reagent was added
to the reaction tube to quantify the amount of free Pi and the
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color development was stopped by the addition of citric acid. The
A650 of the sample was determined and the absorbance units calibrated against a standard of known concentrations of KH2PO4.
Each time point was done three independent times and the mean
± standard deviation was calculated.
Gel filtration chromatography. Gel filtration was performed
as previously described.55 Two milligrams of purified Hsp104p
or Hsp104p-E190K were incubated for 5 minutes on ice with
Buffer B (40 mM Tris-HCL, pH 8.0, 15 mM NaCl, 5 mM
MgCl2, 10 mM ATP) before loading onto Sephacryl S-300 High
Resolution resin (Amersham Biosciences). The column was
equilibrated in Buffer B and was run at 4°C at a flow rate of
0.05 mL/min. Fractions (5 mL) were collected and analyzed for
the presence of Hsp104 by western blot using an antibody probe
against Hsp104p. Resolved bands were quantified using Image J.
Molecular weights of Hsp104p and Hsp104p-E190K were estimated by comparison of their elution profiles with the following standards: thyroglobulin Mr 670,000; catalase Mr 250,000;
bovine serum albumin Mr 66,000.
[PSI +] induction assays. [PSI+] induction assays were performed as described previously.50 Plasmid shuffled strains containing the Rnq1p mutants were transformed with a Ura-marked
plasmid carrying SUP35 (pSUP2,56) and plated on selective media
for both plasmids. Individual transformants were grown in selective media to OD600 ~1.6 and plated on YPD. After five days of
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